var title_f12_21_12624="Faces pain scale";
var content_f12_21_12624=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PC%2F67351&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=0\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PC%2F67351&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=0\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 589px\">",
"   <div class=\"ttl\">",
"    Faces pain scale",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 569px; height: 135px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Schematic representation of the faces pain scale, rated from 0 to 6 left to right.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Bieri, D, Reeve, RA, Champion, GD, et al. Pain 1990; 41:139. Copyright &copy; 1990 with permission from Elsevier Science.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f12_21_12624=[""].join("\n");
var outline_f12_21_12624=null;
var title_f12_21_12625="Lomefloxacin: International drug information";
var content_f12_21_12625=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Lomefloxacin: International drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"list fbnlist drugH1Div drugBrandNames\" id=\"F4151757\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     International Brand Names",
"    </span>",
"    <ul>",
"     <li>",
"      Bareon (JP);",
"     </li>",
"     <li>",
"      Chimono (IT);",
"     </li>",
"     <li>",
"      Decalogiflox (FR);",
"     </li>",
"     <li>",
"      Logiflox (FR);",
"     </li>",
"     <li>",
"      Lomef (IN);",
"     </li>",
"     <li>",
"      Lomeflon (JP);",
"     </li>",
"     <li>",
"      Maxaquin (BR, CH, EC, IT, PT);",
"     </li>",
"     <li>",
"      Okacin (AR, AT, BE, CH, DE, DK, IT, LU, PL);",
"     </li>",
"     <li>",
"      Ontop (IN);",
"     </li>",
"     <li>",
"      Uniquin (AT, IT, PT)",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list synlist drugH1Div drugBrandNames\" id=\"F4151758\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Index Terms",
"    </span>",
"    <ul>",
"     <li>",
"      Lomefloxacin Hydrochloride",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list_set htclist drugH1Div drugBrandNames\" id=\"F4151759\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacologic Category",
"    </span>",
"    <ul>",
"     <li>",
"      <span class=\"list-set-name\">",
"       Antibiotic, Quinolone",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block iuse drugH1Div\" id=\"F4151760\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Reported Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Acute bacterial exacerbation of chronic bronchitis caused by susceptible gram-negative organisms; urinary tract infections (uncomplicated and complicated) caused by susceptible organisms; surgical prophylaxis (transrectal prostate biopsy or transurethral procedures)",
"    </p>",
"   </div>",
"   <div class=\"block idos drugH1Div\" id=\"F4151762\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Range",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Adults: Oral: 400 mg once daily",
"    </p>",
"   </div>",
"   <div class=\"block prod-avail drugH1Div\" id=\"F11821113\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Product Availability",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Product available in various countries; not currently available in the U.S.",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F4151763\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Tablet: 400 mg",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 10492 Version 28.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1003-122.72.76.133-CAE5397922-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f12_21_12625=[""].join("\n");
var outline_f12_21_12625=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F4151757\">",
"      International Brand Names",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F4151758\">",
"      Index Terms",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F4151759\">",
"      Pharmacologic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F4151760\">",
"      Reported Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F4151762\">",
"      Dosage Range",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F11821113\">",
"      Product Availability",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F4151763\">",
"      Dosage Forms",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_INT/10492\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_INT/10492|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f12_21_12626="Interactive diabetes case 4: Uncontrolled diabetes in a 51-year-old man on insulin and two oral agents";
var content_f12_21_12626=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Interactive diabetes case 4: Uncontrolled diabetes in a 51-year-old man on insulin and two oral agents",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?12/21/12626/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?12/21/12626/contributors\">",
"     Lloyd Axelrod, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?12/21/12626/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?12/21/12626/contributors\">",
"     David M Nathan, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?12/21/12626/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?12/21/12626/contributors\">",
"     Jean E Mulder, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?12/21/12626/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Jan 29, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     CASE",
"    </span>",
"    &nbsp;&mdash;&nbsp;A 51-year-old construction worker seeks your advice because of frequent hypoglycemic reactions.",
"   </p>",
"   <p>",
"    Three years ago the patient was diagnosed with type 2 diabetes following six months of polyuria, blurred vision and weight loss. He had lost 40 pounds, from 225 to 185 pounds. He was treated with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?7/48/7944?source=see_link\">",
"     metformin",
"    </a>",
"    1000 mg by mouth twice a day. The blood glucose values on treatment improved from the low 300s to the low 200s, and he regained about 10 pounds of weight.",
"   </p>",
"   <p>",
"    About one year ago the blood glucose values rose to the mid 200s, the patient was tired all the time and his weight fell again, this time to 180 pounds. Nine months ago",
"    <a class=\"drug drug_general\" href=\"UTD.htm?39/28/40391?source=see_link\">",
"     glipizide",
"    </a>",
"    5 mg by mouth every morning before breakfast was added to his regimen with no improvement in the blood glucose levels. Six months ago, the dose of glipizide was increased to 10 mg before breakfast and, two weeks later, to 10 mg before breakfast and supper, again with no improvement in metabolic control.",
"   </p>",
"   <p>",
"    Four months ago, NPH insulin was added, initially 10 units twice a day, before breakfast and supper, with progressive increases in dose to 35 units before breakfast and 10 units before supper. His weight increased again, this time to 210 pounds. He is checking his blood glucose levels twice daily, before each of his doses of NPH insulin. You review his glucose diary. The glucose values are variable. Before breakfast, the glucose values range from 130 to 240",
"    <span class=\"nowrap\">",
"     mg/dL",
"    </span>",
"    (7.2 to 13.3",
"    <span class=\"nowrap\">",
"     mmol/L),",
"    </span>",
"    before supper the values are 60 to 90",
"    <span class=\"nowrap\">",
"     mg/dL",
"    </span>",
"    (3.3 to 5",
"    <span class=\"nowrap\">",
"     mmol/L),",
"    </span>",
"    occasionally just over 100",
"    <span class=\"nowrap\">",
"     mg/dL",
"    </span>",
"    (5.6",
"    <span class=\"nowrap\">",
"     mmol/L).",
"    </span>",
"    He has symptoms of hypoglycemia about three times a week, between 11 AM and noon, usually related to omission of his morning snack and increased physical activity at work. (He is also very active on weekends, playing and teaching hockey.) Occasionally he also has a reaction in the afternoon at work. Two months ago he had a severe reaction at work with loss of consciousness in the afternoon.",
"   </p>",
"   <p>",
"    The patient eats three meals a day with snacks in the midmorning and at 2 PM. He saw a nutritionist and was advised to control portion size and avoid concentrated sweets. He did not learn how to count carbohydrates. The A1C was 8.80 percent four months ago, and 5.9 percent one month ago. The patient's weight is 210 pounds, and at 5' 7\" his body mass index is 33. He has hypertension treated with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?0/58/937?source=see_link\">",
"     lisinopril",
"    </a>",
"    10 mg every morning, and hypercholesterolemia treated with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?34/37/35417?source=see_link\">",
"     atorvastatin",
"    </a>",
"    10 mg by mouth every evening. His mother, age 85 years, has had type 2 diabetes since her late 70s.",
"   </p>",
"   <p>",
"    What is your assessment and plan?",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      You decide that the patient probably has type 2 diabetes based on his clinical presentation, the positive family history of type 2 diabetes and the presence of other features of the metabolic syndrome, including obesity, hypertension, and hypercholesterolemia. You advise him to adjust his insulin to reflect his glucose values. You decrease the morning dose of NPH to 25 units to reduce or eliminate afternoon hypoglycemia, increase the evening dose of NPH to 14 units before supper to control the morning hyperglycemia, explain the benefits of counting carbohydrates, and refer him to a nutritionist. You anticipate the need for further adjustments in insulin. (See",
"      <a class=\"medical medical_answer\" href=\"UTD.htm?12/21/12626-a1?source=see_link\">",
"       \"Interactive diabetes case 4: Uncontrolled diabetes in a 51-year-old man on insulin and two oral agents - A1\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      You conclude that the variability of blood glucose values and the occurrence of hypoglycemia late in the day on small doses of insulin for a patient with type 2 diabetes raise the possibility latent autoimmune diabetes in adults (LADA). You advise him to adjust his insulin to reflect his glucose values. You decrease the morning dose of NPH to 25 units to reduce or eliminate afternoon hypoglycemia, increase the evening dose of NPH to 14 units before supper to control the morning hyperglycemia, explain the benefits of counting carbohydrates, and refer him to a nutritionist. You anticipate the need for further adjustments in insulin. You order anti-islet antibodies (GAD and IA-2 [glutamic acid decarboxylase and islet antigen 2, respectively] antibodies). (See",
"      <a class=\"medical medical_answer\" href=\"UTD.htm?12/21/12626-a2?source=see_link\">",
"       \"Interactive diabetes case 4: Uncontrolled diabetes in a 51-year-old man on insulin and two oral agents - A2\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      You decide that the patient probably has type 2 diabetes based on his clinical presentation, the positive family history of type 2 diabetes and the presence of other features of the metabolic syndrome, including obesity, hypertension and hypercholesterolemia. You advise him to increase his caloric intake at lunch and in the afternoon to reduce or eliminate hypoglycemia late in the day. (See",
"      <a class=\"medical medical_answer\" href=\"UTD.htm?12/21/12626-a3?source=see_link\">",
"       \"Interactive diabetes case 4: Uncontrolled diabetes in a 51-year-old man on insulin and two oral agents - A3\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      You decide that the patient probably has type 2 diabetes based on his clinical presentation, the positive family history of type 2 diabetes, and the presence of other features of the metabolic syndrome, including obesity, hypertension, and hypercholesterolemia. In view of the variability of his BS values before breakfast, you advise him to use a sliding scale for the morning NPH insulin dose, as follows: for BS &lt;100 take 20 units, for BS 101 to 200 take NPH 25 units, for BS 201 to 300 take 35 units. You do not change the afternoon dose of insulin. You explain the benefits of counting carbohydrates, and refer him to a nutritionist. (See",
"      <a class=\"medical medical_answer\" href=\"UTD.htm?12/21/12626-a4?source=see_link\">",
"       \"Interactive diabetes case 4: Uncontrolled diabetes in a 51-year-old man on insulin and two oral agents - A4\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 4263 Version 5.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1104-61.234.146.186-481C146FAB-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f12_21_12626=[""].join("\n");
var outline_f12_21_12626=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      CASE",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_answer\" href=\"UTD.htm?12/21/12626-a1?source=related_link\">",
"      Interactive diabetes case 4: Uncontrolled diabetes in a 51-year-old man on insulin and two oral agents - A1",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_answer\" href=\"UTD.htm?12/21/12626-a2?source=related_link\">",
"      Interactive diabetes case 4: Uncontrolled diabetes in a 51-year-old man on insulin and two oral agents - A2",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_answer\" href=\"UTD.htm?12/21/12626-a3?source=related_link\">",
"      Interactive diabetes case 4: Uncontrolled diabetes in a 51-year-old man on insulin and two oral agents - A3",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_answer\" href=\"UTD.htm?12/21/12626-a4?source=related_link\">",
"      Interactive diabetes case 4: Uncontrolled diabetes in a 51-year-old man on insulin and two oral agents - A4",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f12_21_12627="Malathion: Drug information";
var content_f12_21_12627=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Malathion: Drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   (For additional information",
"   <a class=\"drug drug_patient\" href=\"UTD.htm?11/5/11348?source=see_link\">",
"    see \"Malathion: Patient drug information\"",
"   </a>",
"   and",
"   <a class=\"drug drug_pediatric\" href=\"UTD.htm?10/23/10611?source=see_link\">",
"    see \"Malathion: Pediatric drug information\"",
"   </a>",
"   )",
"   <br/>",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F191126\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Ovide&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ex_sect_xr thclist drugH1Div drugBrandNames\" id=\"F191149\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacologic Category",
"    </span>",
"    <ul>",
"     <li>",
"      Antiparasitic Agent, Topical;",
"     </li>",
"     <li>",
"      Pediculocide;",
"     </li>",
"     <li>",
"      Scabicidal Agent",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block doa drugH1Div\" id=\"F191127\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Adult",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     <b>",
"      Head lice:",
"     </b>",
"     Topical:  Apply sufficient amount to cover and thoroughly moisten dry hair and scalp; shampoo after 8-12 hours. If required, repeat with second application in 7-9 days. Further treatment is generally not necessary.",
"    </p>",
"   </div>",
"   <div class=\"block dop drugH1Div\" id=\"F191139\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Pediatric",
"    </span>",
"    <p>",
"     (For additional information",
"     <a class=\"drug drug_pediatric\" href=\"UTD.htm?10/23/10611?source=see_link\">",
"      see \"Malathion: Pediatric drug information\"",
"     </a>",
"     )",
"    </p>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Children &ge;6 years: Refer to adult dosing. Use is contraindicated in neonates and infants.",
"    </p>",
"   </div>",
"   <div class=\"block doe drugH1Div\" id=\"F191128\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Geriatric",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Refer to adult dosing.",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F191116\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Lotion, topical: 0.5% (59 mL)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Ovide&reg;: 0.5% (59 mL) [contains isopropyl alcohol 78%]",
"    </p>",
"   </div>",
"   <div class=\"block geq drugH1Div\" id=\"F191107\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Generic Equivalent Available: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Yes",
"    </p>",
"   </div>",
"   <div class=\"block adm drugH1Div\" id=\"F191118\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Administration",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Topical lotion. For external use only; avoid contact with eyes. Apply to dry hair and scalp and rub gently until thoroughly moistened; pay special attention to the back of the head and neck. Allow hair to dry naturally; do not use heat; leave hair uncovered. After 8-12 hours, the hair should be washed with a nonmedicated shampoo; rinse and use a fine-toothed (nit) comb to remove dead lice and eggs. Evaluate other family members to determine if infested and require treatment. Wash hands immediately after use.",
"    </p>",
"    <p style=\"text-indent:0em;margin-top:2em;\">",
"     Malathion should be a portion of a whole lice removal program, which should include washing or dry cleaning all clothing, hats, bedding, and towels recently worn or used by the patient and washing combs, brushes, and hair accessories in hot water.",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F191117\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Topical treatment of",
"     <i>",
"      Pediculus capitis",
"     </i>",
"     (head lice and their ova)",
"    </p>",
"   </div>",
"   <div class=\"block ars drugH1Div\" id=\"F191147\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions Significant",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Frequency not defined.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Dermatologic: Chemical burns (including second-degree burns), skin/scalp irritation, stinging sensations",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Ocular: Conjunctivitis (following contact with eyes)",
"    </p>",
"   </div>",
"   <div class=\"block coi drugH1Div\" id=\"F191120\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Contraindications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Hypersensitivity to malathion or any component of the formulation; use in neonates and/or infants",
"    </p>",
"   </div>",
"   <div class=\"block war drugH1Div\" id=\"F191110\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warnings/Precautions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Concerns related to adverse effects:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Dermatologic effects: Discontinue use temporarily if skin irritation occurs. Chemical burns, including second-degree burns, and stinging sensations may occur with use.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Special populations:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Pediatrics: Use under direct adult supervision in children &ge;6 years of age.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Other warnings/precautions:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Appropriate use: For topical use on scalp hair only; leave hair uncovered after application (allow hair to dry naturally). Avoid contact with eyes; flush immediately with water if eye contact occurs. Wash hands after application.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Flammable: Lotion is flammable; do not expose lotion or hair wetted with malathion to open flames or electric heat sources (eg, hair dryer, curling iron, flat iron). Do not smoke while applying lotion or while hair is wet.",
"    </p>",
"   </div>",
"   <div class=\"block cyt drugH1Div\" id=\"F13299642\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Metabolism/Transport Effects",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     None known.",
"    </p>",
"   </div>",
"   <div class=\"block dri drugH1Div\" id=\"F6221440\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Drug Interactions",
"    </span>",
"    <br/>",
"    <br/>",
"    <div class=\"lexi\" id=\"lexiInteractAddInfo\">",
"     (For additional information:",
"     <a class=\"dip\" href=\"./drug-interaction\" target=\"_blank\">",
"      Launch Lexi-Interact&trade; Drug Interactions Program",
"     </a>",
"     )",
"    </div>",
"    <div class=\"lexi\" id=\"lexiInteractImgB\">",
"     <img border=\"0\" height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"    <p style=\"text-indent:0em;display:inline\">",
"     There are no known significant interactions.",
"    </p>",
"   </div>",
"   <div class=\"block prf drugH1Div\" id=\"F191113\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Risk Factor",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     B (",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?16/42/17068\">",
"      show table",
"     </a>",
"     )",
"    </p>",
"   </div>",
"   <div class=\"block pri drugH1Div\" id=\"F191123\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Implications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Teratogenic effects were not observed in animal reproduction studies.",
"    </p>",
"   </div>",
"   <div class=\"block lac drugH1Div\" id=\"F13704327\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Lactation",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Excretion in breast milk unknown/use caution",
"    </p>",
"   </div>",
"   <div class=\"block brc drugH1Div\" id=\"F13704328\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Breast-Feeding Considerations",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     It is unknown if the malathion 0.5% lotion formulation is excreted in breast milk. Use with caution if administered to or handled by breast-feeding mothers.",
"    </p>",
"   </div>",
"   <div class=\"block fee drugH1Div\" id=\"F191122\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pricing: U.S. (Medi-Span&reg;)",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Lotion",
"     </b>",
"     (Malathion External)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     0.5% (59 mL): $156.45",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Lotion",
"     </b>",
"     (Ovide External)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     0.5% (59 mL): $187.62",
"    </p>",
"   </div>",
"   <div class=\"list fbnlist drugH1Div drugBrandNames\" id=\"F5539890\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     International Brand Names",
"    </span>",
"    <ul>",
"     <li>",
"      A-Lices 1% (HK, MY, NZ, PH, SG);",
"     </li>",
"     <li>",
"      Derbac-M (IE, NZ);",
"     </li>",
"     <li>",
"      Lice Care (SG);",
"     </li>",
"     <li>",
"      Lice Rid (AU);",
"     </li>",
"     <li>",
"      Malation (EE, NO);",
"     </li>",
"     <li>",
"      Malthionex (LU);",
"     </li>",
"     <li>",
"      Olicide (PT);",
"     </li>",
"     <li>",
"      Organoderm (DE);",
"     </li>",
"     <li>",
"      Prioderm (AE, BE, BF, BH, BJ, CH, CI, CY, DK, EG, ET, FI, FR, GH, GM, GN, IE, IL, IQ, IR, JO, KE, KW, LB, LR, LU, LY, MA, ML, MR, MU, MW, NE, NG, NL, NO, OM, QA, SA, SC, SD, SE, SL, SN, SY, TN, TZ, UG, YE, ZA, ZM, ZW);",
"     </li>",
"     <li>",
"      Quellada-M (GB);",
"     </li>",
"     <li>",
"      Radikal (BE, LU);",
"     </li>",
"     <li>",
"      Sinpar (UY)",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <div class=\"reference\">",
"      &ldquo;Drugs for Parasitic Infections,&rdquo;",
"      <i>",
"       Med Lett Drugs Ther",
"      </i>",
"      , 1993, 35(911):111-22.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?12/21/12627/abstract-text/8246830/pubmed\" id=\"8246830\" target=\"_blank\">",
"        8246830",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Frankowski BL and Bocchini JA Jr, &ldquo;Head Lice,&rdquo;",
"      <i>",
"       Pediatrics",
"      </i>",
"      , 2010, 126(2):392-403.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?12/21/12627/abstract-text/20660553/pubmed\" id=\"20660553\" target=\"_blank\">",
"        20660553",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 9584 Version 33.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-125.39.66.147-B2407C6BAC-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f12_21_12627=[""].join("\n");
var outline_f12_21_12627=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F191126\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F191149\">",
"      Pharmacologic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F191127\">",
"      Dosing: Adult",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F191139\">",
"      Dosing: Pediatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F191128\">",
"      Dosing: Geriatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F191116\">",
"      Dosage Forms: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F191107\">",
"      Generic Equivalent Available: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F191118\">",
"      Administration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F191117\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F191147\">",
"      Adverse Reactions Significant",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F191120\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F191110\">",
"      Warnings/Precautions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13299642\">",
"      Metabolism/Transport Effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F6221440\">",
"      Drug Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F191113\">",
"      Pregnancy Risk Factor",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F191123\">",
"      Pregnancy Implications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13704327\">",
"      Lactation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13704328\">",
"      Breast-Feeding Considerations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F191122\">",
"      Pricing: U.S. (Medi-Span&reg;)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F5539890\">",
"      International Brand Names",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/9584\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/9584|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"UTD.htm?11/5/11348?source=related_link\">",
"      Malathion: Patient drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"UTD.htm?10/23/10611?source=related_link\">",
"      Malathion: Pediatric drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f12_21_12628="Flail mitral valve four chamber echocardiogram";
var content_f12_21_12628=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic2\" style=\"width: 1040px;\">",
"  <div class=\"videoplayer\" h264=\"./images/CARD/60709/4chfmitv_conv.mp4?title=Flail+mitral+valve+four+chamber+echocardiogram\" style=\"width:320px;height:256px\">",
"  </div>",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Flail mitral valve",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 271px; height: 430px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The four chamber view from a 2-D echocardiogram shows a flail posterior mitral valve leaflet which has exaggerated motion in diastole and prolapses into the left atrial during systole. There is a bright echo seen at the tip of the valve, suggesting papillary muscle rupture as the etiology. Enlargement of the left atrium and ventricle is present, suggesting significant mitral regurgitation.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Thomas Binder, MD. University of Vienna.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f12_21_12628=[""].join("\n");
var outline_f12_21_12628=null;
var title_f12_21_12629="Eletriptan: Patient drug information";
var content_f12_21_12629=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"drugTitle\">",
"   Eletriptan: Patient drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <p>",
"    (For additional information",
"    <a class=\"drug drug_general\" href=\"UTD.htm?41/29/42452?source=see_link\">",
"     see \"Eletriptan: Drug information\"",
"    </a>",
"    )",
"   </p>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F164501\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Relpax&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F855134\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Relpax&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt war-os drugH1Div\" id=\"F10021452\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warning",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700568",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       A very bad and sometimes deadly health problem called serotonin syndrome may happen. The risk may be greater if you take this drug with certain other drugs. Call your doctor right away if you have dizziness, very bad headache, agitation, hallucinations, fever, fast heartbeat, a heartbeat that does not feel normal, flushing, seizures, shakiness, sweating a lot, change in balance, change in thinking clearly and with logic, very bad upset stomach and throwing up, or very bad loose stools.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700602",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Sometimes drugs are not safe when you take them with certain other drugs. Taking them together can cause bad side effects. This is one of those drugs. Be sure to talk to your doctor about all the drugs you take.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yya-os drugH1Div\" id=\"F10021454\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What is this drug used for?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691956",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat migraine headaches.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt coi-os drugH1Div\" id=\"F10021453\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I need to tell my doctor before I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2702014",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an allergy to eletriptan or any other part of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705171",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are allergic to any drugs, foods, or other substances. Tell your doctor about the allergy and what signs you had, like rash; hives; itching; shortness of breath; wheezing; cough; swelling of face, lips, tongue, or throat; or any other signs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2703479",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any of these health problems: Chest pain or pressure, heart disease, very bad liver disease, pain in your legs while walking, poor blood flow, poor bowel blood flow, stroke, or very high blood pressure.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701342",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are using this drug to stop you from getting migraine headaches.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2703859",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have taken certain drugs used for low mood (depression) like isocarboxazid, phenelzine, or tranylcypromine or drugs used for Parkinson's disease like selegiline or rasagiline in the last 14 days. Taking this drug within 14 days of those drugs can cause very bad high blood pressure. Talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2703847",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have taken almotriptan, frovatriptan, naratriptan, rizatriptan, sumatriptan, or zolmitriptan in the last 24 hours.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2703853",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have taken dihydroergotamine, ergotamine, or methysergide in the last 24 hours.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yye-os drugH1Div\" id=\"F10021458\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some things I need to know or do while I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697290",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have liver disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696717",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Check all drugs you are taking with your doctor. This drug may not mix well with some other drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s4128402",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you drink grapefruit juice or eat grapefruit often, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696618",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Avoid beer, wine, or mixed drinks.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697753",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Use care if you have risks for heart disease (high blood pressure, high cholesterol, overweight, high blood sugar (diabetes), cigarette smoking, man older than 40 years of age, other family members with early heart disease, woman after change of life). Talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697641",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are pregnant or plan on getting pregnant. You will need to talk about the benefits and risks of using this drug while you are pregnant.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697636",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are breast-feeding. You will need to talk about any risks to your baby.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyf-os drugH1Div\" id=\"F10021459\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects of this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698051",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Feeling dizzy. Rise slowly over a few minutes when sitting or lying down. Be careful climbing.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698272",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Upset stomach or throwing up. Many small meals, good mouth care, sucking hard, sugar-free candy, or chewing sugar-free gum may help.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698027",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Dry mouth. Good mouth care, sucking hard, sugar-free candy, or chewing sugar-free gum may help. See a dentist often.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyh-os drugH1Div\" id=\"F10021461\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects that I need to call my doctor about right away?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698721",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you think there has been an overdose, call 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center (file://www.aapcc.org), or emergency room (ER) right away.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699066",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698640",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Trouble breathing.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698625",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Chest pain or pressure, a fast heartbeat, or passing out.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699058",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Change in thinking clearly and with logic.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699057",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Big change in balance.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698599",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Agitation, twitching, sweating, or muscle stiffness.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699112",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very nervous and excitable.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699042",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very upset stomach or throwing up.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698619",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Change in strength on 1 side is greater than the other, trouble speaking or thinking, change in balance, or blurred eyesight.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699030",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad headache or if headache is not better after the first dose.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699006",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad belly pain or bloody loose stools.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698988",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Numbness or tingling in your hands or feet.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699086",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Sudden change in eyesight, eye pain, or irritation.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698603",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any rash.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698977",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Side effect or health problem is not better or you are feeling worse.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyc-os drugH1Div\" id=\"F10021456\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How is this drug best taken?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695914",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take with or without food. Take with food if it causes an upset stomach.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695208",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If your headache comes back after the first dose, 1 more dose may be taken 2 hours after the first one.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698544",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a diary of your headaches.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyd-os drugH1Div\" id=\"F10021457\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I do if I miss a dose?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696572",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       This drug is taken on an as needed basis.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyi-os drugH1Div\" id=\"F10021462\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How do I store and/or throw out this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699336",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store at room temperature.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699266",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store in a dry place. Do not store in a bathroom.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyj-os drugH1Div\" id=\"F10021463\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     General drug facts",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699675",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If your symptoms or health problems do not get better or if they become worse, call your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699673",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not share your drugs with others and do not take anyone else's drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699678",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep all drugs out of the reach of children and pets.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699709",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any questions about this drug, please talk with your doctor, pharmacist, or other health care provider.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s3302581",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       In Canada, take any unused drugs to the pharmacy. Also, visit file://www.hc-sc.gc.ca/hl-vs/iyh-vsv/med/disposal-defaire-eng.php#th to learn about the right way to get rid of unused drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       These are not all of the side effects that may occur. If you have questions about side effects, call your doctor. Call your doctor for medical advice about side effects.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699683",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with the doctor before starting any new drug, including prescription or OTC, natural products, or vitamins.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 12412 Version 36.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1104-122.72.76.133-9E6425AB09-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f12_21_12629=[""].join("\n");
var outline_f12_21_12629=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F164501\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F855134\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10021452\">",
"      Warning",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10021454\">",
"      What is this drug used for?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10021453\">",
"      What do I need to tell my doctor before I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10021458\">",
"      What are some things I need to know or do while I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10021459\">",
"      What are some side effects of this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10021461\">",
"      What are some side effects that I need to call my doctor about right away?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10021456\">",
"      How is this drug best taken?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10021457\">",
"      What do I do if I miss a dose?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10021462\">",
"      How do I store and/or throw out this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10021463\">",
"      General drug facts",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?41/29/42452?source=related_link\">",
"      Eletriptan: Drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f12_21_12630="Lichen planus PI";
var content_f12_21_12630=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PI%2F87024&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PI%2F87024&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 535px\">",
"   <div class=\"ttl\">",
"    Lichen planus",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 515px; height: 430px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Lichen planus can look different on different people and on different body parts.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f12_21_12630=[""].join("\n");
var outline_f12_21_12630=null;
var title_f12_21_12631="Junctional escape tutorial";
var content_f12_21_12631=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F53638&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F53638&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic2\" style=\"width: 1100px;\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Junctional escape rhythm",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 83px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Escape junctional beat or rhythm occurs when there is failure of impulse generation from the sinus node or atrial myocardium. The 4th and 5th beats of this tracing are junctional beats that are not preceeded by a P wave and occur after a pause that is longer than the underlying sinus cycle length.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
"  <div class=\"figure\" style=\"width: 456px\">",
"   <div class=\"ttl\">",
"    Sinus rhythm",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 456px; height: 103px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The normal P wave in sinus rhythm is slightly notched since activation of the right atrium precedes that of the left atrium. The P wave is upright in a positive direction in leads I and II. A P wave with a uniform morphology precedes each QRS complex. The rate is between 60 and 100 beats per minute and the cycle length is uniform between sequential P waves and QRS complexes. In addition, the P wave morphology and PR intervals are identical from beat to beat.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f12_21_12631=[""].join("\n");
var outline_f12_21_12631=null;
var title_f12_21_12632="Evaluation of the adult with acute wrist pain";
var content_f12_21_12632=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"   </img>",
"  </div>",
"  <div id=\"printHeaderText\">",
"   Official reprint from  UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"   <a href=\"file://www.uptodate.com\">",
"    www.uptodate.com",
"   </a>",
"   <br>",
"    &copy;2013 UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"   </br>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"4\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Evaluation of the adult with acute wrist pain",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?12/21/12632/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?12/21/12632/contributors\">",
"     Bruce C Anderson, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?12/21/12632/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?12/21/12632/contributors\">",
"     Karl B Fields, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?12/21/12632/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?12/21/12632/contributors\">",
"     Jonathan Grayzel, MD, FAAEM",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?12/21/12632/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Dec 17, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Of all the joints in the upper extremities, the wrist joint is most susceptible to injury. Falls onto an outstretched arm or direct blows to the wrist cause a spectrum of injuries, including simple sprain, scaphoid fracture, perilunate dislocation, or distal radius fracture. &nbsp;",
"   </p>",
"   <p>",
"    This topic review will provide an overview to acute wrist pain or injury in the adult. Subacute and chronic causes of wrist pain and specific wrist injuries are discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/52/20298?source=see_link\">",
"     \"Evaluation of the adult with subacute or chronic wrist pain\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?4/49/4886?source=see_link\">",
"     \"Overview of carpal fractures\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?21/13/21722?source=see_link\">",
"     \"Distal radius fractures in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/51/1848?source=see_link\">",
"     \"Scaphoid fractures\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?41/15/42230?source=see_link\">",
"     \"Clinical manifestations and diagnosis of carpal tunnel syndrome\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     ANATOMY AND BIOMECHANICS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The anatomy and biomechanics of the wrist are reviewed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?13/45/14039?source=see_link\">",
"     \"Anatomy and basic biomechanics of the wrist\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     ETIOLOGY AND PRESENTATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients who are experiencing a problem that is unique or intrinsic to the wrist present either with complaints of painful movement (eg, simple sprain, radiocarpal arthritis, scaphoid fracture), swelling that is localized (ganglion) or diffuse (extensor tenosynovitis or complex regional pain syndrome [reflex sympathetic dystrophy]), or changes in sensation aggravated by use of the wrist (carpal tunnel syndrome).",
"   </p>",
"   <p>",
"    In addition to the standard questions about pain (ie, onset, duration,",
"    <span class=\"nowrap\">",
"     palliation/provocation,",
"    </span>",
"    quality, location, and radiation), specific aspects of the history can be helpful in diagnosis. Questions about previous injuries and treatment, including past surgery, and about associated conditions, such as arthritis or diabetes, are important. To evaluate chronic wrist pain, the clinician should inquire about activities the patient performs frequently either at work (eg, typing) or leisure (eg, racquet sports).",
"   </p>",
"   <p>",
"    The degree of force and the position of the wrist during an acute injury determine the site of greatest impact and the structures most likely to be injured. As an example, a force loading the radial side of an extended, pronated wrist (eg, falling forward) is more likely to injure the scaphoid, while a force loading the ulnar side of an extended, supinated wrist (eg, falling back) is more likely to injure the triquetrum or lunate [",
"    <a class=\"abstract\" href=\"UTD.htm?12/21/12632/abstract/1,2\">",
"     1,2",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Pain patterns",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h3\">",
"     Dorsal wrist pain",
"    </span>",
"    &nbsp;&mdash;&nbsp;Dorsal wrist pain aggravated by flexion and extension is the most common wrist complaint. It is caused by injury to the ligaments surrounding the joint, the synovium, or the bony structures of the radiocarpal joint (",
"    <a class=\"graphic graphic_figure graphicRef78359 \" href=\"UTD.htm?26/34/27172\">",
"     figure 1",
"    </a>",
"    ). If these symptoms follow an injury (eg, a fall to an outstretched arm or direct blow), a comprehensive examination and radiographic studies are necessary to distinguish ligament injuries (simple sprain and perilunate dislocation) from more involved injuries to the articular cartilage (chondral fracture) and bones (scaphoid and distal radius fractures). &nbsp;",
"   </p>",
"   <p>",
"    Dorsal wrist pain aggravated by movement of the fingers and associated with dorsal swelling and inflammatory changes over the entire back of the wrist and hand is the characteristic presentation of the much less common extensor tenosynovitis. Focal dorsal pain in the region of the base of the thumb metacarpal may represent carpometacarpal joint osteoarthritis.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h3\">",
"     Dorsal wrist swelling",
"    </span>",
"    &nbsp;&mdash;&nbsp;Dorsal wrist swelling occurs much less commonly than wrist pain. Painless dorsal wrist swelling is the characteristic complaint of patients with a ganglion cyst (a small minority of patients can experience pain when the cyst places pressure on the adjacent tendons or the superficial branch of the radial nerve). Some dorsal ganglia can cause significant pain and yet remain virtually undetectable by palpation, the so-called occult dorsal ganglia. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?40/16/41223?source=see_link\">",
"     \"Ganglia and nodules\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Localized swelling of the radiocarpal joint is usually too subtle to be noticed. The dorsal swelling of tenosynovitis and of complex regional pain syndrome (reflex sympathetic dystrophy) extends from the wrist to the back of the hand. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?31/37/32344?source=see_link\">",
"     \"Etiology, clinical manifestations, and diagnosis of complex regional pain syndrome in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h3\">",
"     Paresthesias, hypesthesias, and volar pain",
"    </span>",
"    &nbsp;&mdash;&nbsp;Paresthesias and hypesthesias, particularly of the thumb and thenar eminence, aggravated by wrist movement or position are characteristic of median nerve compression from carpal tunnel syndrome (CTS) (",
"    <a class=\"graphic graphic_figure graphicRef59856 \" href=\"UTD.htm?1/28/1477\">",
"     figure 2",
"    </a>",
"    )&nbsp;(",
"    <a class=\"graphic graphic_figure graphicRef69097 \" href=\"UTD.htm?1/31/1527\">",
"     figure 3",
"    </a>",
"    ). Pain is generally located on the volar aspect of the wrist. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?41/15/42230?source=see_link\">",
"     \"Clinical manifestations and diagnosis of carpal tunnel syndrome\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Compression of the ulnar nerve in Guyon's canal, though far more uncommon than CTS, can occur as a result of trauma or pressure from redundant tissue, and can produce paresthesias and hypesthesias in the small and ring fingers. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/12/38089?source=see_link&amp;anchor=H19484196#H19484196\">",
"     \"Ulnar neuropathy at the elbow and wrist\", section on 'Sites of ulnar nerve lesions'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/12/38089?source=see_link&amp;anchor=H87963063#H87963063\">",
"     \"Ulnar neuropathy at the elbow and wrist\", section on 'Ulnar neuropathy at the wrist'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h3\">",
"     Wrist pain and grip weakness",
"    </span>",
"    &nbsp;&mdash;&nbsp;The combination of wrist pain and grip weakness is characteristic of de Quervain's tenosynovitis. The pain is generally located on the radial aspect of the wrist and reproduced with direct palpation of the involved tendons (",
"    <a class=\"graphic graphic_figure graphicRef56302 \" href=\"UTD.htm?41/25/42386\">",
"     figure 4",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/40/27270?source=see_link\">",
"     \"de Quervain's tenosynovitis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Although less common, injury to the triangular fibrocartilage complex and fracture of the hook of the hamate can also present with this combination of symptoms [",
"    <a class=\"abstract\" href=\"UTD.htm?12/21/12632/abstract/3\">",
"     3",
"    </a>",
"    ]. With these two injuries, pain is located on the ulnar aspect of the wrist (",
"    <a class=\"graphic graphic_figure graphicRef69097 \" href=\"UTD.htm?1/31/1527\">",
"     figure 3",
"    </a>",
"    )&nbsp;(see",
"    <a class=\"local\" href=\"#H16\">",
"     'Other traumatic injuries'",
"    </a>",
"    below). Arthritis of the base of the thumb (carpometacarpal arthritis) and other focal tendinopathies also may present with a combination of pain and grip weakness.",
"   </p>",
"   <p>",
"    Among active individuals, overuse of the wrist can result in tendinopathy, involving the common extensor tendon hood or specific extensor or flexor tendons. Generally, there is focal tenderness over the involved tendon, and pain is exacerbated by passive motion. Grip strength may be compromised due to pain.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h3\">",
"     Stiffness",
"    </span>",
"    &nbsp;&mdash;&nbsp;Morning stiffness is characteristic of rheumatoid arthritis, which typically presents with symmetrical joint symptoms. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?12/46/13033?source=see_link\">",
"     \"Clinical features of rheumatoid arthritis\"",
"    </a>",
"    .) Wrist stiffness may also be a feature of carpal tunnel syndrome. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?41/15/42230?source=see_link\">",
"     \"Clinical manifestations and diagnosis of carpal tunnel syndrome\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h1\">",
"     DIFFERENTIAL DIAGNOSIS",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Wrist trauma",
"    </span>",
"    &nbsp;&mdash;&nbsp;Injuries to the wrist represent a spectrum of conditions that include simple wrist sprain, perilunate dislocation, scaphoid fracture, and distal radius fracture. Often, these diagnoses are made by x-ray. Differentiating a sprain from a fracture by examination alone can be difficult, but in general sprains result in less swelling and less loss of motion than fractures (see below). Improperly treated ligamentous injuries or fractures can result in chronic carpal instability with concomitant pain and weakness.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h3\">",
"     Wrist sprain",
"    </span>",
"    &nbsp;&mdash;&nbsp;A sprained wrist is an injury to the supporting ligaments of the radiocarpal joint. Most sprains are associated with mild pain or stiffness and normal range of motion, although loss of flexion and extension can occur with more severe sprains. The majority of sprains resolve within two weeks with conservative therapy (ice, immobilization, gentle passive stretching exercises).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h3\">",
"     Scaphoid fracture",
"    </span>",
"    &nbsp;&mdash;&nbsp;The scaphoid (ie, navicular) is the most commonly injured carpal bone (",
"    <a class=\"graphic graphic_figure graphicRef78359 \" href=\"UTD.htm?26/34/27172\">",
"     figure 1",
"    </a>",
"    )&nbsp;(",
"    <a class=\"graphic graphic_figure graphicRef56302 \" href=\"UTD.htm?41/25/42386\">",
"     figure 4",
"    </a>",
"    ). Typically, there is a history of a blunt blow to the wrist or a fall forward onto an outstretched hand and wrist. The blood supply to the scaphoid is precarious, predisposing to the development of avascular necrosis or fracture nonunion. Furthermore, radiographic signs of a fracture may not be present on initial x-rays. Therefore, in the acute setting clinicians must assume a fracture is present and treat appropriately if there is any significant clinical suspicion of a scaphoid injury regardless of the absence of x-ray findings. Close follow-up is crucial to determine definitively if a fracture is present (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef75655 \" href=\"UTD.htm?12/45/13010\">",
"     image 1",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/51/1848?source=see_link\">",
"     \"Scaphoid fractures\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2174433\">",
"    <span class=\"h3\">",
"     Distal radius fracture",
"    </span>",
"    &nbsp;&mdash;&nbsp;Fracture of the distal radius typically occurs due to a fall onto an outstretched arm and hand. It commonly occurs in young patients and in the elderly, particularly those with osteoporosis. Although frequently referred to as Colles fractures, fractures of the distal radius are of several different types that may require different management. To avoid confusion, it is best to avoid the use of eponyms when communicating with a consultant and simply to describe the characteristics of the fracture. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?21/13/21722?source=see_link\">",
"     \"Distal radius fractures in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h3\">",
"     Scapholunate dissociation, lunate dislocation, and related injuries",
"    </span>",
"    &nbsp;&mdash;&nbsp;A fall back onto an outstretched, extended wrist that disrupts the supporting ligaments generally forces the carpal bones to shift dorsally. Both the direction of the traumatic forces and the relative weakness of the volar ligaments contribute to the dorsal displacement.",
"   </p>",
"   <p>",
"    Depending on the amount of force and the position of the wrist a range of possible injuries may occur. Among ligamentous injuries, the most common is disruption of the ligaments stabilizing the lunate and scaphoid, resulting in an abnormal relationship between these bones (often called scapholunate dissociation). With more forceful trauma, dissociation between the lunate and the capitate",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    triquetrum can occur.",
"   </p>",
"   <p>",
"    No specific symptoms are associated with scapholunate dissociation and complaints vary with the severity of injury [",
"    <a class=\"abstract\" href=\"UTD.htm?12/21/12632/abstract/4\">",
"     4",
"    </a>",
"    ]. Patients may complain of swelling and pain over the dorsoradial aspect of the wrist (overlying the scaphoid and lunate), grip weakness, and painful or decreased wrist motion. Tenderness over the scapholunate junction is common. The scaphoid shift test to detect ligamentous instability is described below. (See",
"    <a class=\"local\" href=\"#H37\">",
"     'Scaphoid shift test'",
"    </a>",
"    below.) An interosseous distance greater than 3 mm between the scaphoid and lunate on plain x-ray suggests a ligamentous injury (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef52517 \" href=\"UTD.htm?14/30/14816\">",
"     image 2",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    Greater force can displace the lunate, most often volarly (ie, lunate dislocation), or dislocate the bones around the lunate, most often dorsally (ie, perilunate dislocation) (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef58140 \" href=\"UTD.htm?23/15/23807\">",
"     image 3",
"    </a>",
"    and",
"    <a class=\"graphic graphic_diagnosticimage graphicRef77044 \" href=\"UTD.htm?31/25/32145\">",
"     image 4",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?12/21/12632/abstract/1\">",
"     1",
"    </a>",
"    ]. Such injuries generally result in pain and limited wrist motion, and they may cause compression of the median nerve. (See",
"    <a class=\"local\" href=\"#H20\">",
"     'Carpal tunnel syndrome'",
"    </a>",
"    below.) X-rays demonstrate that the normal linear alignment of the capitate, lunate, and radius has been disrupted. Scapholunate dissociation and related injuries are difficult to manage and should be referred to a hand surgeon.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h3\">",
"     Other traumatic injuries",
"    </span>",
"    &nbsp;&mdash;&nbsp;A hamate fracture generally results from a direct blow to the wrist or chronic repetitive strain, often secondary to racket sports. The hook of the hamate extends in a palmar direction. Fracture of the hook of the hamate is associated with tenderness in this area and weakness in grip strength. Routine radiographs often do not reveal the fracture; CT or bone scan may be necessary if the diagnosis is uncertain. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?9/25/9620?source=see_link\">",
"     \"Hamate fractures\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Kienb&ouml;ck's disease is the name used to describe avascular necrosis of the lunate. It generally follows episodes of repetitive microtrauma or an acute traumatic wrist injury that goes undiagnosed. Patients usually experience progressive wrist pain, loss of motion, and weakness. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/52/20298?source=see_link&amp;anchor=H5769646#H5769646\">",
"     \"Evaluation of the adult with subacute or chronic wrist pain\", section on 'Kienb&ouml;ck's disease of the lunate'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Injury to the triangular fibrocartilage complex (TFCC) is typically caused by blunt trauma that forces the wrist into dorsiflexion and pronation, or by repetitive trauma (often in gymnasts) (",
"    <a class=\"graphic graphic_figure graphicRef80101 \" href=\"UTD.htm?0/13/211\">",
"     figure 5",
"    </a>",
"    ). Patients present with dorsal ulnar wrist pain; cartilage tears may cause clicking, crepitus, and swelling over the ulnar area. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/52/20298?source=see_link&amp;anchor=H5769552#H5769552\">",
"     \"Evaluation of the adult with subacute or chronic wrist pain\", section on 'Triangular fibrocartilage complex injury'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h2\">",
"     Nontraumatic wrist pain",
"    </span>",
"    &nbsp;&mdash;&nbsp;There exist a wide range of causes for wrist pain unrelated to trauma, including carpal tunnel syndrome and tendinopathy. Chronic causes of wrist pain are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/52/20298?source=see_link\">",
"     \"Evaluation of the adult with subacute or chronic wrist pain\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Occasionally it may be difficult to differentiate nontraumatic pathology from wrist pain resulting from a subacute injury, eg, scaphoid fracture. The clinician should obtain x-rays in such circumstances.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h3\">",
"     Carpal tunnel syndrome",
"    </span>",
"    &nbsp;&mdash;&nbsp;Carpal tunnel syndrome (CTS) is the most common nerve entrapment disorder. It is caused by increased pressure and consequent compression of the median nerve within the carpal tunnel (",
"    <a class=\"graphic graphic_figure graphicRef53265 \" href=\"UTD.htm?18/45/19158\">",
"     figure 6",
"    </a>",
"    )&nbsp;(",
"    <a class=\"graphic graphic_figure graphicRef59856 \" href=\"UTD.htm?1/28/1477\">",
"     figure 2",
"    </a>",
"    ). Median nerve impingement may result from diseases that invade the carpal tunnel, swelling of tendon sheaths within the tunnel, stenosis of the tunnel by bone enlargement, or thickening and degeneration of the volar carpal ligament. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?23/22/23911?source=see_link\">",
"     \"Etiology of carpal tunnel syndrome\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The clinical features of CTS are variable, but they usually include pain and paresthesia in the thumb, index, middle and radial side of the ring finger (the distribution of the median nerve). Paresthesia and sensory deficits may involve the entire palm area in some cases due to variable innervation. In addition, pain may radiate proximally into the forearm and occasionally to the shoulder. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?41/15/42230?source=see_link\">",
"     \"Clinical manifestations and diagnosis of carpal tunnel syndrome\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h3\">",
"     Thumb conditions presenting as wrist pain",
"    </span>",
"    &nbsp;&mdash;&nbsp;A small percentage of patients with de Quervain's tenosynovitis and carpometacarpal arthritis present with wrist pain.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <strong>",
"       de Quervain's tenosynovitis",
"      </strong>",
"      is an inflammation of the short extensor and abductor tendons of the thumb (",
"      <a class=\"graphic graphic_figure graphicRef56302 \" href=\"UTD.htm?41/25/42386\">",
"       figure 4",
"      </a>",
"      ). Repetitive or unaccustomed use of the thumb (gripping and grasping) leads to friction and irritation of the tendons as they cross the distal radial styloid. Bilateral or unilateral tenosynovitis may also accompany pregnancy, direct trauma, and systemic diseases, such as rheumatoid arthritis and calcium apatite deposition disease [",
"      <a class=\"abstract\" href=\"UTD.htm?12/21/12632/abstract/5\">",
"       5",
"      </a>",
"      ]. Left untreated, the condition can progress to fibrosis and loss of flexibility of the thumb in flexion (stenosing tenosynovitis). (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?26/40/27270?source=see_link\">",
"       \"de Quervain's tenosynovitis\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h1\">",
"     EXAMINATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Examination of the wrist begins with inspection, palpation, measurement of the range of motion of the radiocarpal joint in flexion and extension, measurement or estimation of grip strength, and estimation of the looseness of supporting ligaments. Findings should be compared with the uninjured wrist. These functional tests correlate directly with the severity of wrist sprain, fracture of the distal radius or carpal bones, and chronic arthritis. Involvement of the wrist is further documented by inspecting the dorsum for subtle signs of effusion or the presence of a ganglion and by directed palpation of involved areas, often including the scaphoid and lunate bones for local tenderness (",
"    <a class=\"graphic graphic_table graphicRef51902 \" href=\"UTD.htm?24/44/25292\">",
"     table 1",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    For patients complaining of pain favoring the radial side of the wrist, specific maneuvers identifying arthritis or tenosynovitis of the thumb must be performed.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h2\">",
"     Overall wrist function",
"    </span>",
"    &nbsp;&mdash;&nbsp;When examining the patient presenting with wrist pain, the first priority is to evaluate the motion of the radiocarpal joint. An acute change in range of motion in flexion and extension coupled combined with local tenderness over the dorsum distinguishes direct involvement of the wrist joint from periarticular conditions (eg, wrist sprain, tenosynovitis) and conditions that refer pain through the wrist (eg, carpal tunnel syndrome, cervical radiculopathy).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h3\">",
"     Range of motion",
"    </span>",
"    &nbsp;&mdash;&nbsp;Wrist range of motion in flexion (volar flexion) and extension (dorsiflexion) are measured (",
"    <a class=\"graphic graphic_picture graphicRef77797 \" href=\"UTD.htm?14/22/14688\">",
"     picture 1",
"    </a>",
"    and",
"    <a class=\"graphic graphic_picture graphicRef64970 \" href=\"UTD.htm?26/19/26928\">",
"     picture 2",
"    </a>",
"    ). The normal range of flexion and extension are 90 degrees and 80 degrees, respectively. Endpoint pain and stiffness are also evaluated. Loss of full flexion of the wrist is the first sign of a developing effusion of the radiocarpal joint. Loss of flexion and extension directly correlate with the severity of arthritis, wrist sprain, and traumatic conditions, such as scaphoid fracture and perilunate dislocation.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25\">",
"    <span class=\"h2\">",
"     Directed palpation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Palpation of the affected area may aid diagnosis in patients with mild to moderate pain. Patients with a traumatic injury should be evaluated by radiograph following assessment of their neurovascular status.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26\">",
"    <span class=\"h3\">",
"     Dorsal palpation",
"    </span>",
"    &nbsp;&mdash;&nbsp;The radiocarpal joint, extensor carpi ulnaris (ECU) and extensor carpi radialis (ECR) tendons, and the lunate can be palpated in this region. The junction of the distal radius, scaphoid, and lunate bones occurs directly under the intersection of the extensor tendon of the index finger and a line drawn perpendicular to the most distal aspect of the radius (",
"    <a class=\"graphic graphic_picture graphicRef72283 \" href=\"UTD.htm?37/6/37999\">",
"     picture 3",
"    </a>",
"    )&nbsp;(",
"    <a class=\"graphic graphic_figure graphicRef78359 \" href=\"UTD.htm?26/34/27172\">",
"     figure 1",
"    </a>",
"    ). Another useful landmark for dorsal palpation is Lister's tubercle which lies in approximately the middle of the distal radius, aligned with the middle metacarpal. Between these bony landmarks lie the lunate and capitate.",
"   </p>",
"   <p>",
"    Mild tenderness at the radiocarpal joint line is consistent with a simple sprain, while more significant tenderness is consistent with a more severe injury, such as distal radius fracture, or a nontraumatic process, such as gout. However, pain tolerance among patients varies widely, and there can be significant overlap in the tenderness caused by these entities.",
"   </p>",
"   <p>",
"    Focal tenderness along either the ECU or ECR is consistent with tendonitis. ECU tenosynovitis commonly occurs among participants in activities involving frequent ulnar deviation, such as racket sports and rowing.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H27\">",
"    <span class=\"h3\">",
"     Palpation of the scaphoid bone and adjacent structures",
"    </span>",
"    &nbsp;&mdash;&nbsp;The anatomical snuff box is comprised of the distal radial styloid proximally, the base of the thumb distally, the abductor pollicis longus (APL) and extensor pollicis brevis (EPB) radially, and, at the ulnar aspect, the extensor pollicis longus (EPL). The scaphoid bone forms the floor of the snuff box, which is best palpated with the wrist in ulnar deviation (",
"    <a class=\"graphic graphic_picture graphicRef78551 \" href=\"UTD.htm?9/18/9519\">",
"     picture 4",
"    </a>",
"    )&nbsp;(",
"    <a class=\"graphic graphic_figure graphicRef56302 \" href=\"UTD.htm?41/25/42386\">",
"     figure 4",
"    </a>",
"    ). Tenderness in the anatomical snuff box is attributed to the scaphoid bone (fracture, avascular necrosis, or arthritis). Focal tenderness along the APL, EPB, and EPL, or at the radial styloid, over which the tendons cross, is consistent with De Quervain's tenosynovitis. This diagnosis can be confirmed with further testing (",
"    <a class=\"graphic graphic_picture graphicRef67845 \" href=\"UTD.htm?21/28/21967\">",
"     picture 5",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/40/27270?source=see_link\">",
"     \"de Quervain's tenosynovitis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H28\">",
"    <span class=\"h3\">",
"     Radial volar palpation",
"    </span>",
"    &nbsp;&mdash;&nbsp;The scaphoid tuberosity, and flexor carpi radialis (FCR) and palmaris longus (PL) tendons can be palpated in this region (",
"    <a class=\"graphic graphic_figure graphicRef69097 \" href=\"UTD.htm?1/31/1527\">",
"     figure 3",
"    </a>",
"    ). The radial pulse can be felt and the median nerve, although it cannot be directly palpated, can be assessed indirectly (",
"    <a class=\"graphic graphic_figure graphicRef59856 \" href=\"UTD.htm?1/28/1477\">",
"     figure 2",
"    </a>",
"    ). (See",
"    <a class=\"local\" href=\"#H35\">",
"     'Signs of nerve compression'",
"    </a>",
"    below.) The scaphoid tuberosity is palpated distal to the volar aspect of the radial styloid. The FCR is felt just radial to the PL with the wrist in flexion; they run in the middle of the wrist in the same orientation and in approximate alignment with the middle finger. The median nerves run deep and just radial to the PL.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H29\">",
"    <span class=\"h3\">",
"     Ulnar volar palpation",
"    </span>",
"    &nbsp;&mdash;&nbsp;The pisiform and hook of the hamate, between which run the ulnar nerve and artery in Guyon's canal, and the flexor carpi ulnaris (FCU) tendon can be palpated in this region (",
"    <a class=\"graphic graphic_figure graphicRef69097 \" href=\"UTD.htm?1/31/1527\">",
"     figure 3",
"    </a>",
"    ). The pisiform is the bony prominence at the base of the hypothenar eminence; the hook of the hamate lies just radial and distal to the pisiform. Focal pain over the hamate in patients with an appropriate history is consistent with a fracture. (See",
"    <a class=\"local\" href=\"#H16\">",
"     'Other traumatic injuries'",
"    </a>",
"    above.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H30\">",
"    <span class=\"h3\">",
"     Palpation of the ulnar styloid and TFCC",
"    </span>",
"    &nbsp;&mdash;&nbsp;Distal to the prominent ulnar styloid lies the location of the triangular fibrocartilage complex (TFCC). While the TFCC is not directly palpable, focal tenderness distal to the ulnar styloid is consistent with TFCC injury. (See",
"    <a class=\"local\" href=\"#H16\">",
"     'Other traumatic injuries'",
"    </a>",
"    above.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H31\">",
"    <span class=\"h2\">",
"     Strength assessment",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H32\">",
"    <span class=\"h3\">",
"     Grip strength",
"    </span>",
"    &nbsp;&mdash;&nbsp;Measurement of grip strength provides an indirect measurement of the integrity and strength of the forearm muscles. Grip strength can be crudely estimated by manual gripping of the examiner's fingers (",
"    <a class=\"graphic graphic_picture graphicRef80580 \" href=\"UTD.htm?26/46/27375\">",
"     picture 6",
"    </a>",
"    ). Physical measurement using a dynamometer is more accurate and reproducible (",
"    <a class=\"graphic graphic_picture graphicRef56541 \" href=\"UTD.htm?3/18/3360\">",
"     picture 7",
"    </a>",
"    ). The differential diagnosis of reduced grip strength includes disuse atrophy, wrist or hand arthritis, carpal tunnel syndrome, De Quervain's tenosynovitis, triangular fibrocartilage complex injury, severe epicondylitis, and C8 radiculopathy.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H33\">",
"    <span class=\"h3\">",
"     Forearm muscle strength",
"    </span>",
"    &nbsp;&mdash;&nbsp;Forearm strength can be objectively measured in extension (",
"    <a class=\"graphic graphic_picture graphicRef65284 \" href=\"UTD.htm?41/62/42991\">",
"     picture 8",
"    </a>",
"    ) and in flexion and compared side to side. The differential diagnosis of muscle weakness is the same as for grip strength. (See",
"    <a class=\"local\" href=\"#H32\">",
"     'Grip strength'",
"    </a>",
"    above.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H34\">",
"    <span class=\"h2\">",
"     Maneuvers assessing specific conditions",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H35\">",
"    <span class=\"h3\">",
"     Signs of nerve compression",
"    </span>",
"    &nbsp;&mdash;&nbsp;The two classic tests for nerve compression at the wrist (carpal tunnel syndrome) include the Hoffman-Tinel test and the Phalen maneuver. These are described separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?41/15/42230?source=see_link&amp;anchor=H5#H5\">",
"     \"Clinical manifestations and diagnosis of carpal tunnel syndrome\", section on 'Provocative maneuvers'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H36\">",
"    <span class=\"h3\">",
"     Scaphoid compression test",
"    </span>",
"    &nbsp;&mdash;&nbsp;Also referred to as the axial grind test, this maneuver can be used in combination with an assessment of snuffbox tenderness to help determine whether a scaphoid fracture is present. It is performed by holding the thumb and gradually pushing in toward the scaphoid along the longitudinal axis of the thumb metacarpal. Studies suggest it is a sensitive and moderately specific test [",
"    <a class=\"abstract\" href=\"UTD.htm?12/21/12632/abstract/6\">",
"     6",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H37\">",
"    <span class=\"h3\">",
"     Scaphoid shift test",
"    </span>",
"    &nbsp;&mdash;&nbsp;This scaphoid shift test (sometimes called the Watson test) can be used to detect laxity of the scaphoid ligaments. It is describe separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/52/20298?source=see_link&amp;anchor=H5769529#H5769529\">",
"     \"Evaluation of the adult with subacute or chronic wrist pain\", section on 'Special tests'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H38\">",
"    <span class=\"h3\">",
"     Dorsal ganglion",
"    </span>",
"    &nbsp;&mdash;&nbsp;A dorsal ganglion may appear as a readily palpable lesion on the dorsum of the wrist (",
"    <a class=\"graphic graphic_picture graphicRef60204 \" href=\"UTD.htm?11/63/12287\">",
"     picture 9",
"    </a>",
"    ). If there is any question regarding distinction between a ganglion and a solid mass, the former transilluminates while the latter does not and each appears differently on ultrasound.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H39\">",
"    <span class=\"h3\">",
"     Compression of the base of the thumb",
"    </span>",
"    &nbsp;&mdash;&nbsp;Compression of the base of the thumb in the AP direction is performed to screen the carpometacarpal joint as a source of wrist pain (",
"    <a class=\"graphic graphic_picture graphicRef65989 \" href=\"UTD.htm?15/11/15551\">",
"     picture 10",
"    </a>",
"    ). Distinguishing carpometacarpal strain from osteoarthritis requires x-rays of the thumb.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H40\">",
"    <span class=\"h3\">",
"     Diffuse dorsal swelling",
"    </span>",
"    &nbsp;&mdash;&nbsp;Diffuse dorsal swelling of the tenosynovial sheath suggests the presence of tenosynovitis, complex regional pain syndrome (reflex sympathetic dystrophy), or cellulitis (",
"    <a class=\"graphic graphic_picture graphicRef69321 \" href=\"UTD.htm?22/52/23375\">",
"     picture 11",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H41\">",
"    <span class=\"h1\">",
"     CONFIRMATORY MANEUVERS AND PROCEDURES",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H42\">",
"    <span class=\"h2\">",
"     Radiography",
"    </span>",
"    &nbsp;&mdash;&nbsp;Plain films of the wrist are primarily indicated in patients with suspected fracture. Any patient with a history of trauma and focal pain or tenderness should have x-rays. Distinguishing carpometacarpal strain from osteoarthritis also requires x-rays of the thumb.",
"   </p>",
"   <p>",
"    Standard radiographic wrist projections include posteroanterior, posteroanterior oblique, and lateral views. Posteroanterior ulnar deviation views are important in patients with a suspected scaphoid fracture. It is worth emphasizing that a complete wrist series with scaphoid views will miss a small, but significant percentage of acute scaphoid fractures.",
"   </p>",
"   <p>",
"    Simple sprains should have a normal radiograph (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef61652 \" href=\"UTD.htm?10/32/10767\">",
"     image 5",
"    </a>",
"    ). Scaphoid fractures are small and often nondisplaced; they may not be visible until one to two weeks later (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef75655 \" href=\"UTD.htm?12/45/13010\">",
"     image 1",
"    </a>",
"    ). CT or bone scan may be necessary to identify fractures of the scaphoid, distal radius, or other wrist bones in patients with suspicious symptoms and normal findings on plain x-ray [",
"    <a class=\"abstract\" href=\"UTD.htm?12/21/12632/abstract/7\">",
"     7",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Radiographs should also be evaluated for signs of ligament disruption, specifically of the scapholunate ligament. This is demonstrated by a widened space (&gt;3 mm) between the scaphoid and the lunate (the \"Terry Thomas\" sign), which can be accentuated by taking a PA of the hand with the hand closed in a fist and the wrist in ulnar deviation. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/51/1848?source=see_link\">",
"     \"Scaphoid fractures\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H43\">",
"    <span class=\"h2\">",
"     Local anesthetic block/joint aspiration",
"    </span>",
"    &nbsp;&mdash;&nbsp;The physical examination for carpal tunnel syndrome is relatively insensitive. Electrodiagnostic testing has a relatively high sensitivity, but it is somewhat painful and expensive. Median nerve block with injection of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?34/34/35360?source=see_link\">",
"     lidocaine",
"    </a>",
"    can be used as a diagnostic procedure (",
"    <a class=\"graphic graphic_picture graphicRef55670 \" href=\"UTD.htm?27/6/27759\">",
"     picture 12",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    Corticosteroid injection provides significantly greater relief of symptoms than either splinting or NSAIDs up to two months following injection [",
"    <a class=\"abstract\" href=\"UTD.htm?12/21/12632/abstract/8-10\">",
"     8-10",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?42/62/44008?source=see_link&amp;anchor=H9#H9\">",
"     \"Treatment of carpal tunnel syndrome\", section on 'Glucocorticoid injection'",
"    </a>",
"    .) The procedure can be dangerous, however, and should only be performed by physicians with specific training in carpal tunnel injection. Nerve atrophy or necrosis may occur if corticosteroid enters the median nerve sheath directly. In the worst case, permanent nerve injury with a claw hand deformity can ensue. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/57/28564?source=see_link\">",
"     \"Joint aspiration or injection in adults: Complications\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Diagnostic aspiration can confirm the diagnosis of dorsal ganglion (",
"    <a class=\"graphic graphic_picture graphicRef71977 \" href=\"UTD.htm?31/62/32751\">",
"     picture 13",
"    </a>",
"    ). The cyst fluid is typically thick, tenacious, and non-bloody.",
"   </p>",
"   <p>",
"    Aspiration of the wrist joint can help distinguish the various causes of wrist effusion (",
"    <a class=\"graphic graphic_picture graphicRef63037 \" href=\"UTD.htm?30/33/31263\">",
"     picture 14",
"    </a>",
"    ). Anesthetic block confirms involvement of the wrist in difficult cases.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H46306460\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Due to its location and anatomy, the wrist is susceptible to a range of injuries. Obtaining a clear history and correlating the history and symptom location with wrist anatomy are important elements of diagnosis. Therefore, a basic understanding of wrist anatomy and function is essential. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?13/45/14039?source=see_link\">",
"       \"Anatomy and basic biomechanics of the wrist\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Patients experiencing a problem that is intrinsic to the wrist present either with complaints of painful movement (eg, sprain, scaphoid fracture), swelling that is localized (ganglion) or diffuse (extensor tenosynovitis or complex regional pain syndrome), or changes in sensation aggravated by use of the wrist (carpal tunnel syndrome). (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Etiology and presentation'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Wrist pain is characterized according to location, mechanism, onset, and associated symptoms and signs. The diagnoses most often associated with particular pain patterns are described in the text. (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Pain patterns'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The degree of force and the position of the wrist during acute trauma determine the site of greatest impact and the structures most likely to be injured. Injuries to the wrist often occur following a fall onto an outstretched hand. Potential injuries in this setting include sprain, scaphoid fracture, distal radius fracture, ligamentous injury (eg, lunate dislocation), and fractures of other carpal bones. Pain and swelling unrelated to trauma are characteristic of dorsal ganglion and carpal tunnel syndrome. (See",
"      <a class=\"local\" href=\"#H11\">",
"       'Wrist trauma'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H17\">",
"       'Nontraumatic wrist pain'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Examination of the wrist includes palpation, measurement of the range of motion of the radiocarpal joint in flexion and extension, measurement or estimation of grip strength, and an estimation of the looseness of the supporting ligaments. Special tests are sometimes used to assess for specific conditions. Findings should be compared with the uninjured wrist. (See",
"      <a class=\"local\" href=\"#H22\">",
"       'Examination'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Plain radiographs of the wrist are primarily indicated in patients with suspected fracture or arthritis. Any patient with a history of trauma and focal pain or tenderness should have x-rays. (See",
"      <a class=\"local\" href=\"#H42\">",
"       'Radiography'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/21/12632/abstract/1\">",
"      Halikis MN, Taleisnik J. Soft-tissue injuries of the wrist. Clin Sports Med 1996; 15:235.",
"     </a>",
"    </li>",
"    <li>",
"     Seitz WH, Papandrea RF. Fractures and dislocations of the wrist. In: Rockwood and Green's Fractures in Adults, Bucholz RW, Heckman JD (Eds), Lippincott Williams &amp; Wilkins, Philadelphia 2002. p.749.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/21/12632/abstract/3\">",
"      Honing EW. Wrist injuries part 1: pinpointing pathology in a complex joint. Phys Sportsmed 1998; 26:40.",
"     </a>",
"    </li>",
"    <li>",
"     Garcia-Elias, Marc. Carpal Instability. In: Green's Operative Hand Surgery, 6th ed, Wolfe, SW, Hotchkiss, RN, Pederson, WC, Kozin, SH. (Eds), Elsevier, Philadelphia 2011. Vol I, p.483.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/21/12632/abstract/5\">",
"      Schumacher HR Jr, Dorwart BB, Korzeniowski OM. Occurrence of De Quervain's tendinitis during pregnancy. Arch Intern Med 1985; 145:2083.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/21/12632/abstract/6\">",
"      Grover R. Clinical assessment of scaphoid injuries and the detection of fractures. J Hand Surg Br 1996; 21:341.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/21/12632/abstract/7\">",
"      Welling RD, Jacobson JA, Jamadar DA, et al. MDCT and radiography of wrist fractures: radiographic sensitivity and fracture patterns. AJR Am J Roentgenol 2008; 190:10.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/21/12632/abstract/8\">",
"      Green DP. Diagnostic and therapeutic value of carpal tunnel injection. J Hand Surg Am 1984; 9:850.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/21/12632/abstract/9\">",
"      Dammers JW, Veering MM, Vermeulen M. Injection with methylprednisolone proximal to the carpal tunnel: randomised double blind trial. BMJ 1999; 319:884.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/21/12632/abstract/10\">",
"      Marshall S, Tardif G, Ashworth N. Local corticosteroid injection for carpal tunnel syndrome. Cochrane Database Syst Rev 2002; :CD001554.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 245 Version 12.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.3 - C21.34",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Morehouse School of Medicine",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-190.92.87.104-9A95019A57-S473950.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f12_21_12632=[""].join("\n");
var outline_f12_21_12632=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H46306460\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      ANATOMY AND BIOMECHANICS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      ETIOLOGY AND PRESENTATION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Pain patterns",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      - Dorsal wrist pain",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      - Dorsal wrist swelling",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      - Paresthesias, hypesthesias, and volar pain",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      - Wrist pain and grip weakness",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      - Stiffness",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      DIFFERENTIAL DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Wrist trauma",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      - Wrist sprain",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      - Scaphoid fracture",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H2174433\">",
"      - Distal radius fracture",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      - Scapholunate dissociation, lunate dislocation, and related injuries",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      - Other traumatic injuries",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      Nontraumatic wrist pain",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      - Carpal tunnel syndrome",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      - Thumb conditions presenting as wrist pain",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      EXAMINATION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      Overall wrist function",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      - Range of motion",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H25\">",
"      Directed palpation",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H26\">",
"      - Dorsal palpation",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H27\">",
"      - Palpation of the scaphoid bone and adjacent structures",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H28\">",
"      - Radial volar palpation",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H29\">",
"      - Ulnar volar palpation",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H30\">",
"      - Palpation of the ulnar styloid and TFCC",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H31\">",
"      Strength assessment",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H32\">",
"      - Grip strength",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H33\">",
"      - Forearm muscle strength",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H34\">",
"      Maneuvers assessing specific conditions",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H35\">",
"      - Signs of nerve compression",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H36\">",
"      - Scaphoid compression test",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H37\">",
"      - Scaphoid shift test",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H38\">",
"      - Dorsal ganglion",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H39\">",
"      - Compression of the base of the thumb",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H40\">",
"      - Diffuse dorsal swelling",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H41\">",
"      CONFIRMATORY MANEUVERS AND PROCEDURES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H42\">",
"      Radiography",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H43\">",
"      Local anesthetic block/joint aspiration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H46306460\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"EM/245\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"EM/245|DiagnosticImage\">",
"      <a href=\"#\" title=\"DIAGNOSTIC IMAGES\">",
"       DIAGNOSTIC IMAGES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?12/45/13010\" title=\"diagnostic image 1\">",
"      Scaphoid fracture",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?14/30/14816\" title=\"diagnostic image 2\">",
"      Scapholunate dissociation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?23/15/23807\" title=\"diagnostic image 3\">",
"      Perilunate dislocation AP",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?31/25/32145\" title=\"diagnostic image 4\">",
"      Perilunate dislocation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?10/32/10767\" title=\"diagnostic image 5\">",
"      Normal wrist radiograph",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"EM/245|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?26/34/27172\" title=\"figure 1\">",
"      Anatomy wrist dorsal",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?1/28/1477\" title=\"figure 2\">",
"      Carpal tunnel syndrome structures",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?1/31/1527\" title=\"figure 3\">",
"      Anatomy of the volar aspect of the wrist",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?41/25/42386\" title=\"figure 4\">",
"      Anatomy wrist radial",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?0/13/211\" title=\"figure 5\">",
"      Triangular fibrocartilage complex",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?18/45/19158\" title=\"figure 6\">",
"      Cross section of wrist",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"EM/245|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?14/22/14688\" title=\"picture 1\">",
"      Passive wrist range of motion in flexion",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?26/19/26928\" title=\"picture 2\">",
"      Passive wrist range of motion in extension",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?37/6/37999\" title=\"picture 3\">",
"      Radiocarpal joint line pain",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?9/18/9519\" title=\"picture 4\">",
"      Snuffbox palpation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?21/28/21967\" title=\"picture 5\">",
"      Palpation radial styloid",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?26/46/27375\" title=\"picture 6\">",
"      Manual testing grip strength",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?3/18/3360\" title=\"picture 7\">",
"      Dynamometry",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?41/62/42991\" title=\"picture 8\">",
"      Isometric test forearm strength",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?11/63/12287\" title=\"picture 9\">",
"      Dorsal ganglion",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?15/11/15551\" title=\"picture 10\">",
"      Carpometacarpal compression",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?22/52/23375\" title=\"picture 11\">",
"      Swelling tenosynovial sheath",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?27/6/27759\" title=\"picture 12\">",
"      Median nerve block",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?31/62/32751\" title=\"picture 13\">",
"      Dorsal ganglion aspiration",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?30/33/31263\" title=\"picture 14\">",
"      Radiocarpal joint aspiration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"EM/245|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?24/44/25292\" title=\"table 1\">",
"      Wrist examination",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?13/45/14039?source=related_link\">",
"      Anatomy and basic biomechanics of the wrist",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?12/46/13033?source=related_link\">",
"      Clinical features of rheumatoid arthritis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?41/15/42230?source=related_link\">",
"      Clinical manifestations and diagnosis of carpal tunnel syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?21/13/21722?source=related_link\">",
"      Distal radius fractures in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?23/22/23911?source=related_link\">",
"      Etiology of carpal tunnel syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?31/37/32344?source=related_link\">",
"      Etiology, clinical manifestations, and diagnosis of complex regional pain syndrome in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?19/52/20298?source=related_link\">",
"      Evaluation of the adult with subacute or chronic wrist pain",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?40/16/41223?source=related_link\">",
"      Ganglia and nodules",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?9/25/9620?source=related_link\">",
"      Hamate fractures",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/57/28564?source=related_link\">",
"      Joint aspiration or injection in adults: Complications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?4/49/4886?source=related_link\">",
"      Overview of carpal fractures",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?1/51/1848?source=related_link\">",
"      Scaphoid fractures",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?42/62/44008?source=related_link\">",
"      Treatment of carpal tunnel syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?37/12/38089?source=related_link\">",
"      Ulnar neuropathy at the elbow and wrist",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?26/40/27270?source=related_link\">",
"      de Quervain's tenosynovitis",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f12_21_12633="Diagnostic testing for low back pain";
var content_f12_21_12633=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Diagnostic testing for low back pain",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?12/21/12633/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?12/21/12633/contributors\">",
"     Thomas O Staiger, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?12/21/12633/contributors\">",
"     Medley Gatewood, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?12/21/12633/contributors\">",
"     Joyce E Wipf, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?12/21/12633/contributors\">",
"     Richard A Deyo, MD, MPH",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?12/21/12633/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?12/21/12633/contributors\">",
"     Steven J Atlas, MD, MPH",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?12/21/12633/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?12/21/12633/contributors\">",
"     Fenny H Lin, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?12/21/12633/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Nov 30, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Back pain is the second most common symptom-related reason for physician visits in the United States. Up to 84 percent of adults have low back pain at some time in their lives [",
"    <a class=\"abstract\" href=\"UTD.htm?12/21/12633/abstract/1,2\">",
"     1,2",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    An etiologic diagnosis is not established for most patients with back pain in whom episodes of back pain are self-limited and resolve without specific therapy. Rarely, acute back pain is a symptom of serious neurologic compromise (ie, cauda equina syndrome) or a harbinger of serious medical illness, including infection, malignancy, or an inflammatory condition. The challenge for clinicians is to identify the relatively few patients with a significant probability of a more serious problem who require further evaluation.",
"   </p>",
"   <p>",
"    Diagnostic tests in general are indicated if the test will help guide specific patient management strategies and improve patient outcomes. Diagnostic testing performed without clear indication, in a population with low pre-test probability of the condition being tested for, can lead to a cascade of unnecessary further testing to evaluate false positive results, unnecessary interventions, and lead to avoidable patient anxiety and medical expense.",
"   </p>",
"   <p>",
"    Uncomplicated acute low back pain is a self-limited condition that requires no imaging or laboratory studies. A history and physical exam alone are sufficient to evaluate most patients with back pain of less than four weeks duration [",
"    <a class=\"abstract\" href=\"UTD.htm?12/21/12633/abstract/3\">",
"     3",
"    </a>",
"    ]. Patients with \"red flags\" for a serious underlying condition (eg, fracture, neoplasm, infection, cauda equina syndrome or other significant neurologic deficits), or those who are surgical candidates for persistent nerve-impingement symptoms, may warrant additional diagnostic studies. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/10/18601?source=see_link\">",
"     \"Approach to the diagnosis and evaluation of low back pain in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    This discussion will focus on the rationale and indications for performing diagnostic testing in the evaluation of patients with low back pain. An overall approach to the initial evaluation of patients with low back pain is discussed separately (see",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/10/18601?source=see_link\">",
"     \"Approach to the diagnosis and evaluation of low back pain in adults\"",
"    </a>",
"    ). Evaluation of patients presenting to the emergency department with significant acute trauma involving the spine is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?30/34/31274?source=see_link\">",
"     \"Evaluation and acute management of cervical spinal column injuries in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Treatment of acute low back pain and subacute and chronic low back pain are also discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?13/21/13658?source=see_link\">",
"     \"Treatment of acute low back pain\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/24/19850?source=see_link\">",
"     \"Subacute and chronic low back pain: Pharmacologic and noninterventional treatment\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?38/52/39753?source=see_link\">",
"     \"Subacute and chronic low back pain: Nonsurgical interventional treatment\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?34/5/34905?source=see_link\">",
"     \"Subacute and chronic low back pain: Surgical treatment\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     LABORATORY STUDIES",
"    </span>",
"    &nbsp;&mdash;&nbsp;A variety of laboratory studies have been recommended in the evaluation of patients with back pain, but the predictive value has been determined for relatively few blood tests: erythrocyte sedimentation rate (ESR), C-reactive protein (CRP) and the white blood cell count (WBC). These laboratory tests are most useful in detecting patients who may have infection or malignancy, and may be considered in patients with unexplained low back pain who have not improved within four weeks.",
"   </p>",
"   <p>",
"    In patients with osteomyelitis or other spinal infection, the sensitivity of an elevated ESR, CRP, and WBC is 76 to 95 percent, 82 to 98 percent, and 35 to 61 percent, respectively [",
"    <a class=\"abstract\" href=\"UTD.htm?12/21/12633/abstract/4-6\">",
"     4-6",
"    </a>",
"    ]. An ESR &ge;20 has a sensitivity of 78 percent and a specificity of 67 percent in the detection of an occult malignancy (",
"    <a class=\"graphic graphic_table graphicRef81266 \" href=\"UTD.htm?29/36/30283\">",
"     table 1",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?12/21/12633/abstract/7\">",
"     7",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A urinalysis is not generally helpful in evaluating low back pain, but may be considered in patients with unexplained unilateral back pain, searching for subclinical pyelonephritis. The urine dipstick is insensitive for detecting Bence-Jones protein. For patients in whom the possibility of multiple myeloma is considered, suggested by an elevated ESR, advanced age, or other clinical signs, a urine protein electrophoresis and serum protein electrophoresis should be obtained. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?34/13/35034?source=see_link\">",
"     \"Clinical features, laboratory manifestations, and diagnosis of multiple myeloma\"",
"    </a>",
"    .) The specificity of an HLA B27 antigen for ankylosing spondylitis is low; it should not be used as a screening test for this disorder but may be useful if x-ray findings are equivocal. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?13/20/13640?source=see_link\">",
"     \"Diagnosis and differential diagnosis of ankylosing spondylitis in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     RADIOGRAPHIC TESTING",
"    </span>",
"    &nbsp;&mdash;&nbsp;In a 2005 analysis, approximately one-quarter of patients 18 to 50 years of age with acute low back pain who received imaging tests had no identifiable indication for imaging [",
"    <a class=\"abstract\" href=\"UTD.htm?12/21/12633/abstract/8\">",
"     8",
"    </a>",
"    ]. Routine plain films at the initial office visit are associated with expense and gonadal radiation exposure for little demonstrated benefit [",
"    <a class=\"abstract\" href=\"UTD.htm?12/21/12633/abstract/9\">",
"     9",
"    </a>",
"    ]. Lumbar radiography in primary care patients with mechanical low back pain is not associated with improved patient functioning, severity of pain, or overall health status [",
"    <a class=\"abstract\" href=\"UTD.htm?12/21/12633/abstract/10\">",
"     10",
"    </a>",
"    ]. Inappropriate use of lumbar imaging can lead to irrelevant findings and trigger unneeded therapy, additional costly studies, and unwarranted surgical interventions [",
"    <a class=\"abstract\" href=\"UTD.htm?12/21/12633/abstract/11,12\">",
"     11,12",
"    </a>",
"    ]. A systematic review and meta-analysis of six trials that compared immediate imaging (radiography, MRI or CT) with usual care for patients with acute and subacute low back pain found no significant differences in short (up to 3 months) or long-term (6 to 12 months) outcomes for measures of patient pain or function [",
"    <a class=\"abstract\" href=\"UTD.htm?12/21/12633/abstract/13\">",
"     13",
"    </a>",
"    ]. Patients with worrisome signs or symptoms for infection or malignancy were excluded from the trials, but the presence of lumboradicular signs was variable.",
"   </p>",
"   <p>",
"    Lumbar x-rays, CT and MRI scans are often abnormal in asymptomatic patients. Abnormalities of these tests in patients with low back pain must be interpreted with caution.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In one study, 23 percent of asymptomatic adults had degenerative changes on plain x-rays of the lumbar spine; these changes are age-related and anticipated with advancing age [",
"      <a class=\"abstract\" href=\"UTD.htm?12/21/12633/abstract/14\">",
"       14",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      In a community-based study of 188 individuals 40 to 80 years old, 60 percent of males and 67 percent of females had facet joint osteoarthritic changes on lumbar CT scans; radiologic facet joint osteoarthritis increased with age and there was no correlation with low back pain [",
"      <a class=\"abstract\" href=\"UTD.htm?12/21/12633/abstract/15\">",
"       15",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Disc herniations on MRI are seen in 22 to 36 percent of asymptomatic adults, and spinal stenosis is present in up to 21 percent of studies in patients over age 60 [",
"      <a class=\"abstract\" href=\"UTD.htm?12/21/12633/abstract/16-19\">",
"       16-19",
"      </a>",
"      ]. Findings on CT are similar [",
"      <a class=\"abstract\" href=\"UTD.htm?12/21/12633/abstract/20\">",
"       20",
"      </a>",
"      ]. &nbsp;",
"     </li>",
"     <li>",
"      The LAIDBack study reported that moderate or severe central stenosis, root compression, and disc extrusions were likely to be diagnostically relevant [",
"      <a class=\"abstract\" href=\"UTD.htm?12/21/12633/abstract/21\">",
"       21",
"      </a>",
"      ]. Other MRI findings, however, were common in people without back pain (desiccation of discs, bulging discs, disc protrusion, loss of disc height).",
"     </li>",
"     <li>",
"      Spondylolysis (a defect in the pars interarticularis of the neural arch, usually due to a stress fracture) is equally common in patients with and without low back pain symptoms [",
"      <a class=\"abstract\" href=\"UTD.htm?12/21/12633/abstract/22\">",
"       22",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Schmorl's nodes, representing herniation of the nucleus pulposus into the adjacent end plate, can be seen in approximately 20 percent of MRI studies in patients without back pain (",
"      <a class=\"graphic graphic_diagnosticimage graphicRef64470 \" href=\"UTD.htm?2/37/2646\">",
"       image 1",
"      </a>",
"      ) [",
"      <a class=\"abstract\" href=\"UTD.htm?12/21/12633/abstract/23\">",
"       23",
"      </a>",
"      ]. Although Schmorl's nodes are associated with degenerative changes in the lower back, they are not an independent risk factor for back pain.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Even when radiographic findings are consistent with clinical presentations, the magnitude of radiographic findings does not necessarily correlate with the clinical outcome, and clinical improvement may precede improvements in the radiographic defect [",
"    <a class=\"abstract\" href=\"UTD.htm?12/21/12633/abstract/24-26\">",
"     24-26",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    An approach to determining when it is appropriate to order radiographic studies in patients with low back pain is outlined in an algorithm (",
"    <a class=\"graphic graphic_algorithm graphicRef50346 \" href=\"UTD.htm?36/31/37362\">",
"     algorithm 1",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Red flags",
"    </span>",
"    &nbsp;&mdash;&nbsp;The American College of Radiology has published a list of ten findings, based on a patient's history, suggesting a need for radiologic investigation to evaluate for potential complicated low back pain. These criteria have been referred to as \"red flags\" (",
"    <a class=\"graphic graphic_table graphicRef68550 \" href=\"UTD.htm?25/54/26475\">",
"     table 2",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?12/21/12633/abstract/27\">",
"     27",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Plain x-rays",
"    </span>",
"    &nbsp;&mdash;&nbsp;The majority of patients with low back pain of less than four weeks duration do not require imaging [",
"    <a class=\"abstract\" href=\"UTD.htm?12/21/12633/abstract/3,28\">",
"     3,28",
"    </a>",
"    ]. Radiography should be obtained selectively in patients with low back pain who have one or more indications of a serious underlying condition (",
"    <a class=\"graphic graphic_algorithm graphicRef50346 \" href=\"UTD.htm?36/31/37362\">",
"     algorithm 1",
"    </a>",
"    ). Plain radiographs infrequently detect findings that change management, but often detect findings unrelated to symptoms, and are associated with gonadal radiation exposure and high aggregate costs.",
"   </p>",
"   <p>",
"    Plain radiographs do not detect herniated discs, but can show evidence of infection, fracture, malignancy, spondylolisthesis, degenerative changes, disc space narrowing, and prior surgery. Normal plain films do not exclude malignancy or infection in patients with a suspicious history. In a systematic review, plain radiography was 60 percent sensitive and 95 percent specific for malignancy and 82 percent sensitive and 57 percent specific for infection [",
"    <a class=\"abstract\" href=\"UTD.htm?12/21/12633/abstract/29\">",
"     29",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Patient characteristics associated with an occult malignancy were identified in a study of 1,975 patients presenting to a public hospital with a complaint of back pain [",
"    <a class=\"abstract\" href=\"UTD.htm?12/21/12633/abstract/7\">",
"     7",
"    </a>",
"    ]. Thirteen patients had pain that was ultimately attributed to an occult malignancy. Findings associated with the presence of cancer included:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Age &gt;50",
"     </li>",
"     <li>",
"      Prior cancer history",
"     </li>",
"     <li>",
"      Unexplained weight loss",
"     </li>",
"     <li>",
"      No improvement following one month of conservative therapy",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Features in the history of patients with acute low back pain that indicate an increased risk for vertebral fractures, and suggest consideration of plain x-rays, are [",
"    <a class=\"abstract\" href=\"UTD.htm?12/21/12633/abstract/3\">",
"     3",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Recent significant trauma",
"     </li>",
"     <li>",
"      Recent mild trauma (ie, minor fall or heavy lifting) in a patient over age 50",
"     </li>",
"     <li>",
"      History of prolonged glucocorticoid use",
"     </li>",
"     <li>",
"      Osteoporosis",
"     </li>",
"     <li>",
"      Patient over age 70",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Obtaining x-rays on every patient with one of the above risk factors for cancer or fracture would facilitate early detection of the relatively few patients with serious underlying problems, but would generate many negative studies [",
"    <a class=\"abstract\" href=\"UTD.htm?12/21/12633/abstract/30\">",
"     30",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The yield of plain radiographs may be increased by using the ESR as a screening test [",
"    <a class=\"abstract\" href=\"UTD.htm?12/21/12633/abstract/7\">",
"     7",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H2\">",
"     'Laboratory studies'",
"    </a>",
"    above.) Malignancy and infection are very unlikely in patients with an ESR &lt;20 and no more than one risk factor for a systemic illness [",
"    <a class=\"abstract\" href=\"UTD.htm?12/21/12633/abstract/4,7\">",
"     4,7",
"    </a>",
"    ]. CRP may have similar or greater value than the ESR, based on its sensitivity, though CRP has not been similarly evaluated.",
"   </p>",
"   <p>",
"    When x-rays are indicated, anteroposterior and lateral views are usually adequate. Oblique views substantially increase the risks of radiation exposure, particularly for women, and add little new diagnostic information [",
"    <a class=\"abstract\" href=\"UTD.htm?12/21/12633/abstract/3\">",
"     3",
"    </a>",
"    ]. Flexion-extension views may be helpful in patients who have had surgical fusion procedures or in those with spondylolisthesis. A pelvic or hip x-ray should be considered for older patients in whom osteoarthritis of the hip may present as low back pain. If a patient's low back symptoms do not lateralize, a standing pelvis film will evaluate both hips for the presence of osteoarthritis; if symptoms lateralize, a two-view hip (standing frontal and frog-leg views) is appropriate.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Specialized radiographic studies",
"    </span>",
"    &nbsp;&mdash;&nbsp;Advanced imaging is infrequently indicated early in the course of patients with low back pain. However, the clinician must be vigilant to identify patients requiring specialized testing. An MRI or CT scan (or a myelogram in specific circumstances (see",
"    <a class=\"local\" href=\"#H9\">",
"     'Myelogram'",
"    </a>",
"    below)), should be performed for the following patients [",
"    <a class=\"abstract\" href=\"UTD.htm?12/21/12633/abstract/3\">",
"     3",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Clinical exam findings or other tests suggesting possible emergent conditions affecting the spine: cauda equina syndrome, infection, tumor, fracture with neurologic impingement, or other mass lesions or defects. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?18/10/18601?source=see_link\">",
"       \"Approach to the diagnosis and evaluation of low back pain in adults\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Radicular symptoms consistent with a disc herniation and symptoms lasting &gt;four to six weeks that are severe enough to consider surgical intervention.",
"     </li>",
"     <li>",
"      History of neurogenic claudication and other findings suggesting spinal stenosis and symptoms of sufficient duration (often several months) and severity to consider surgical intervention. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?1/28/1480?source=see_link\">",
"       \"Lumbar spinal stenosis: Pathophysiology, clinical features, and diagnosis\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    While MRI is widely considered to be the best test for diagnosing most pathologic conditions of the spine, other imaging studies may be appropriate in certain conditions. One study found similar diagnostic accuracy for CT, MRI, CT-myelography, and myelography for surgical confirmed lumbar disc herniation [",
"    <a class=\"abstract\" href=\"UTD.htm?12/21/12633/abstract/31\">",
"     31",
"    </a>",
"    ]. Another study of patients with acute low-back and radicular pain found no significant difference in diagnostic accuracy of MRI, CT, or CT myelography for herniated disc among the 95 patients who underwent MRI plus one of the other two studies [",
"    <a class=\"abstract\" href=\"UTD.htm?12/21/12633/abstract/32\">",
"     32",
"    </a>",
"    ]. The authors suggest that the factors of cost, radiation dose, and invasiveness should influence selection of modality.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h3\">",
"     Magnetic resonance imaging",
"    </span>",
"    &nbsp;&mdash;&nbsp;MRI without contrast is generally considered the best initial test for most patients with low back pain who require advanced imaging [",
"    <a class=\"abstract\" href=\"UTD.htm?12/21/12633/abstract/27,33\">",
"     27,33",
"    </a>",
"    ]. It provides axial as well as sagittal views which can demonstrate normal and pathologic discs, ligaments, nerve roots, epidural fat, as well as the shape and size of the spinal canal. MRI enhancement with IV gadolinium allows the distinction of scar from disc in patients with prior back surgery. CT scan provides better definition than MRI for bone structures. (See",
"    <a class=\"local\" href=\"#H8\">",
"     'CT scan'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    MRI is particularly useful in patients with suspected disc herniations, spinal stenosis, osteomyelitis, discitis, spinal epidural abscess, bone metastases, arachnoiditis, and neural tube defects. The sensitivity of MRI for detecting spinal metastases is 0.83 to 0.93, and its specificity is 0.9 to 0.97. For detecting spine infection, sensitivity is 0.96 and specificity is 0.92 [",
"    <a class=\"abstract\" href=\"UTD.htm?12/21/12633/abstract/26\">",
"     26",
"    </a>",
"    ]. As previously noted, MRI findings must be carefully correlated with a patient's clinical findings, as disc abnormalities are common in asymptomatic patients [",
"    <a class=\"abstract\" href=\"UTD.htm?12/21/12633/abstract/16\">",
"     16",
"    </a>",
"    ] and increase with age [",
"    <a class=\"abstract\" href=\"UTD.htm?12/21/12633/abstract/34\">",
"     34",
"    </a>",
"    ]. Annular tears are often seen on MRI but are usually not clinically significant. In one retrospective, observational study, including a comment on the report of the MRI about the prevalence of similar findings in asymptomatic patients was associated with a decrease in the use of opioids compared to patients whose MRI report did not contain such content [",
"    <a class=\"abstract\" href=\"UTD.htm?12/21/12633/abstract/35\">",
"     35",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/10/18601?source=see_link\">",
"     \"Approach to the diagnosis and evaluation of low back pain in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    MRI is currently recommended for patients with persistent symptoms due to a lumbosacral radiculopathy who have not responded to conservative treatment and are not deemed surgical candidates [",
"    <a class=\"abstract\" href=\"UTD.htm?12/21/12633/abstract/36\">",
"     36",
"    </a>",
"    ]. A randomized trial evaluated the effect of MRI scanning on decision making and outcomes for patients with lumbosacral radiculopathy referred for epidural steroid injection [",
"    <a class=\"abstract\" href=\"UTD.htm?12/21/12633/abstract/37\">",
"     37",
"    </a>",
"    ]. The trial found that symptoms were slightly, but not statistically, better for those patients in whom MRI information was available prior to administration of epidural steroid injections [",
"    <a class=\"abstract\" href=\"UTD.htm?12/21/12633/abstract/36\">",
"     36",
"    </a>",
"    ]. We continue to recommend MRI for patients with lumbosacral radiculopathy who have symptoms or findings suggestive of a serious condition, such as infection, metastases, or cauda equine syndrome, and for patients with persistent symptoms who are candidates for invasive therapy such as injections or discectomy. (See",
"    <a class=\"local\" href=\"#H15\">",
"     'Guidelines'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    Routine use of MRI in place of plain radiography is not warranted. In a controlled trial, 380 patients whose primary care provider felt radiography was indicated were randomized to either plain spine radiographs or MRI. Functional outcomes were nearly identical between the two groups. While physicians and patients preferred the rapid MRI, the use of early MRI was associated with an increase in the cost of care as well as the number of spine operations performed [",
"    <a class=\"abstract\" href=\"UTD.htm?12/21/12633/abstract/11\">",
"     11",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    MRI does not use ionizing radiation and has no apparent adverse biologic effects. However, due to the strong magnetic field involved, MRIs cannot be performed in all patients. Contraindications for MRI are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?5/35/5689?source=see_link\">",
"     \"Principles of magnetic resonance imaging\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Gadolinium contrast is contraindicated in patients with moderate to severe renal failure (requiring dialysis or estimated GFR less than 30",
"    <span class=\"nowrap\">",
"     mL/min),",
"    </span>",
"    who are at risk for nephrogenic systemic fibrosis [",
"    <a class=\"abstract\" href=\"UTD.htm?12/21/12633/abstract/38\">",
"     38",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?30/22/31082?source=see_link\">",
"     \"Nephrogenic systemic fibrosis/nephrogenic fibrosing dermopathy in advanced renal failure\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Because the gantry tube diameter is small and the imaging time is long, claustrophobic patients may have difficulty tolerating an MRI. Premedication with an anxiolytic may be needed. Open, low-field MRI units may also be useful, but image quality is sometimes inferior to that of high-field-magnet MRI.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H88179979\">",
"    <span class=\"h4\">",
"     Modic changes",
"    </span>",
"    &nbsp;&mdash;&nbsp;A common and sometimes confusing finding on spinal MRI is the report of Modic changes. Modic changes refer to specific signal changes in the vertebral endplate and adjacent bone marrow on a spine MRI. Modic type I changes appear to represent marrow edema and hypervascularity, and type II changes reflect fatty replacement of marrow. Both may be associated with fissured endplates. The rarer type III changes represent subchondral bone sclerosis [",
"    <a class=\"abstract\" href=\"UTD.htm?12/21/12633/abstract/39,40\">",
"     39,40",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The reported prevalence of Modic changes varies widely, reflecting small samples, variable subject selection, and methodological flaws. These changes are common in patients with back pain, with any type of Modic change typically reported in about 20 to 40 percent of patients with back pain. These changes also occur in approximately 6 to 10 percent of asymptomatic adults [",
"    <a class=\"abstract\" href=\"UTD.htm?12/21/12633/abstract/39,40\">",
"     39,40",
"    </a>",
"    ]. The prevalence of Modic changes increases with age and appears to be associated with degenerative disc changes. Additionally, the type of Modic change in a single patient may progress or regress over time [",
"    <a class=\"abstract\" href=\"UTD.htm?12/21/12633/abstract/41\">",
"     41",
"    </a>",
"    ]. A systematic review found only a small number treatment studies involving patients with Modic changes and concluded that it is unclear whether the presence of these changes is helpful in guiding the selection of treatment options [",
"    <a class=\"abstract\" href=\"UTD.htm?12/21/12633/abstract/42\">",
"     42",
"    </a>",
"    ]. &nbsp;",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h3\">",
"     CT scan",
"    </span>",
"    &nbsp;&mdash;&nbsp;CT is superior to MRI for demonstrating bony abnormalities such as sacroiliac joint disease, fractures, spondylolisthesis, unstable fusions, abnormal facet joints, degenerative changes, and congenital abnormalities. CT may be helpful when radiographs of the spine are abnormal or non-diagnostic following trauma and can detect the sacroiliac changes of ankylosing spondylitis before these are apparent on plain radiographs.",
"   </p>",
"   <p>",
"    Distinguishing disc from scar is difficult with CT, even after intravenous contrast injection. Intravenous contrast assists in the diagnosis of spinal epidural abscess, though CT is inferior to MRI for making this diagnosis [",
"    <a class=\"abstract\" href=\"UTD.htm?12/21/12633/abstract/43\">",
"     43",
"    </a>",
"    ]. CT is safe in patients with an implant containing any ferromagnetic material, though imaging artifacts may complicate interpretation. The radiation exposure from a lumbar CT can be 10-fold or greater, compared to a plain film. Use of simulated low-dose multidetector CT scans may allow reduction of radiation exposure compared to standard CT scanning, although this technology is not widely available at this time [",
"    <a class=\"abstract\" href=\"UTD.htm?12/21/12633/abstract/44\">",
"     44",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Relative radiation doses for spine imaging studies are shown in a table (",
"    <a class=\"graphic graphic_table graphicRef55620 \" href=\"UTD.htm?34/14/35052\">",
"     table 3",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h3\">",
"     Myelogram",
"    </span>",
"    &nbsp;&mdash;&nbsp;At one time, myelogram followed by CT scan was considered to be the definitive workup prior to disc herniation surgery. MRI is increasingly regarded as sufficient in most patients, especially those with an uncomplicated single herniated lumbar disc. Myelograms may be useful in patients with multiple disc abnormalities, multilevel radiculopathies, extruded free disc fragments, a disc fragment in the lateral recess, or previous lumbar surgery.",
"   </p>",
"   <p>",
"    Myelography involves injection of nonionic water-soluble contrast agents into the spinal canal, followed by x-rays or a CT scan. While the contrast agents (such as",
"    <a class=\"drug drug_general\" href=\"UTD.htm?35/45/36565?source=see_link\">",
"     iopamidol",
"    </a>",
"    and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?30/14/30949?source=see_link\">",
"     iohexol",
"    </a>",
"    ) are generally safe and have minimal side effects, there are risks to this invasive procedure. Risks are similar to those of routine lumbar puncture, with the addition of chemical meningitis, and rare seizures and allergic reactions. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/6/19561?source=see_link\">",
"     \"Lumbar puncture: Technique; indications; contraindications; and complications in adults\"",
"    </a>",
"    .) Total radiation exposure is slightly greater than that of lumbar CT.",
"   </p>",
"   <p>",
"    Myelography may be superior to MRI or CT for diagnosing herniated discs in patients with previous lumbar surgery [",
"    <a class=\"abstract\" href=\"UTD.htm?12/21/12633/abstract/31\">",
"     31",
"    </a>",
"    ]. A 2006 literature review failed to show any benefit of myelography over CT or MRI in diagnosing lumbar stenosis [",
"    <a class=\"abstract\" href=\"UTD.htm?12/21/12633/abstract/45\">",
"     45",
"    </a>",
"    ]. CT-myelogram is an acceptable alternative to MRI in a patient for whom a spinal epidural abscess is suspected [",
"    <a class=\"abstract\" href=\"UTD.htm?12/21/12633/abstract/46\">",
"     46",
"    </a>",
"    ]. Given the invasiveness of the procedure, myelography and CT-myelography should only be used in specific or extenuating circumstances, and are not tests usually ordered at the discretion of the primary care physician, but preferably with the consultation of a spine specialist.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Counseling patients who request imaging",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients often expect that an imaging study will be ordered during their initial visit for back pain, or that radicular back pain always requires an MRI to confirm a disc herniation. Patients who perceive that they have received an adequate explanation for the cause of their problem are less likely to want additional diagnostic tests and more likely to be satisfied with the visit than those who do not think they have been given an adequate explanation [",
"    <a class=\"abstract\" href=\"UTD.htm?12/21/12633/abstract/47\">",
"     47",
"    </a>",
"    ]. In addition, a careful physical exam with ongoing commentary (&ldquo;I&rsquo;m checking strength for any sign of nerve injury&rdquo;) may be reassuring for patients and help make it clear that the clinician is not inappropriately bypassing a further diagnostic evaluation or dismissing the symptoms.",
"   </p>",
"   <p>",
"    Although it is not possible to provide a definitive physiologic diagnosis for low back pain in the majority of patients, clinicians can plausibly reassure patients without red flags that they appear to have \"mechanical\" or non-specific low back pain, and that it is very unlikely that they have a serious underlying problem. Patients should be assured that improvement is to be expected. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/10/18601?source=see_link\">",
"     \"Approach to the diagnosis and evaluation of low back pain in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Patients with no red flags in their history or other clear indication for imaging should be advised that:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      They are unlikely to have a serious underlying condition. Fewer than one percent of patients in primary care have back pain due to neoplasms, spinal infections, or cauda equina syndrome [",
"      <a class=\"abstract\" href=\"UTD.htm?12/21/12633/abstract/48\">",
"       48",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Incidental imaging findings on x-ray studies, unrelated to their pain, are common, and may lead to unnecessary further tests or interventions. Disc herniations are found in 22 to 40 percent of asymptomatic adults, and degenerative changes on plain films in 23 percent [",
"      <a class=\"abstract\" href=\"UTD.htm?12/21/12633/abstract/14,16-19\">",
"       14,16-19",
"      </a>",
"      ]. These findings may lead to unnecessary further tests or interventions. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Radiographic testing'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Imaging is appropriate if they do not improve as expected.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In one randomized trial, low-risk patients who received an educational intervention rather than a plain x-ray were equally satisfied with their care and had equally good clinical outcomes [",
"    <a class=\"abstract\" href=\"UTD.htm?12/21/12633/abstract/49\">",
"     49",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h1\">",
"     OTHER STUDIES",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Electromyography",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although radiculopathy is a common reason for electromyography (EMG) referral, the value of EMG in assessing radicular symptoms is highly variable [",
"    <a class=\"abstract\" href=\"UTD.htm?12/21/12633/abstract/50\">",
"     50",
"    </a>",
"    ]. Patients with radicular pain",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    sensory changes, in the absence of motor findings, often do not have detectable electrophysiologic changes on either nerve conduction studies or needle electrode examination.",
"   </p>",
"   <p>",
"    Electrodiagnostic testing and neuroimaging are complementary diagnostic tools for assessing nerve function and structure, respectively. EMG is most helpful in evaluating patients with radiculopathy who may be surgical candidates and who have poor correlation between their radicular symptoms and neuroimaging, and in patients with multilevel disease evident on neuroimaging. Patients with radicular weakness and pain that correlates with their impingement level on neuroimaging may often be managed without an EMG.",
"   </p>",
"   <p>",
"    EMG can sometimes demonstrate abnormalities compatible with radiculopathy, even in the absence of definitive neuroimaging findings. In two studies of patients who underwent both EMG and CT prior to lumbar surgery, EMG was 100 percent sensitive for detecting surgically confirmed disc herniations, while CT was 94 to 97 percent sensitive [",
"    <a class=\"abstract\" href=\"UTD.htm?12/21/12633/abstract/51,52\">",
"     51,52",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Somatosensory evoked potentials lack sufficient sensitivity or specificity for acute radiculopathy, and there is no evidence that they add significant value for this diagnosis [",
"    <a class=\"abstract\" href=\"UTD.htm?12/21/12633/abstract/53\">",
"     53",
"    </a>",
"    ] but are sometimes helpful in localizing surgically treatable lesions in patients with spinal stenosis. &nbsp;",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Bone scan",
"    </span>",
"    &nbsp;&mdash;&nbsp;Radionuclide bone scans are of limited value in evaluating patients with back pain. They are more sensitive for detecting occult infection or a neoplasm than are plain radiographs [",
"    <a class=\"abstract\" href=\"UTD.htm?12/21/12633/abstract/3\">",
"     3",
"    </a>",
"    ]. The yield of a bone scan is very low in patients who have both normal plain films and a normal ESR [",
"    <a class=\"abstract\" href=\"UTD.htm?12/21/12633/abstract/4,7\">",
"     4,7",
"    </a>",
"    ]. An MRI provides greater sensitivity and specificity for vertebral osteomyelitis and malignancy, at a cost roughly twice that of a bone scan [",
"    <a class=\"abstract\" href=\"UTD.htm?12/21/12633/abstract/54\">",
"     54",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Discography",
"    </span>",
"    &nbsp;&mdash;&nbsp;Discography is a test in which contrast is injected under fluoroscopy into the nucleus of a disc thought to be the cause of a patient's low back pain. The test is considered positive if it demonstrates an annular disruption (contrast extravasation through tears in disc) and reproduces the patient's usual back pain.",
"   </p>",
"   <p>",
"    The value of discography is very controversial because of the absence of a clearly defined gold-standard reference test [",
"    <a class=\"abstract\" href=\"UTD.htm?12/21/12633/abstract/55\">",
"     55",
"    </a>",
"    ], known complications, and its inability to identify patients in whom interventions are associated with better outcomes. In one study, 32 patients with low back pain and a positive discogram who underwent spinal fusion were compared to a reference group of 34 patients who had spinal fusion for an unstable spondylolisthesis. At least \"minimally acceptable outcomes\" were achieved by 91 percent of patients with an unstable spondylolisthesis versus 43 percent of those with a positive discogram. The authors concluded that positive discography did not reliably identify patients with \"intradiscal lesions\" responsible for serious, chronic low back pain.",
"   </p>",
"   <p>",
"    Potential complications of discography include discitis, headache, worsening of chronic back pain, accelerated disc degeneration, and disc herniation [",
"    <a class=\"abstract\" href=\"UTD.htm?12/21/12633/abstract/56,57\">",
"     56,57",
"    </a>",
"    ]. This test is not recommended by the American Pain Society as a procedure for diagnosing low back pain [",
"    <a class=\"abstract\" href=\"UTD.htm?12/21/12633/abstract/58\">",
"     58",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h1\">",
"     GUIDELINES",
"    </span>",
"    &nbsp;&mdash;&nbsp;The American College of Radiology has published a guideline to assist practitioners in decisions regarding imaging for patients with low back pain [",
"    <a class=\"abstract\" href=\"UTD.htm?12/21/12633/abstract/27\">",
"     27",
"    </a>",
"    ]. This guideline reviews the evidence and rates the appropriateness of imaging studies (plain film, CT, MRI with and without contrast, myelography and bone scan) for six presentations of back pain.",
"   </p>",
"   <p>",
"    Guidelines from the American College of Physicians advise that imaging studies be performed in patients with acute low back pain who have major risk factors for cancer (new onset of low back pain with history of cancer, multiple risk factors for cancer, or strong clinical suspicion of cancer), risk factors for spinal infection, risk factors for or signs of cauda equina syndrome, or severe or progressive neurologic deficits (",
"    <a class=\"graphic graphic_table graphicRef52983 \" href=\"UTD.htm?29/27/30141\">",
"     table 4",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?12/21/12633/abstract/36\">",
"     36",
"    </a>",
"    ]. They also advise imaging after a trial of therapy in patients with minor risk factors for cancer (unexplained weight loss or age &gt;50 years), risk factors for inflammatory back disease, risk factors for vertebral compression fracture, signs or symptoms of radiculopathy, or risk factors for or symptoms of symptomatic spinal stenosis. Repeated imaging is only advised in patients with new or changed low back symptoms.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topics (see",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?36/7/36978?source=see_link\">",
"       \"Patient information: Low back pain in adults (The Basics)\"",
"      </a>",
"      and",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?32/16/33026?source=see_link\">",
"       \"Patient information: Do I need imaging for low back pain? (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Beyond the Basics topics (see",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?8/47/8950?source=see_link\">",
"       \"Patient information: Low back pain in adults (Beyond the Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A history and physical exam alone are sufficient to evaluate most patients with back pain of less than four weeks duration. Patients with \"red flags\" (",
"      <a class=\"graphic graphic_table graphicRef68550 \" href=\"UTD.htm?25/54/26475\">",
"       table 2",
"      </a>",
"      ) for a serious underlying condition (eg, fracture, neoplasm, infection, cauda equina syndrome or other significant neurologic deficits), or those who are surgical candidates for persistent nerve-impingement symptoms, may warrant additional diagnostic studies. (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Laboratory tests (CBC, ESR, and possibly CRP) are useful in detecting patients who may have spinal infection or malignancy, should be ordered in patients with history suggesting these conditions, and considered in patients with low back pain who have not improved within four weeks. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Laboratory studies'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Lumbar x-rays, CT, and MRI scans are often abnormal in asymptomatic patients. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Radiographic testing'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Plain radiographs do not detect herniated discs but can show evidence of infection, fracture, malignancy, spondylolisthesis, degenerative changes, disc space narrowing, and prior surgery. An ESR (or CRP) may be a useful screening test to determine which patients with risk factors for systemic illness should proceed to a radiologic study. (See",
"      <a class=\"local\" href=\"#H5\">",
"       'Plain x-rays'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      An MRI or CT should be performed when the clinical examination suggests emergent conditions (cauda equina syndrome, infection, tumor, fracture with neurologic impingement, or other mass lesions or defects) or in patients with at least four to six weeks of radicular symptoms or a several month history of neurogenic claudication who would be appropriate surgical candidates for disc disease or spinal stenosis respectively. (See",
"      <a class=\"local\" href=\"#H6\">",
"       'Specialized radiographic studies'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      MRI is generally considered the best initial test for most patients with low back pain who require advanced imaging, though CT scan gives better definition of bony structures. MRI is contraindicated in many patients with implanted ferromagnetic materials, and gadolinium contrast is contraindicated in patients with moderate to severe renal failure. (See",
"      <a class=\"local\" href=\"#H7\">",
"       'Magnetic resonance imaging'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H8\">",
"       'CT scan'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      A myelogram is rarely needed for patients with low back pain. It may be useful in patients with multiple disc abnormalities, multilevel radiculopathies, extruded free disc fragments, a disc fragment in the lateral recess, or previous lumbar surgery. Myelograms should be ordered at the discretion of a spine specialist. (See",
"      <a class=\"local\" href=\"#H9\">",
"       'Myelogram'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Electromyography (EMG) is most helpful in evaluating patients with radiculopathy who may be surgical candidates and who have poor correlation between their radicular symptoms and neuroimaging, and in patients with multilevel disease evident on neuroimaging. Somatosensory evoked potentials do not add significant value for most patients. (See",
"      <a class=\"local\" href=\"#H12\">",
"       'Electromyography'",
"      </a>",
"      above.) &nbsp;",
"     </li>",
"     <li>",
"      Radionuclide bone scans are of limited value in evaluating patients with back pain. The value of discography is controversial in the diagnosis of herniated disc as a cause of chronic low back pain. (See",
"      <a class=\"local\" href=\"#H13\">",
"       'Bone scan'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H14\">",
"       'Discography'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/21/12633/abstract/1\">",
"      Deyo RA, Tsui-Wu YJ. Descriptive epidemiology of low-back pain and its related medical care in the United States. Spine (Phila Pa 1976) 1987; 12:264.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/21/12633/abstract/2\">",
"      Cassidy JD, Carroll LJ, C&ocirc;t&eacute; P. The Saskatchewan health and back pain survey. The prevalence of low back pain and related disability in Saskatchewan adults. Spine (Phila Pa 1976) 1998; 23:1860.",
"     </a>",
"    </li>",
"    <li>",
"     Bigos SJ, Bowyer OR, Braen GR, et al. Acute low back pain problems in adults. Clinical practice guideline No 14. Agency for Health Care Policy and Research, Public Health Service; US Department of Health and Human Services, Rockville, MD, 1994.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/21/12633/abstract/4\">",
"      Chelsom J, Solberg CO. Vertebral osteomyelitis at a Norwegian university hospital 1987-97: clinical features, laboratory findings and outcome. Scand J Infect Dis 1998; 30:147.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/21/12633/abstract/5\">",
"      Beronius M, Bergman B, Andersson R. Vertebral osteomyelitis in G&ouml;teborg, Sweden: a retrospective study of patients during 1990-95. Scand J Infect Dis 2001; 33:527.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/21/12633/abstract/6\">",
"      Kapeller P, Fazekas F, Krametter D, et al. Pyogenic infectious spondylitis: clinical, laboratory and MRI features. Eur Neurol 1997; 38:94.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/21/12633/abstract/7\">",
"      Deyo RA, Diehl AK. Cancer as a cause of back pain: frequency, clinical presentation, and diagnostic strategies. J Gen Intern Med 1988; 3:230.",
"     </a>",
"    </li>",
"    <li>",
"     National Committee for Quality Assurance. The state of health care quality 2006. Available at: www.ncqa.org (Accessed on October 11, 2011).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/21/12633/abstract/9\">",
"      Liang M, Komaroff AL. Roentgenograms in primary care patients with acute low back pain: a cost-effectiveness analysis. Arch Intern Med 1982; 142:1108.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/21/12633/abstract/10\">",
"      Kendrick D, Fielding K, Bentley E, et al. Radiography of the lumbar spine in primary care patients with low back pain: randomised controlled trial. BMJ 2001; 322:400.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/21/12633/abstract/11\">",
"      Jarvik JG, Hollingworth W, Martin B, et al. Rapid magnetic resonance imaging vs radiographs for patients with low back pain: a randomized controlled trial. JAMA 2003; 289:2810.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/21/12633/abstract/12\">",
"      Srinivas SV, Deyo RA, Berger ZD. Application of &ldquo;less is more&rdquo; to low back pain. Arch Intern Med 2012; 172:1016.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/21/12633/abstract/13\">",
"      Chou R, Fu R, Carrino JA, Deyo RA. Imaging strategies for low-back pain: systematic review and meta-analysis. Lancet 2009; 373:463.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/21/12633/abstract/14\">",
"      Biering-S&oslash;rensen F, Hansen FR, Schroll M, Runeborg O. The relation of spinal x-ray to low-back pain and physical activity among 60-year-old men and women. Spine (Phila Pa 1976) 1985; 10:445.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/21/12633/abstract/15\">",
"      Kalichman L, Li L, Kim DH, et al. Facet joint osteoarthritis and low back pain in the community-based population. Spine (Phila Pa 1976) 2008; 33:2560.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/21/12633/abstract/16\">",
"      Jensen MC, Brant-Zawadzki MN, Obuchowski N, et al. Magnetic resonance imaging of the lumbar spine in people without back pain. N Engl J Med 1994; 331:69.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/21/12633/abstract/17\">",
"      Boden SD, Davis DO, Dina TS, et al. Abnormal magnetic-resonance scans of the lumbar spine in asymptomatic subjects. A prospective investigation. J Bone Joint Surg Am 1990; 72:403.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/21/12633/abstract/18\">",
"      Weishaupt D, Zanetti M, Hodler J, Boos N. MR imaging of the lumbar spine: prevalence of intervertebral disk extrusion and sequestration, nerve root compression, end plate abnormalities, and osteoarthritis of the facet joints in asymptomatic volunteers. Radiology 1998; 209:661.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/21/12633/abstract/19\">",
"      Jarvik JG, Hollingworth W, Heagerty PJ, et al. Three-year incidence of low back pain in an initially asymptomatic cohort: clinical and imaging risk factors. Spine (Phila Pa 1976) 2005; 30:1541.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/21/12633/abstract/20\">",
"      Wiesel SW, Tsourmas N, Feffer HL, et al. A study of computer-assisted tomography. I. The incidence of positive CAT scans in an asymptomatic group of patients. Spine (Phila Pa 1976) 1984; 9:549.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/21/12633/abstract/21\">",
"      Jarvik JJ, Hollingworth W, Heagerty P, et al. The Longitudinal Assessment of Imaging and Disability of the Back (LAIDBack) Study: baseline data. Spine (Phila Pa 1976) 2001; 26:1158.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/21/12633/abstract/22\">",
"      Magora A, Schwartz A. Relation between low back pain and X-ray changes. 4. Lysis and olisthesis. Scand J Rehabil Med 1980; 12:47.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/21/12633/abstract/23\">",
"      Williams FM, Manek NJ, Sambrook PN, et al. Schmorl's nodes: common, highly heritable, and related to lumbar disc disease. Arthritis Rheum 2007; 57:855.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/21/12633/abstract/24\">",
"      Komori H, Shinomiya K, Nakai O, et al. The natural history of herniated nucleus pulposus with radiculopathy. Spine (Phila Pa 1976) 1996; 21:225.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/21/12633/abstract/25\">",
"      Matsubara Y, Kato F, Mimatsu K, et al. Serial changes on MRI in lumbar disc herniations treated conservatively. Neuroradiology 1995; 37:378.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/21/12633/abstract/26\">",
"      Oland G, Hoff TG. Intraspinal cross-section areas measured on myelography--computed tomography. The relation to outcome in nonoperated lumbar disc herniation. Spine (Phila Pa 1976) 1996; 21:1985.",
"     </a>",
"    </li>",
"    <li>",
"     Bradley WG Jr, Seidenwurm DJ, Brunberg JA, et al. Low back pain. American College of Radiology (ACR), 2005. Available at: www.guideline.gov/summary/summary.aspx?doc_id=8599#s24 (Accessed on October 11, 2011).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/21/12633/abstract/28\">",
"      Chou R, Qaseem A, Snow V, et al. Diagnosis and treatment of low back pain: a joint clinical practice guideline from the American College of Physicians and the American Pain Society. Ann Intern Med 2007; 147:478.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/21/12633/abstract/29\">",
"      Jarvik JG, Deyo RA. Diagnostic evaluation of low back pain with emphasis on imaging. Ann Intern Med 2002; 137:586.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/21/12633/abstract/30\">",
"      Suarez-Almazor ME, Belseck E, Russell AS, Mackel JV. Use of lumbar radiographs for the early diagnosis of low back pain. Proposed guidelines would increase utilization. JAMA 1997; 277:1782.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/21/12633/abstract/31\">",
"      Jackson RP, Cain JE Jr, Jacobs RR, et al. The neuroradiographic diagnosis of lumbar herniated nucleus pulposus: II. A comparison of computed tomography (CT), myelography, CT-myelography, and magnetic resonance imaging. Spine (Phila Pa 1976) 1989; 14:1362.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/21/12633/abstract/32\">",
"      Thornbury JR, Fryback DG, Turski PA, et al. Disk-caused nerve compression in patients with acute low-back pain: diagnosis with MR, CT myelography, and plain CT. Radiology 1993; 186:731.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/21/12633/abstract/33\">",
"      Miller GM, Forbes GS, Onofrio BM. Magnetic resonance imaging of the spine. Mayo Clin Proc 1989; 64:986.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/21/12633/abstract/34\">",
"      Cheung KM, Karppinen J, Chan D, et al. Prevalence and pattern of lumbar magnetic resonance imaging changes in a population study of one thousand forty-three individuals. Spine (Phila Pa 1976) 2009; 34:934.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/21/12633/abstract/35\">",
"      McCullough BJ, Johnson GR, Martin BI, Jarvik JG. Lumbar MR imaging and reporting epidemiology: do epidemiologic data in reports affect clinical management? Radiology 2012; 262:941.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/21/12633/abstract/36\">",
"      Chou R, Qaseem A, Owens DK, et al. Diagnostic imaging for low back pain: advice for high-value health care from the American College of Physicians. Ann Intern Med 2011; 154:181.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/21/12633/abstract/37\">",
"      Cohen SP, Gupta A, Strassels SA, et al. Effect of MRI on treatment results or decision making in patients with lumbosacral radiculopathy referred for epidural steroid injections: a multicenter, randomized controlled trial. Arch Intern Med 2012; 172:134.",
"     </a>",
"    </li>",
"    <li>",
"     Center for Drug Evaluation and Research. Public Health Advisory. Update on Magnetic Resonance Imaging (MRI) Contrast Agents Containing Gadolinium and Nephrogenic Fibrosing Dermopathy. Food and Drug Administration. Available at: www.fda.gov/cder/drug/advisory/gadolinium_agents_20061222.htm (Accessed on May 03, 2007).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/21/12633/abstract/39\">",
"      Zhang YH, Zhao CQ, Jiang LS, et al. Modic changes: a systematic review of the literature. Eur Spine J 2008; 17:1289.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/21/12633/abstract/40\">",
"      Jensen TS, Karppinen J, Sorensen JS, et al. Vertebral endplate signal changes (Modic change): a systematic literature review of prevalence and association with non-specific low back pain. Eur Spine J 2008; 17:1407.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/21/12633/abstract/41\">",
"      Hutton MJ, Bayer JH, Powell JM. Modic vertebral body changes: the natural history as assessed by consecutive magnetic resonance imaging. Spine (Phila Pa 1976) 2011; 36:2304.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/21/12633/abstract/42\">",
"      Jensen RK, Leboeuf-Yde C. Is the presence of modic changes associated with the outcomes of different treatments? A systematic critical review. BMC Musculoskelet Disord 2011; 12:183.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/21/12633/abstract/43\">",
"      Rigamonti D, Liem L, Sampath P, et al. Spinal epidural abscess: contemporary trends in etiology, evaluation, and management. Surg Neurol 1999; 52:189.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/21/12633/abstract/44\">",
"      Bohy P, de Maertelaer V, Roquigny A, et al. Multidetector CT in patients suspected of having lumbar disk herniation: comparison of standard-dose and simulated low-dose techniques. Radiology 2007; 244:524.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/21/12633/abstract/45\">",
"      de Graaf I, Prak A, Bierma-Zeinstra S, et al. Diagnosis of lumbar spinal stenosis: a systematic review of the accuracy of diagnostic tests. Spine (Phila Pa 1976) 2006; 31:1168.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/21/12633/abstract/46\">",
"      Rothman SL. The diagnosis of infections of the spine by modern imaging techniques. Orthop Clin North Am 1996; 27:15.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/21/12633/abstract/47\">",
"      Deyo RA, Diehl AK. Patient satisfaction with medical care for low-back pain. Spine (Phila Pa 1976) 1986; 11:28.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/21/12633/abstract/48\">",
"      Deyo RA, Rainville J, Kent DL. What can the history and physical examination tell us about low back pain? JAMA 1992; 268:760.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/21/12633/abstract/49\">",
"      Deyo RA, Diehl AK, Rosenthal M. Reducing roentgenography use. Can patient expectations be altered? Arch Intern Med 1987; 147:141.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/21/12633/abstract/50\">",
"      Levin KH. Electrodiagnostic approach to the patient with suspected radiculopathy. Neurol Clin 2002; 20:397.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/21/12633/abstract/51\">",
"      Park ES, Park CI, Kim AY, Park MK. Relationship between electromyography and computed tomography in the evaluation of low back pain. Yonsei Med J 1993; 34:84.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/21/12633/abstract/52\">",
"      Khatri BO, Baruah J, McQuillen MP. Correlation of electromyography with computed tomography in evaluation of lower back pain. Arch Neurol 1984; 41:594.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/21/12633/abstract/53\">",
"      Dumitru D, Dreyfuss P. Dermatomal/segmental somatosensory evoked potential evaluation of L5/S1 unilateral/unilevel radiculopathies. Muscle Nerve 1996; 19:442.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/21/12633/abstract/54\">",
"      Algra PR, Bloem JL, Tissing H, et al. Detection of vertebral metastases: comparison between MR imaging and bone scintigraphy. Radiographics 1991; 11:219.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/21/12633/abstract/55\">",
"      Carragee EJ, Lincoln T, Parmar VS, Alamin T. A gold standard evaluation of the \"discogenic pain\" diagnosis as determined by provocative discography. Spine (Phila Pa 1976) 2006; 31:2115.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/21/12633/abstract/56\">",
"      Cohen SP, Larkin TM, Barna SA, et al. Lumbar discography: a comprehensive review of outcome studies, diagnostic accuracy, and principles. Reg Anesth Pain Med 2005; 30:163.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/21/12633/abstract/57\">",
"      Carragee EJ, Don AS, Hurwitz EL, et al. 2009 ISSLS Prize Winner: Does discography cause accelerated progression of degeneration changes in the lumbar disc: a ten-year matched cohort study. Spine (Phila Pa 1976) 2009; 34:2338.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/21/12633/abstract/58\">",
"      Chou R, Loeser JD, Owens DK, et al. Interventional therapies, surgery, and interdisciplinary rehabilitation for low back pain: an evidence-based clinical practice guideline from the American Pain Society. Spine (Phila Pa 1976) 2009; 34:1066.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 7783 Version 23.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-203.80.222.8-3836C529BC-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f12_21_12633=[""].join("\n");
var outline_f12_21_12633=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H16\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      LABORATORY STUDIES",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      RADIOGRAPHIC TESTING",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Red flags",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Plain x-rays",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Specialized radiographic studies",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      - Magnetic resonance imaging",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H88179979\">",
"      Modic changes",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      - CT scan",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      - Myelogram",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Counseling patients who request imaging",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      OTHER STUDIES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Electromyography",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Bone scan",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Discography",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      GUIDELINES",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PC/7783\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PC/7783|ALG\">",
"      <a href=\"#\" title=\"ALGORITHMS\">",
"       ALGORITHMS",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_algorithm\" href=\"UTD.htm?36/31/37362\" title=\"algorithm 1\">",
"      LBP sciatica chart",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PC/7783|DiagnosticImage\">",
"      <a href=\"#\" title=\"DIAGNOSTIC IMAGES\">",
"       DIAGNOSTIC IMAGES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?2/37/2646\" title=\"diagnostic image 1\">",
"      Schmorl nodes of the spine",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PC/7783|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?29/36/30283\" title=\"table 1\">",
"      Cancer tests for back pain",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?25/54/26475\" title=\"table 2\">",
"      Red flag symptoms of low back pain",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?34/14/35052\" title=\"table 3\">",
"      Relative radiation doses for spine imaging studies",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?29/27/30141\" title=\"table 4\">",
"      ACP Best Practice Advice - Lower back pain",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?18/10/18601?source=related_link\">",
"      Approach to the diagnosis and evaluation of low back pain in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?34/13/35034?source=related_link\">",
"      Clinical features, laboratory manifestations, and diagnosis of multiple myeloma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?13/20/13640?source=related_link\">",
"      Diagnosis and differential diagnosis of ankylosing spondylitis in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?30/34/31274?source=related_link\">",
"      Evaluation and acute management of cervical spinal column injuries in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?19/6/19561?source=related_link\">",
"      Lumbar puncture: Technique; indications; contraindications; and complications in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?1/28/1480?source=related_link\">",
"      Lumbar spinal stenosis: Pathophysiology, clinical features, and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?30/22/31082?source=related_link\">",
"      Nephrogenic systemic fibrosis/nephrogenic fibrosing dermopathy in advanced renal failure",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?32/16/33026?source=related_link\">",
"      Patient information: Do I need imaging for low back pain? (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?8/47/8950?source=related_link\">",
"      Patient information: Low back pain in adults (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?36/7/36978?source=related_link\">",
"      Patient information: Low back pain in adults (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?5/35/5689?source=related_link\">",
"      Principles of magnetic resonance imaging",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?38/52/39753?source=related_link\">",
"      Subacute and chronic low back pain: Nonsurgical interventional treatment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?19/24/19850?source=related_link\">",
"      Subacute and chronic low back pain: Pharmacologic and noninterventional treatment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?34/5/34905?source=related_link\">",
"      Subacute and chronic low back pain: Surgical treatment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?13/21/13658?source=related_link\">",
"      Treatment of acute low back pain",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f12_21_12634="Cytomegalovirus infection in pregnancy";
var content_f12_21_12634=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"6\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Cytomegalovirus infection in pregnancy",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?12/21/12634/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?12/21/12634/contributors\">",
"     Jeanne S Sheffield, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?12/21/12634/contributors\">",
"     Suresh B Boppana, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?12/21/12634/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?12/21/12634/contributors\">",
"     Louise Wilkins-Haug, MD, PhD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?12/21/12634/contributors\">",
"     Martin S Hirsch, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?12/21/12634/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?12/21/12634/contributors\">",
"     Vanessa A Barss, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?12/21/12634/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Mar 14, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Cytomegalovirus (CMV) is a ubiquitous DNA herpesvirus that causes a wide variety of clinical manifestations. It is the most common congenital viral infection, with birth prevalence of about 0.5 percent (range 0.2 to 2.5 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?12/21/12634/abstract/1,2\">",
"     1,2",
"    </a>",
"    ]. The factors responsible for transmission to the fetus and severity of congenital CMV infection are not well understood. Preexisting maternal CMV seropositivity substantially decreases, but does not completely eliminate, fetal infection, suggesting partial protection from maternal immunity [",
"    <a class=\"abstract\" href=\"UTD.htm?12/21/12634/abstract/3,4\">",
"     3,4",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Although the majority of congenital infections are asymptomatic, 5 to 20 percent of infants born to mothers with primary CMV infection are overtly symptomatic. These children have a mortality rate of about 5 percent, and severe neurologic morbidity occurs in 50 to 60 percent of survivors [",
"    <a class=\"abstract\" href=\"UTD.htm?12/21/12634/abstract/5,6\">",
"     5,6",
"    </a>",
"    ]. Asymptomatic infants are also at risk of developing long-term neurodevelopment morbidity, but the risk is much lower than in symptomatic neonates.",
"   </p>",
"   <p>",
"    CMV infection in pregnant women and fetuses will be reviewed here. CMV in newborns, infants, and children, as well as in immunocompetent and immunocompromised hosts, is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?35/51/36664?source=see_link\">",
"     \"Cytomegalovirus infection and disease in newborns, infants, children and adolescents\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?13/25/13722?source=see_link\">",
"     \"Epidemiology, clinical manifestations, and treatment of cytomegalovirus infection in immunocompetent hosts\"",
"    </a>",
"    .) Also see topics related to CMV in specific settings of immunocompromise (eg, transplant recipients, HIV infection).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     CLASSIFICATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;CMV infections in pregnant women are classified as:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <strong>",
"       Primary",
"      </strong>",
"      if the initial acquisition of virus (ie, seroconversion from negative to positive) occurs during pregnancy",
"     </li>",
"     <li>",
"      <strong>",
"       Nonprimary",
"      </strong>",
"      if maternal antibody to CMV was present before conception. Like other herpesviruses, CMV establishes latency after the host is initially infected. Nonprimary infection, also sometimes called recurrent or secondary infection, may be due to reactivation of latent virus or reinfection with a new strain.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     SEROPREVALENCE",
"    </span>",
"    &nbsp;&mdash;&nbsp;Seroprevalence for CMV increases with age, ranging from 50 to 100 percent, depending upon the geographic area and socioeconomic status [",
"    <a class=\"abstract\" href=\"UTD.htm?12/21/12634/abstract/1,2\">",
"     1,2",
"    </a>",
"    ]. A United States-based epidemiologic study demonstrated seropositivity in approximately 58 percent of young women aged 15 to 44 years; as many as half a million women in the United States develop primary CMV infections each year [",
"    <a class=\"abstract\" href=\"UTD.htm?12/21/12634/abstract/7-9\">",
"     7-9",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Preexisting maternal antibody to CMV is the most important protective factor against congenital CMV infection [",
"    <a class=\"abstract\" href=\"UTD.htm?12/21/12634/abstract/4\">",
"     4",
"    </a>",
"    ]. The prevalence of preexisting antibody is influenced by several factors, which are somewhat interdependent. Seroprevalence is highest in the following groups:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Women in lower socioeconomic conditions. The seropositivity rate is 50 to 60 percent for American middle class women versus 70 to 85 percent for those in lower socioeconomic groups. However, recurrent infections are more common in lower socioeconomic groups (3.6 versus 1.7 percent in an upper socioeconomic group) [",
"      <a class=\"abstract\" href=\"UTD.htm?12/21/12634/abstract/10\">",
"       10",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Women residing in developing countries",
"     </li>",
"     <li>",
"      Non-Hispanic black and Mexican-American women compared to non-Hispanic white women [",
"      <a class=\"abstract\" href=\"UTD.htm?12/21/12634/abstract/7\">",
"       7",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Women over 25 to 30 years of age [",
"      <a class=\"abstract\" href=\"UTD.htm?12/21/12634/abstract/2,4\">",
"       2,4",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Women of higher parity [",
"      <a class=\"abstract\" href=\"UTD.htm?12/21/12634/abstract/11\">",
"       11",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Women with children under age 3 years, especially if they are in daycare since seropositivity rates are higher among children in daycare (seropositivity: 50 to 70 percent versus 20 percent in the general population of young children in the US) [",
"      <a class=\"abstract\" href=\"UTD.htm?12/21/12634/abstract/2,12,13\">",
"       2,12,13",
"      </a>",
"      ]. Young children with primary CMV infection shed the virus in their urine and saliva for a median of 18 months.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     SEROCONVERSION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The rate of seroconversion during pregnancy ranges from 1 to 7 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?12/21/12634/abstract/14\">",
"     14",
"    </a>",
"    ]. Person-to-person transmission usually occurs by contact with infected nasopharyngeal secretions, urine, saliva, semen, cervical and vaginal secretions, breast milk, tissue, or blood. The risk of seroconversion is highest in households with young children in daycare centers.",
"   </p>",
"   <p>",
"    A review of studies that described rates of CMV seroconversion in different US subgroups reported the following rates [",
"    <a class=\"abstract\" href=\"UTD.htm?12/21/12634/abstract/14\">",
"     14",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Pregnant women: summary annual rate 2.3 percent (95% CI 2.1-2.4 percent)",
"     </li>",
"     <li>",
"      Healthcare workers, including those caring for infants and children: summary annual rate 2.3 percent (95% CI 1.9-2.9 percent)",
"     </li>",
"     <li>",
"      Day-care providers: summary annual rate 8.5 percent (95% CI 6.1-11.6 percent)",
"     </li>",
"     <li>",
"      Parents of a child who was not shedding CMV: summary annual rate 2.1 percent (95% CI 0.3-6.8 percent)",
"     </li>",
"     <li>",
"      Parents of a child who was shedding CMV: summary annual rate 24 percent (95% CI 18-30 percent)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Other groups with elevated risk of seroconversion included families with a CMV-shedding member, female minority adolescents, and women attending sexually transmitted disease clinics.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h1\">",
"     VERTICAL TRANSMISSION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Maternal transmission to the fetus or newborn is most common following primary maternal infection. Following primary maternal infection, anti-CMV antibodies develop and the virus becomes latent. However, as with other herpesvirus infections, periodic reactivation with viral shedding is possible, especially in immunocompromised individuals (eg, organ transplant recipients, individuals with HIV infection). Maternal antibodies to CMV do not prevent reactivation or reinfection with a new viral strain, and thus do not reliably prevent congenital infection. There is some evidence that more than one viral strain can be transmitted to the fetus, either as a single event with co-disseminating strains, or by multiple transmission events of individual viruses, or both [",
"    <a class=\"abstract\" href=\"UTD.htm?12/21/12634/abstract/15\">",
"     15",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3786126\">",
"    <span class=\"h2\">",
"     Route",
"    </span>",
"    &nbsp;&mdash;&nbsp;Transmission of CMV from the mother to the fetus or newborn can occur in several ways:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Most commonly, CMV infects the placenta (placental cytotrophoblasts are permissive to CMV replication) and is then transmitted to the",
"      <span class=\"nowrap\">",
"       embryo/fetus,",
"      </span>",
"      where the virus is replicated in multiple tissues, including renal tubular epithelium [",
"      <a class=\"abstract\" href=\"UTD.htm?12/21/12634/abstract/16\">",
"       16",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Ascending infection from the maternal genital tract is thought to be rare antepartum, but possible [",
"      <a class=\"abstract\" href=\"UTD.htm?12/21/12634/abstract/17\">",
"       17",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Intrapartum and postnatal transmission can occur via",
"      <span class=\"nowrap\">",
"       ingestion/aspiration",
"      </span>",
"      of cervicovaginal secretions during delivery or via breastfeeding. Rates of cervical CMV excretion vary depending upon various factors, including age, socioeconomic status, and geography of the populations studied [",
"      <a class=\"abstract\" href=\"UTD.htm?12/21/12634/abstract/5,18-22\">",
"       5,18-22",
"      </a>",
"      ]. In one study, up to 57 percent of babies whose mothers shed CMV at or around the time of delivery became infected [",
"      <a class=\"abstract\" href=\"UTD.htm?12/21/12634/abstract/19\">",
"       19",
"      </a>",
"      ]. In another study, 96 percent of seropositive mothers had detectable CMV viral DNA in breast milk when tested in the early postpartum period [",
"      <a class=\"abstract\" href=\"UTD.htm?12/21/12634/abstract/23\">",
"       23",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In contrast, presence of CMV DNA in maternal blood at the time of amniocentesis does not appear to be a risk factor for iatrogenic antepartum transmission [",
"    <a class=\"abstract\" href=\"UTD.htm?12/21/12634/abstract/24\">",
"     24",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3786034\">",
"    <span class=\"h2\">",
"     Rate",
"    </span>",
"    &nbsp;&mdash;&nbsp;A systematic review found that primary maternal infection was transmitted to the fetus in 32 percent of cases [",
"    <a class=\"abstract\" href=\"UTD.htm?12/21/12634/abstract/1\">",
"     1",
"    </a>",
"    ]. For women infected before conception, the rate of fetal infection was 1.4 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?12/21/12634/abstract/1\">",
"     1",
"    </a>",
"    ]. This rate appears to be higher if the pregnancy occurs within two years of a primary infection [",
"    <a class=\"abstract\" href=\"UTD.htm?12/21/12634/abstract/2,4,25,26\">",
"     2,4,25,26",
"    </a>",
"    ]. Because CMV DNA has been detected in blood of 20 percent of immunocompetent patients as long as six months after diagnosis of primary infection, some experts suggest that a woman wait at least six months after a primary infection before attempting to conceive; however, data are limited and other experts suggest waiting a minimum of three or four months [",
"    <a class=\"abstract\" href=\"UTD.htm?12/21/12634/abstract/2,27\">",
"     2,27",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Although several studies have suggested that gestational age has no apparent influence on the risk of transmission of CMV in utero [",
"    <a class=\"abstract\" href=\"UTD.htm?12/21/12634/abstract/6\">",
"     6",
"    </a>",
"    ], one group observed an increased risk of transmission in late gestation [",
"    <a class=\"abstract\" href=\"UTD.htm?12/21/12634/abstract/28,29\">",
"     28,29",
"    </a>",
"    ]. Their study, which is the largest published series, included 524 women who seroconverted during pregnancy [",
"    <a class=\"abstract\" href=\"UTD.htm?12/21/12634/abstract/29\">",
"     29",
"    </a>",
"    ]. They found that the rate of transmission increased throughout pregnancy and was approximately 35, 44, and 73 percent, for the first, second, and third trimesters, respectively. The authors did not describe any outcome other than transmission (ie, amniotic fluid or neonatal urine positive for CMV).",
"   </p>",
"   <p>",
"    Another series evaluated vertical transmission rates in 508 women who seroconverted preconception (12 months to 8 weeks before conception), periconception (eight weeks before to six weeks after conception), or in the first, second, and third trimesters [",
"    <a class=\"abstract\" href=\"UTD.htm?12/21/12634/abstract/30\">",
"     30",
"    </a>",
"    ]. Vertical transmission rates were 0, 4.6, 34.8, 42, and 58.6 percent, respectively. The overall (preconception and postconception) transmission rate was 23.2 percent, but 39.9 percent for women who converted during pregnancy. The 17 fetuses infected during the third trimester had no apparent disease after birth, however, the median follow-up was only 18 months.",
"   </p>",
"   <p>",
"    Although perinatal transmission may increase as gestation advances, sequelae in offspring appear to be less severe the later in gestation transmission occurs (see",
"    <a class=\"local\" href=\"#H8\">",
"     'Congenital infection'",
"    </a>",
"    below).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h1\">",
"     CLINICAL FEATURES",
"    </span>",
"    &nbsp;&mdash;&nbsp;The integrity of the host immune system affects the spectrum of disease: hosts with impaired cellular immunity are at risk for severe and disseminated infection. CMV infection in both pregnant women and their offspring is usually asymptomatic. However, severe congenital infection can develop and late sequelae can arise, which has led to substantial interest in prenatal diagnosis (see",
"    <a class=\"local\" href=\"#H14\">",
"     'Prenatal diagnosis'",
"    </a>",
"    below).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Maternal infection",
"    </span>",
"    &nbsp;&mdash;&nbsp;Primary CMV infection in a pregnant woman may cause a mild febrile illness and other nonspecific symptoms, but is not clinically apparent in 90 percent of cases. Pregnancy does not appear to affect clinical severity. Reinfection with a different strain of CMV or reactivation of virus in women with preexisting antibody generally does not cause maternal clinical illness. A study of 316 pregnant women with antibodies to CMV, 102 of whom had primary infection, reported that clinical manifestations (fever, asthenia, myalgia, flu-like syndrome)",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    laboratory abnormalities occurred in 61 women with primary infection (60 percent), in 20 women with recurrent infection (19 percent), and in 13 control women (12 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?12/21/12634/abstract/31\">",
"     31",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The clinical manifestations of CMV infection in adults are discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?13/25/13722?source=see_link\">",
"     \"Epidemiology, clinical manifestations, and treatment of cytomegalovirus infection in immunocompetent hosts\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Congenital infection",
"    </span>",
"    &nbsp;&mdash;&nbsp;Primary CMV infection is more likely than nonprimary infection to cause symptoms at birth and long-term disability. It is estimated that 25 percent of congenital CMV infections in the United States result from primary maternal infection [",
"    <a class=\"abstract\" href=\"UTD.htm?12/21/12634/abstract/32\">",
"     32",
"    </a>",
"    ]. This estimate was based on summary data on mother-to-fetus transmission rates from a comprehensive literature review and previously reported nationally representative data on age and race-specific CMV seroprevalence and seroincidence.",
"   </p>",
"   <p>",
"    Most newborns of women with primary CMV infection and almost all newborns of women with nonprimary infection in pregnancy are initially asymptomatic. Ten to 15 percent of these initially asymptomatic newborns develop neurodevelopmental damage within the first three years of life [",
"    <a class=\"abstract\" href=\"UTD.htm?12/21/12634/abstract/33\">",
"     33",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Approximately 5 to 20 percent of newborns of mothers with primary CMV infection are overtly symptomatic at birth (eg, small for gestational age, microcephaly, ventriculomegaly, chorioretinitis, hepatitis, splenomegaly, thrombocytopenia, petechiae). These newborns have a mortality rate of about 5 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?12/21/12634/abstract/5,6\">",
"     5,6",
"    </a>",
"    ], and 50 to 60 percent of survivors develop severe long-term neurologic morbidity (eg, progressive hearing",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    visual loss, cognitive impairment). Symptomatic disease at birth and severe sequelae are most common with primary infection acquired in the first half of pregnancy [",
"    <a class=\"abstract\" href=\"UTD.htm?12/21/12634/abstract/2,16,29,30,34-39\">",
"     2,16,29,30,34-39",
"    </a>",
"    ]. Nonprimary infection results in symptomatic disease at birth in 0.2 to 2 percent of cases; death is rare [",
"    <a class=\"abstract\" href=\"UTD.htm?12/21/12634/abstract/2,40,41\">",
"     2,40,41",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The features of congenital infection result, in part, from viral replication in different organs (eg, salivary gland, lung, liver, kidney, intestine, adrenal gland, placenta, and the central nervous system) [",
"    <a class=\"abstract\" href=\"UTD.htm?12/21/12634/abstract/42\">",
"     42",
"    </a>",
"    ]. Other pathogenic mechanisms that may explain the features of congenital CMV infection include a sepsis-like syndrome, immunopathologic reactions (eg, granulomatous reactions [particularly in the liver]), immune complex formation, vasculitis, and impairment in CMV-specific cell-mediated immunity [",
"    <a class=\"abstract\" href=\"UTD.htm?12/21/12634/abstract/43\">",
"     43",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The clinical features of congenital infection are discussed in detail elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?35/51/36664?source=see_link\">",
"     \"Cytomegalovirus infection and disease in newborns, infants, children and adolescents\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/24/28041?source=see_link&amp;anchor=H29#H29\">",
"     \"Overview of TORCH infections\", section on 'Congenital cytomegalovirus'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Congenital CMV infection appears to be a cause of intrauterine fetal demise and should be considered in the evaluation of stillbirths of unknown etiology after autopsy [",
"    <a class=\"abstract\" href=\"UTD.htm?12/21/12634/abstract/44\">",
"     44",
"    </a>",
"    ]. Histopathology of the placenta may show diffuse chronic villitis with plasma cells, plasma cell deciduitis, chorionic plate vascular thromboses, hemosiderin in the villi and, less commonly, viral inclusions; these and other histopathological changes are described separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?3/63/4089?source=see_link&amp;anchor=H13#H13\">",
"     \"Placental infections\", section on 'Cytomegalovirus'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3786739\">",
"    <span class=\"h2\">",
"     HIV infection",
"    </span>",
"    &nbsp;&mdash;&nbsp;Compared to immunocompetent women, CMV infection in immunocompromised women is more likely to present with a mononucleosis-like syndrome, as well as myocarditis, hepatitis, pneumonitis, retinitis, gastroenteritis,",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    meningoencephalitis. (See separate topic reviews on these complications in HIV infected individuals).",
"   </p>",
"   <p>",
"    The prevalence of congenital CMV is similar in infants of HIV-infected and noninfected mothers [",
"    <a class=\"abstract\" href=\"UTD.htm?12/21/12634/abstract/45,46\">",
"     45,46",
"    </a>",
"    ]. However, perinatal acquisition of CMV appears to be higher among HIV-infected babies, and dual infection has been associated with a significantly higher rate of HIV progression and CNS disease than in children infected with HIV alone [",
"    <a class=\"abstract\" href=\"UTD.htm?12/21/12634/abstract/45\">",
"     45",
"    </a>",
"    ]. Perinatal CMV transmission from HIV-infected mothers can be decreased by avoiding breastfeeding; HIV-infected mothers are counseled to avoid breastfeeding when an adequate alternative is available [",
"    <a class=\"abstract\" href=\"UTD.htm?12/21/12634/abstract/46\">",
"     46",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/4/15433?source=see_link\">",
"     \"Prenatal evaluation and intrapartum management of the HIV-infected patient in resource-rich settings\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?24/44/25290?source=see_link\">",
"     \"Use of antiretroviral medications in pregnant HIV-infected patients and their infants in resource-rich settings\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h1\">",
"     DIAGNOSIS",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Whom to test",
"    </span>",
"    &nbsp;&mdash;&nbsp;Testing pregnant women for CMV is indicated as part of the diagnostic evaluation of mononucleosis-like illnesses (see",
"    <a class=\"medical medical_review\" href=\"UTD.htm?30/18/31018?source=see_link&amp;anchor=H5#H5\">",
"     \"Infectious mononucleosis in adults and adolescents\", section on 'Clinical manifestations'",
"    </a>",
"    ), when a fetal anomaly suggestive of congenital CMV infection is detected on prenatal ultrasound examination (see",
"    <a class=\"local\" href=\"#H14\">",
"     'Prenatal diagnosis'",
"    </a>",
"    below), or if the woman requests the test [",
"    <a class=\"abstract\" href=\"UTD.htm?12/21/12634/abstract/47\">",
"     47",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Women who are immunocompromised or with known exposure to CMV should have baseline CMV serology performed.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     How to test",
"    </span>",
"    &nbsp;&mdash;&nbsp;The diagnosis of clinically suspected maternal primary CMV infection is based on serology. Seroconversion of CMV-specific IgG in paired acute and convalescent sera is diagnostic of a new acute infection. Presence of CMV IgM is not helpful for timing the onset of infection because it is present in only 75 to 90 percent of women with acute infection, can remain positive for over one year after an acute infection, and can revert from negative to positive in women with CMV reactivation or reinfection with a different strain.",
"   </p>",
"   <p>",
"    In the absence of documented recent seroconversion, it is difficult to impossible to distinguish between primary and nonprimary infection since both can be associated with a four-fold rise in IgG titers and presence of IgM antibodies. Determination of IgG avidity combined with microneutralization assays is helpful to better determine the acuity of the infection and thus the risk of in utero transmission [",
"    <a class=\"abstract\" href=\"UTD.htm?12/21/12634/abstract/48-50\">",
"     48-50",
"    </a>",
"    ]. High anti-CMV IgG avidity (&gt;65 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?12/21/12634/abstract/51\">",
"     51",
"    </a>",
"    ]) suggests that the primary infection occurred more than six months in the past; low avidity anti-CMV IgG (&lt;30 percent) suggests a recent primary infection (within two to four months) [",
"    <a class=\"abstract\" href=\"UTD.htm?12/21/12634/abstract/52\">",
"     52",
"    </a>",
"    ]. The diagnosis of CMV is discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?8/25/8597?source=see_link\">",
"     \"Diagnosis of cytomegalovirus\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Serological tests cannot differentiate among the many strains of CMV.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h1\">",
"     SCREENING",
"    </span>",
"    &nbsp;&mdash;&nbsp;Since CMV infection is usually asymptomatic and transmissible to the fetus, some experts suggest that all women of childbearing age should know their CMV serostatus, although this is controversial [",
"    <a class=\"abstract\" href=\"UTD.htm?12/21/12634/abstract/53-56\">",
"     53-56",
"    </a>",
"    ]. Routine serological screening for CMV is not recommended for several reasons [",
"    <a class=\"abstract\" href=\"UTD.htm?12/21/12634/abstract/2,57\">",
"     2,57",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      No vaccine is available to prevent infection in seronegative women.",
"     </li>",
"     <li>",
"      In seropositive pregnant women, it is difficult to distinguish between primary and nonprimary infection or determine the timing of the infection, which could have occurred many months before conception.",
"     </li>",
"     <li>",
"      There is no evidence that antiviral drug treatment of primary infection in pregnant women prevents or mitigates sequelae of CMV infection in the neonate.",
"     </li>",
"     <li>",
"      Although fetal infection can be detected, there is no way to accurately predict whether or not the fetus will develop significant sequelae.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    On the other hand, proponents of universal screening argue that knowledge that her serology is negative for CMV antibodies and education increase some women's motivation to practice good hygiene and decrease the risk of seroconversion during pregnancy; there is some evidence supporting this hypothesis (see",
"    <a class=\"local\" href=\"#H19\">",
"     'Precautions to prevent transmission'",
"    </a>",
"    below) [",
"    <a class=\"abstract\" href=\"UTD.htm?12/21/12634/abstract/58-60\">",
"     58-60",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Repeated serological screening during pregnancy to detect seroconversion is not commonly performed because of cost, lack of effective treatment, and generally poor ability of positive serology to predict the fetus' long-term outcome. The only study of passive immunization of women diagnosed with primary CMV infection during pregnancy found that passive immunization could reduce the prevalence of congenital CMV infection (see",
"    <a class=\"local\" href=\"#H17\">",
"     'Hyperimmunoglobulin'",
"    </a>",
"    below) [",
"    <a class=\"abstract\" href=\"UTD.htm?12/21/12634/abstract/61\">",
"     61",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    If the value of knowledge of serological status and passive immunization is confirmed, then screening, serial serology in CMV-negative women, and treatment of seroconverters may become a cost-effective approach [",
"    <a class=\"abstract\" href=\"UTD.htm?12/21/12634/abstract/56\">",
"     56",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h1\">",
"     PRENATAL DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;We suggest that prenatal diagnosis be offered to women suspected of having a primary or nonprimary CMV infection, since it is often difficult to distinguish between the two types of infection in a timely manner. The rationale for offering prenatal diagnosis is the potential for severe sequelae in offspring, especially with primary maternal infection. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?35/51/36664?source=see_link\">",
"     \"Cytomegalovirus infection and disease in newborns, infants, children and adolescents\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Amniocentesis to perform PCR for CMV DNA in amniotic fluid is the preferred diagnostic approach for identifying an infected fetus; viral culture is less desirable because of several limitations. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?8/25/8597?source=see_link&amp;anchor=H4#H4\">",
"     \"Diagnosis of cytomegalovirus\", section on 'Cultures'",
"    </a>",
"    .) Reported sensitivity of PCR ranges from 70 to 100 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?12/21/12634/abstract/36,54,55,62\">",
"     36,54,55,62",
"    </a>",
"    ]. Timing of amniocentesis appears to be a critical factor influencing sensitivity: sensitivity appears to be higher after 21 weeks of gestation and by allowing a six-week lag time between maternal infection and amniocentesis [",
"    <a class=\"abstract\" href=\"UTD.htm?12/21/12634/abstract/36,54,55\">",
"     36,54,55",
"    </a>",
"    ]. The six-week lag time reflects the time it takes for placental infection and replication, transmission to the fetus, viral replication in the fetal kidney, and excretion into amniotic fluid. In one series, the sensitivity for cases first sampled before and after 21 weeks of gestation was 30 and 71 percent, respectively [",
"    <a class=\"abstract\" href=\"UTD.htm?12/21/12634/abstract/36\">",
"     36",
"    </a>",
"    ]. If amniocentesis is performed earlier in gestation or soon after diagnosis of maternal infection, it is reliable evidence of fetal infection if positive, but should be repeated later in gestation if negative. Rarely, false positive results occur from contamination of the amniotic fluid sample by maternal fluids.",
"   </p>",
"   <p>",
"    In addition to diagnosis of fetal infection, a major goal of prenatal diagnosis is prediction of sequelae in the offspring. Twenty to 25 percent of infected fetuses develop sequelae observable at birth (10 to 15 percent) or later in childhood (5 to 15 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?12/21/12634/abstract/33,63\">",
"     33,63",
"    </a>",
"    ]. Determination of viral load in amniotic fluid may help to distinguish infected but asymptomatic fetuses from those who are likely to have serious sequelae. For example, a study of 456 women at weeks 21 to 23 of pregnancy found that higher viral loads in amniotic fluid (eg, greater than 100,000 copies per mL) were associated with symptomatic fetuses or newborns [",
"    <a class=\"abstract\" href=\"UTD.htm?12/21/12634/abstract/2,64\">",
"     2,64",
"    </a>",
"    ]. In another small study of 21 fetuses, the median DNA level in amniotic fluid was higher in symptomatic fetuses, but the difference was not statistically significant [",
"    <a class=\"abstract\" href=\"UTD.htm?12/21/12634/abstract/65\">",
"     65",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The following ultrasonographic markers are suggestive, but not diagnostic, of fetal CMV infection [",
"    <a class=\"abstract\" href=\"UTD.htm?12/21/12634/abstract/2,36,54,55,60,66-68\">",
"     2,36,54,55,60,66-68",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Periventricular calcifications",
"     </li>",
"     <li>",
"      Cerebral ventriculomegaly",
"     </li>",
"     <li>",
"      Microcephaly",
"     </li>",
"     <li>",
"      Hyperechogenic fetal bowel",
"     </li>",
"     <li>",
"      Hepatosplenomegaly",
"     </li>",
"     <li>",
"      Polymicrogyria",
"     </li>",
"     <li>",
"      Cerebellar hypoplasia",
"     </li>",
"     <li>",
"      Periventricular (pseudo) cysts",
"     </li>",
"     <li>",
"      Periventricular echogenicity",
"     </li>",
"     <li>",
"      Large cisterna magna",
"     </li>",
"     <li>",
"      Fetal growth restriction",
"     </li>",
"     <li>",
"      Amniotic fluid abnormalities",
"     </li>",
"     <li>",
"      Ascites",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      pleural effusion",
"     </li>",
"     <li>",
"      Hydrops",
"     </li>",
"     <li>",
"      Placental enlargement",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The typical sonographic finding of fetal CMV infection is bilateral periventricular hyperechogenicities (calcifications) (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef54305 \" href=\"UTD.htm?29/22/30053\">",
"     image 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?12/21/12634/abstract/69,70\">",
"     69,70",
"    </a>",
"    ]. These calcifications or hyperechoic foci can be highly reflective and may not cast an acoustic shadow [",
"    <a class=\"abstract\" href=\"UTD.htm?12/21/12634/abstract/71\">",
"     71",
"    </a>",
"    ]. Branching linear echogenic areas in the thalami also occur and correspond to arteries in the basal ganglia and thalamus [",
"    <a class=\"abstract\" href=\"UTD.htm?12/21/12634/abstract/72,73\">",
"     72,73",
"    </a>",
"    ]. The presence of intraventricular filmy, thin adhesions and linear edges traversing the ventricle is typical in CMV infection of the brain [",
"    <a class=\"abstract\" href=\"UTD.htm?12/21/12634/abstract/74-83\">",
"     74-83",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In infected fetuses, serial ultrasound examinations every two to four weeks can be useful to detect development of sonographic abnormalities. Persistent changes, such as ventriculomegaly, periventricular calcifications, growth restriction, microcephaly, and hydrops, suggest the presence of severe disease and high risk of long-term neurodevelopment impairment. Ultrasonographic abnormalities associated with in utero fetal infection have been reported in fewer than 25 percent of fetuses infected in the first half of pregnancy and a normal ultrasound examination does not completely exclude the possibility of a symptomatic neonate or development of long-term neurological morbidity [",
"    <a class=\"abstract\" href=\"UTD.htm?12/21/12634/abstract/36,54,84-86\">",
"     36,54,84-86",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Percutaneous umbilical blood sampling (PUBS) to test fetal blood does not increase diagnostic sensitivity or specificity of amniotic fluid tests. Although the presence of abnormal liver function and hematological tests (especially thrombocytopenia) and elevated &beta;",
"    <sub>",
"     2",
"    </sub>",
"    -microglobulin level are signs of severe disease, individual marker levels are not sufficiently reliable for distinguishing between asymptomatic and symptomatic disease and predicting the likelihood of an unfavorable long-term outcome [",
"    <a class=\"abstract\" href=\"UTD.htm?12/21/12634/abstract/87,88\">",
"     87,88",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Magnetic resonance imaging (MRI) may provide additional information about anomalies, particularly neurological abnormalities [",
"    <a class=\"abstract\" href=\"UTD.htm?12/21/12634/abstract/86,89-91\">",
"     86,89-91",
"    </a>",
"    ]. However, normal ultrasound and MRI do not completely exclude the possibility of development of postnatal hearing loss [",
"    <a class=\"abstract\" href=\"UTD.htm?12/21/12634/abstract/92\">",
"     92",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h1\">",
"     MANAGEMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;Immunocompetent pregnant women with CMV infection should be offered supportive care for symptomatic relief, as needed (eg,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?15/27/15802?source=see_link\">",
"     acetaminophen",
"    </a>",
"    for fever).",
"   </p>",
"   <p>",
"    Although the majority of women with primary CMV diagnosed in the first half of pregnancy will deliver an unaffected infant, some women may elect pregnancy termination to avoid the possibility of congenital infection and subsequent sequelae. This option should be discussed. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?35/51/36664?source=see_link\">",
"     \"Cytomegalovirus infection and disease in newborns, infants, children and adolescents\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The timing and route of delivery are determined by standard maternal and fetal indications. Recovery of CMV from the cervix or urine is not an indication for early delivery.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     Antiviral treatment",
"    </span>",
"    &nbsp;&mdash;&nbsp;Use of antiviral drugs for treatment of CMV infections in immunocompetent adults, including pregnant women, is rarely indicated. Several medications (eg,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?32/30/33248?source=see_link\">",
"     ganciclovir",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?28/56/29575?source=see_link\">",
"     foscarnet",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?20/2/20517?source=see_link\">",
"     cidofovir",
"    </a>",
"    ) are available to treat severe end-organ CMV disease, but none have been shown to decrease perinatal transmission. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?13/25/13722?source=see_link&amp;anchor=H20#H20\">",
"     \"Epidemiology, clinical manifestations, and treatment of cytomegalovirus infection in immunocompetent hosts\", section on 'Therapy'",
"    </a>",
"    .) On the other hand, use of antiviral drugs in symptomatic neonates potentially decreases morbidity and mortality, and is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?35/51/36664?source=see_link&amp;anchor=H19#H19\">",
"     \"Cytomegalovirus infection and disease in newborns, infants, children and adolescents\", section on 'Treatment'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    There are sparse data on the effects of maternal antiviral treatment on intrauterine infection. A pilot study reported that maternal oral administration of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?38/44/39622?source=see_link\">",
"     valacyclovir",
"    </a>",
"    led to therapeutic drug concentrations in the maternal and fetal compartments and a decrease in viral load in fetal blood, but whether it significantly reduced the severity of neonatal disease could not be determined [",
"    <a class=\"abstract\" href=\"UTD.htm?12/21/12634/abstract/93\">",
"     93",
"    </a>",
"    ]. Twenty pregnancies including 21 fetuses were treated for a median of 7 weeks: 10 infants were developing normally at 1 to 5 years of age, 2 infants had severe isolated unilateral deafness, 1 neonate presented with microcephaly and severe deafness but was also diagnosed with incontinentia pigmenti, 1 fetus died in utero, and 6 of the 7 pregnancies that were terminated had evidence of in utero progression of the disease with worsening cerebral lesions. The rate of neonatal disease in treated and untreated mothers was 52 and 58 percent, respectively. Further study is needed to determine whether in utero treatment is safe and improves perinatal outcome.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h2\">",
"     Hyperimmunoglobulin",
"    </span>",
"    &nbsp;&mdash;&nbsp;Hyperimmunoglobulin therapy of pregnant women with primary CMV infection in early pregnancy is a promising, but investigational, approach to reducing symptomatic infection in offspring. Data are limited to the following studies:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A prospective study of intravenous hyperimmune globulin therapy (IVIG) was performed in 157 pregnant women diagnosed with primary CMV infection by serologic screening (n = 148) or serologic testing because of CMV compatible symptoms (n = 8) or an abnormal fetal sonogram (n = 1) [",
"      <a class=\"abstract\" href=\"UTD.htm?12/21/12634/abstract/61\">",
"       61",
"      </a>",
"      ]. Women with evidence of amniotic fluid infection (by culture or PCR) comprised the \"therapy\" group and were offered IVIG at a dose of 200 U per kilogram of maternal weight. Additional doses were offered if ultrasonographic findings suggestive of fetal infection were present. Women who did not undergo amniocentesis were stratified into the \"prevention\" group and offered IVIG at 100 U per kilogram every month until delivery. Amniocentesis was not performed in women who had a primary infection &le;6 weeks before enrollment and pregnancy &lt;20 weeks of gestation, or who declined the intervention. Women in the treatment and prevention groups who declined IVIG therapy were followed for comparison of outcomes. The study reported the following results:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      In the therapy group, only 1 of 31 women who received IVIG gave birth to an infant with symptomatic CMV disease compared with 7 of 14 women in this group who declined IVIG.",
"     </li>",
"     <li>",
"      In the prevention group, 6 of 37 women (16 percent) who received IVIG gave birth to an infant with symptomatic CMV disease compared with 19 of 47 women (40 percent) in this group who declined IVIG.",
"     </li>",
"     <li>",
"      No adverse side effects were reported.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In a subsequent case-control study by the same group including 64 additional congenitally infected children at age 3 (32 cases with hearing deficit",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      psychomotor retardation [symptomatic group] and 32 controls with normal examinations [asymptomatic group]), the odds of symptomatic disease were significantly higher in the absence of maternal IVIG therapy (adjusted OR 14, 95% CI 1.7-110) [",
"      <a class=\"abstract\" href=\"UTD.htm?12/21/12634/abstract/94\">",
"       94",
"      </a>",
"      ]. Only 4 mothers of 32 symptomatic cases received CMV immunoglobulin compared with 27 mothers of the 32 asymptomatic controls.",
"     </li>",
"     <li>",
"      A prospective study beginning in 2002 enrolled 592 consecutive pregnant women with CMV infection prior to 17 weeks of gestation and, beginning in 2007, offered treatment with a single dose of IVIG (200 U per kilogram maternal weight) if CMV was detected in the amniotic fluid [",
"      <a class=\"abstract\" href=\"UTD.htm?12/21/12634/abstract/95\">",
"       95",
"      </a>",
"      ]. Amniocentesis to detect CMV DNA was performed after 20 weeks of gestation and at least 6 weeks after maternal infection in 446 pregnancies. Results were positive in 92 cases; of these, 24 pregnancies were terminated, 31 mothers received IVIG, and 36 mothers (37 fetuses) did not receive this treatment. Fetuses of treated mothers did not differ from fetuses of non-treated mothers according to mother&rsquo;s age, gestational week of infection, CMV load, or detection of abnormal ultrasonography findings. However, there were temporal differences as the &lsquo;no IVIG treatment group&rsquo; was almost entirely comprised of pregnancies prior to 2007, while the &lsquo;IVIG treatment group&rsquo; was limited to pregnancies from 2007-2010.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      At the one year infant evaluation, infants of treated mothers had a significantly lower rate of poor outcome",
"      <span class=\"nowrap\">",
"       (4/31",
"      </span>",
"      infants, 13 percent, 95% CI 1&ndash;25 percent versus",
"      <span class=\"nowrap\">",
"       16/37",
"      </span>",
"      infants, 43 percent, 95% CI 27&ndash;59 percent, P&lt;0.01), where poor outcome was defined as hemiparesis, motor retardation, hyper- or hypotonia, seizures, spastic paraparesis, chorioretinitis, unilateral or bilateral sensorineural hearing loss, necrotizing hemorrhagic enterocolitis, or chronic liver disease.",
"     </li>",
"     <li>",
"      There was a trend toward less sensorineural hearing loss among infants of treated women compared with those of non-treated women",
"      <span class=\"nowrap\">",
"       (3/31",
"      </span>",
"      [10 percent] versus",
"      <span class=\"nowrap\">",
"       11/37",
"      </span>",
"      [30 percent], P = 0.07). Hearing loss was bilateral in 10 infants, of whom 8 were born to non-treated women.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    There are several limitations to interpreting these data. These include the lack of randomization, the absence of a control group that received placebo, the use of historic controls, a small number of adverse events, and use of interventions that differed in the therapy and prevention groups and in cases and controls. None of the studies addressed the financial and logistical issues associated with screening large obstetrical populations for CMV infection and the expense of pursuing false positive results [",
"    <a class=\"abstract\" href=\"UTD.htm?12/21/12634/abstract/96\">",
"     96",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Until data from randomized trials are available, practitioners should emphasize the simple preventive measures noted below (see",
"    <a class=\"local\" href=\"#H18\">",
"     'Prevention'",
"    </a>",
"    below and",
"    <a class=\"local\" href=\"#H19\">",
"     'Precautions to prevent transmission'",
"    </a>",
"    below).",
"   </p>",
"   <p>",
"    Although hyperimmunoglobulin therapy is not generally recommended [",
"    <a class=\"abstract\" href=\"UTD.htm?12/21/12634/abstract/97\">",
"     97",
"    </a>",
"    ], the use of this therapy should be individualized. Some pregnant women with primary CMV infection may choose to undergo this therapy after a discussion of the available data on the efficacy of hyperimmunoglobulin and the limitations of the few published studies, as well as potential side effects of this therapy. It is currently being evaluated in a large multicenter National Institutes of Health (NICHD) trial and the results of this trial will better guide recommendations. A second randomized European trial has just been completed and final data are being analyzed.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h1\">",
"     PREVENTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The prevention of CMV disease in the",
"    <span class=\"nowrap\">",
"     fetus/newborn",
"    </span>",
"    is of utmost importance due to the potentially devastating consequences of this infection. Preventive measures are primarily based on good personal hygiene and using CMV-negative blood products when transfusing seronegative pregnant women and newborns [",
"    <a class=\"abstract\" href=\"UTD.htm?12/21/12634/abstract/96\">",
"     96",
"    </a>",
"    ]. As discussed above, there is preliminary evidence that passive immunization during pregnancy may be effective in those at high risk of transmitting CMV to their fetuses (see",
"    <a class=\"local\" href=\"#H17\">",
"     'Hyperimmunoglobulin'",
"    </a>",
"    above) [",
"    <a class=\"abstract\" href=\"UTD.htm?12/21/12634/abstract/61\">",
"     61",
"    </a>",
"    ]. Passive immunotherapy is not generally recommended, but the use of this therapy should be individualized [",
"    <a class=\"abstract\" href=\"UTD.htm?12/21/12634/abstract/98\">",
"     98",
"    </a>",
"    ]. Candidate vaccines are being tested in animal models.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h2\">",
"     Precautions to prevent transmission",
"    </span>",
"    &nbsp;&mdash;&nbsp;There is weak evidence from randomized trials and a prospective study that knowledge of CMV seronegativity and education can change maternal behavior and decrease seroconversion in pregnant women at high risk of seroconversion [",
"    <a class=\"abstract\" href=\"UTD.htm?12/21/12634/abstract/58-60,99\">",
"     58-60,99",
"    </a>",
"    ]. However, this information does not appear to significantly affect seroconversion rates in nonpregnant women, even in those trying to conceive [",
"    <a class=\"abstract\" href=\"UTD.htm?12/21/12634/abstract/59\">",
"     59",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25104731\">",
"    <span class=\"h3\">",
"     Seronegative pregnant women",
"    </span>",
"    &nbsp;&mdash;&nbsp;Seronegative women should be particularly aware of prevention measures; however, no actions can eliminate all risks of becoming infected with CMV. Guidelines from the Centers for Disease Control and Prevention (CDC) are available at",
"    <a class=\"external\" href=\"file://www.cdc.gov/cmv/\">",
"     file://www.cdc.gov/cmv/",
"    </a>",
"    and include the following:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Practice good personal hygiene throughout pregnancy, especially hand washing with soap and water after contact with diapers or oral and nasal secretions (particularly with a child who is in daycare). Wash well for at least 15 to 20 seconds.",
"     </li>",
"     <li>",
"      Avoid kissing children under age 6 on the mouth or cheek; instead, kiss them on the head or give them a hug.",
"     </li>",
"     <li>",
"      Do not share food, drinks, or oral utensils (eg, fork, spoon, toothbrush, pacifier) with young children.",
"     </li>",
"     <li>",
"      Clean toys, countertops, and other surfaces that come into contact with children&rsquo;s urine or saliva",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25104746\">",
"    <span class=\"h3\">",
"     Breastfeeding women",
"    </span>",
"    &nbsp;&mdash;&nbsp;The demonstrated benefits of breastfeeding outweigh the minimal risk of acquiring CMV from an infected breastfeeding mother. However, HIV-infected mothers should not breastfeed. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/4/15433?source=see_link&amp;anchor=H328432#H328432\">",
"     \"Prenatal evaluation and intrapartum management of the HIV-infected patient in resource-rich settings\", section on 'Counseling regarding breastfeeding'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25104767\">",
"    <span class=\"h3\">",
"     Women who care for young children",
"    </span>",
"    &nbsp;&mdash;&nbsp;Recommendations for women providing care for infants and young children include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Female employees should be educated concerning CMV, its transmission, and hygienic practices, such as handwashing, which minimize the risk of infection.",
"     </li>",
"     <li>",
"      Pregnant women working with infants and young children should be informed of their increased risk of acquiring CMV infection and the possible effects on the unborn child.",
"     </li>",
"     <li>",
"      Routine laboratory screening for CMV antibody in female daycare workers is not recommended, but selective testing of women who desire to know their immune status is reasonable. Susceptible women working with infants and young children do not have to be routinely transferred to other work situations, but may choose to reduce their risk of infection by working with children who are older than 2 and a half years of age and by practicing good hygiene.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25104774\">",
"    <span class=\"h3\">",
"     Healthcare workers",
"    </span>",
"    &nbsp;&mdash;&nbsp;The risk of CMV infection among healthcare workers appears to be no greater than that among the general public. This is probably due, at least in part, to adherence to standard precautions by healthcare providers when handling body fluids and less personal contact in the healthcare setting than in the family setting.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25104821\">",
"    <span class=\"h3\">",
"     Children",
"    </span>",
"    &nbsp;&mdash;&nbsp;There is no need to either screen for CMV or exclude CMV-excreting children from schools or institutions because the virus is frequently found in many healthy children and adults.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h2\">",
"     Vaccine development",
"    </span>",
"    &nbsp;&mdash;&nbsp;No CMV vaccine is available for use in humans, although several candidate vaccines have been developed and tested in clinical trials. In a phase 2 trial that included 464 CMV-seronegative women of childbearing age, an MF59-adjuvanted CMV glycoprotein B subunit vaccine had 50 percent efficacy at preventing CMV infection, which was the primary endpoint [",
"    <a class=\"abstract\" href=\"UTD.htm?12/21/12634/abstract/100\">",
"     100",
"    </a>",
"    ]. Congenital CMV infection was diagnosed in one infant of a vaccinated subject versus three infants of subjects who received placebo. The overall benefits were modest and the study was not powered to assess efficacy in preventing maternal-fetal transmission [",
"    <a class=\"abstract\" href=\"UTD.htm?12/21/12634/abstract/101\">",
"     101",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    It is unlikely that a CMV vaccine will be available for several years. In addition, the strategy of preventing primary maternal infection does not address the CMV-associated hearing loss and other neurologic sequelae in congenitally infected children born to women with preexisting CMV immunity. Ideally, a CMV vaccine that induces high titers of cross-neutralizing antibodies will be developed and will protect individuals from infection with antigenically different CMV strains [",
"    <a class=\"abstract\" href=\"UTD.htm?12/21/12634/abstract/102\">",
"     102",
"    </a>",
"    ]. Although the exact nature of protective immune responses against CMV has not been characterized, a recombinant CMV glycoprotein B vaccine with MF59 adjuvant appeared to boost both antibody and CD4 T-cell responses in previously CMV-seropositive women, thereby raising the possibility that these boosted responses may prevent mother to child transmission of CMV [",
"    <a class=\"abstract\" href=\"UTD.htm?12/21/12634/abstract/103\">",
"     103",
"    </a>",
"    ]. &nbsp;",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topics (see",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?32/39/33395?source=see_link\">",
"       \"Patient information: Avoiding infections in pregnancy (The Basics)\"",
"      </a>",
"      and",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?19/10/19618?source=see_link\">",
"       \"Patient information: Cytomegalovirus (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Beyond the Basics topics (see",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?42/52/43843?source=see_link\">",
"       \"Patient information: Avoiding infections in pregnancy (Beyond the Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Cytomegalovirus (CMV) infections in pregnant women are classified as primary if the initial acquisition of virus occurs during pregnancy. One to 4 percent of pregnant women have primary CMV infections. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Classification'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H4\">",
"       'Seroconversion'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Primary CMV infection may cause a mild febrile illness and other nonspecific symptoms in the mother, but is not apparent in 90 percent of women. (See",
"      <a class=\"local\" href=\"#H7\">",
"       'Maternal infection'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      CMV is transmitted to the fetus in one-third of primary maternal infections. Although most of these infants are asymptomatic at birth, approximately 5 to 20 percent are overtly symptomatic. These children have a mortality rate of about 5 percent, and 50 to 60 percent of survivors develop severe neurologic morbidity (eg, progressive hearing",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      visual loss). Asymptomatic infected infants are also at risk of developing long-term neurodevelopment morbidity, but the risk is lower than in symptomatic neonates. (See",
"      <a class=\"local\" href=\"#H5\">",
"       'Vertical transmission'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H8\">",
"       'Congenital infection'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Nonprimary maternal infections are due to reactivation or reinfection with a different strain. The rate of fetal infection in these cases is 0.2 to 2 percent. Most infants are asymptomatic at birth, but are at risk of long-term neurodevelopmental morbidity. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Classification'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H5\">",
"       'Vertical transmission'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H8\">",
"       'Congenital infection'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Preexisting maternal antibody to CMV is the most important protective factor against congenital CMV infection, but does not completely protect the fetus from infection. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Seroprevalence'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Some experts have suggested that a woman wait at least six months after a primary infection before attempting to conceive since DNA virus has been detected in the blood of 20 percent of immunocompetent patients as long as six months after diagnosis of primary infection. (See",
"      <a class=\"local\" href=\"#H5\">",
"       'Vertical transmission'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The diagnosis of clinically suspected maternal primary CMV infection is based on seroconversion. In the absence of documented seroconversion, the presence of anti-CMV IgG and anti-CMV IgM may represent primary infection, reactivation, or reinfection. In these cases, avidity testing is useful: high antibody avidity suggests primary infection occurred more than six months in the past, while low avidity suggests recent primary infection. (See",
"      <a class=\"local\" href=\"#H12\">",
"       'How to test'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Testing pregnant women for CMV is indicated as part of the diagnostic evaluation of women with mononucleosis-like illnesses, when a fetal anomaly consistent with congenital CMV infection is detected on prenatal ultrasound examination, and if the woman requests the test. (See",
"      <a class=\"local\" href=\"#H11\">",
"       'Whom to test'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      We do not recommend routinely screening pregnant women for CMV infection (",
"      <a class=\"grade\" href=\"._grade_3?title=Grade 1C\">",
"       Grade 1C",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H13\">",
"       'Screening'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Prenatal diagnosis should be offered to pregnant women with CMV infection, given the risk of several sequelae in offspring. Testing includes (1) amniocentesis after 21 weeks of gestation and at least six weeks after the presumed time of maternal infection to perform PCR for CMV DNA and (2) ultrasound assessment of the infected fetus to detect stigmata suggestive of fetal sequelae. (See",
"      <a class=\"local\" href=\"#H14\">",
"       'Prenatal diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Although fetal infection can be detected by PCR, fetal prognosis is difficult to predict. An abnormal ultrasound examination suggests a poor prognosis, while a normal ultrasound examination does not exclude the possibility of a symptomatic neonate or development of long-term neurological morbidity. Quantitative determination of viral load in amniotic fluid may help to predict fetal outcome. (See",
"      <a class=\"local\" href=\"#H14\">",
"       'Prenatal diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      During pregnancy, there is no treatment proven to be effective for prevention of fetal disease or reduction in risk of sequelae. Hyperimmunoglobulin is a promising, but unproven, approach. For pregnant women with primary CMV infection, we discuss available data on the efficacy of hyperimmunoglobulin and the limitations of the few published studies, as well as potential side effects of this therapy. Based on this information, some patients may choose to undergo therapy. (See",
"      <a class=\"local\" href=\"#H17\">",
"       'Hyperimmunoglobulin'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Measures to prevent CMV infection during pregnancy are based on good personal hygiene and using CMV-negative blood products when transfusing seronegative pregnant women. (See",
"      <a class=\"local\" href=\"#H18\">",
"       'Prevention'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/21/12634/abstract/1\">",
"      Kenneson A, Cannon MJ. Review and meta-analysis of the epidemiology of congenital cytomegalovirus (CMV) infection. Rev Med Virol 2007; 17:253.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/21/12634/abstract/2\">",
"      Ornoy A, Diav-Citrin O. Fetal effects of primary and secondary cytomegalovirus infection in pregnancy. Reprod Toxicol 2006; 21:399.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/21/12634/abstract/3\">",
"      Stagno S, Pass RF, Dworsky ME, et al. Congenital cytomegalovirus infection: The relative importance of primary and recurrent maternal infection. N Engl J Med 1982; 306:945.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/21/12634/abstract/4\">",
"      Fowler KB, Stagno S, Pass RF. Maternal immunity and prevention of congenital cytomegalovirus infection. JAMA 2003; 289:1008.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/21/12634/abstract/5\">",
"      Istas AS, Demmler GJ, Dobbins JG, Stewart JA. Surveillance for congenital cytomegalovirus disease: a report from the National Congenital Cytomegalovirus Disease Registry. Clin Infect Dis 1995; 20:665.",
"     </a>",
"    </li>",
"    <li>",
"     Stagno, S. Britt, W. Cytomegalovirus infections. In: Infectious Diseases of the Fetus and Newborn Infant, 6th ed, Remington, JS, Klein, JO, Wilson, CB, Baker, CJ (Eds), Elsevier Saunders, Philadelphia 2006. p.739.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/21/12634/abstract/7\">",
"      Staras SA, Dollard SC, Radford KW, et al. Seroprevalence of cytomegalovirus infection in the United States, 1988-1994. Clin Infect Dis 2006; 43:1143.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/21/12634/abstract/8\">",
"      Demmler GJ. Cytomegalovirus infection: back to the future or no more elephants? Clin Infect Dis 2006; 43:1152.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/21/12634/abstract/9\">",
"      Cannon MJ. Congenital cytomegalovirus (CMV) epidemiology and awareness. J Clin Virol 2009; 46 Suppl 4:S6.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/21/12634/abstract/10\">",
"      Mustakangas P, Sarna S, Amm&auml;l&auml; P, et al. Human cytomegalovirus seroprevalence in three socioeconomically different urban areas during the first trimester: a population-based cohort study. Int J Epidemiol 2000; 29:587.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/21/12634/abstract/11\">",
"      Gratacap-Cavallier B, Bosson JL, Morand P, et al. Cytomegalovirus seroprevalence in French pregnant women: parity and place of birth as major predictive factors. Eur J Epidemiol 1998; 14:147.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/21/12634/abstract/12\">",
"      Fowler KB, Pass RF. Sexually transmitted diseases in mothers of neonates with congenital cytomegalovirus infection. J Infect Dis 1991; 164:259.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/21/12634/abstract/13\">",
"      Pass RF, Hutto C, Lyon MD, Cloud G. Increased rate of cytomegalovirus infection among day care center workers. Pediatr Infect Dis J 1990; 9:465.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/21/12634/abstract/14\">",
"      Hyde TB, Schmid DS, Cannon MJ. Cytomegalovirus seroconversion rates and risk factors: implications for congenital CMV. Rev Med Virol 2010; 20:311.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/21/12634/abstract/15\">",
"      Ross SA, Novak Z, Pati S, et al. Mixed infection and strain diversity in congenital cytomegalovirus infection. J Infect Dis 2011; 204:1003.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/21/12634/abstract/16\">",
"      Fisher S, Genbacev O, Maidji E, Pereira L. Human cytomegalovirus infection of placental cytotrophoblasts in vitro and in utero: implications for transmission and pathogenesis. J Virol 2000; 74:6808.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/21/12634/abstract/17\">",
"      Raynor BD. Cytomegalovirus infection in pregnancy. Semin Perinatol 1993; 17:394.",
"     </a>",
"    </li>",
"    <li>",
"     Ho, M. Cytomegalovirus: biology and infection, 2nd ed, Plenum, New York 1991.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/21/12634/abstract/19\">",
"      Reynolds DW, Stagno S, Hosty TS, et al. Maternal cytomegalovirus excretion and perinatal infection. N Engl J Med 1973; 289:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/21/12634/abstract/20\">",
"      Fowler KB, Stagno S, Pass RF. Maternal age and congenital cytomegalovirus infection: screening of two diverse newborn populations, 1980-1990. J Infect Dis 1993; 168:552.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/21/12634/abstract/21\">",
"      Wong A, Tan KH, Tee CS, Yeo GS. Seroprevalence of cytomegalovirus, toxoplasma and parvovirus in pregnancy. Singapore Med J 2000; 41:151.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/21/12634/abstract/22\">",
"      Hizel S, Parker S, Onde U. Seroprevalence of cytomegalovirus infection among children and females in Ankara, Turkey, 1995. Pediatr Int 1999; 41:506.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/21/12634/abstract/23\">",
"      Hamprecht K, Maschmann J, Vochem M, et al. Epidemiology of transmission of cytomegalovirus from mother to preterm infant by breastfeeding. Lancet 2001; 357:513.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/21/12634/abstract/24\">",
"      Revello MG, Furione M, Zavattoni M, et al. Human cytomegalovirus (HCMV) DNAemia in the mother at amniocentesis as a risk factor for iatrogenic HCMV infection of the fetus. J Infect Dis 2008; 197:593.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/21/12634/abstract/25\">",
"      Fowler KB, Stagno S, Pass RF. Interval between births and risk of congenital cytomegalovirus infection. Clin Infect Dis 2004; 38:1035.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/21/12634/abstract/26\">",
"      Kylat RI, Kelly EN, Ford-Jones EL. Clinical findings and adverse outcome in neonates with symptomatic congenital cytomegalovirus (SCCMV) infection. Eur J Pediatr 2006; 165:773.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/21/12634/abstract/27\">",
"      Revello MG, Zavattoni M, Furione M, et al. Preconceptional primary human cytomegalovirus infection and risk of congenital infection. J Infect Dis 2006; 193:783.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/21/12634/abstract/28\">",
"      Bod&eacute;us M, Hubinont C, Goubau P. Increased risk of cytomegalovirus transmission in utero during late gestation. Obstet Gynecol 1999; 93:658.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/21/12634/abstract/29\">",
"      Bod&eacute;us M, Kabamba-Mukadi B, Zech F, et al. Human cytomegalovirus in utero transmission: follow-up of 524 maternal seroconversions. J Clin Virol 2010; 47:201.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/21/12634/abstract/30\">",
"      Feldman B, Yinon Y, Tepperberg Oikawa M, et al. Pregestational, periconceptional, and gestational primary maternal cytomegalovirus infection: prenatal diagnosis in 508 pregnancies. Am J Obstet Gynecol 2011; 205:342.e1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/21/12634/abstract/31\">",
"      Nigro G, Anceschi MM, Cosmi EV, Congenital Cytomegalic Disease Collaborating Group. Clinical manifestations and abnormal laboratory findings in pregnant women with primary cytomegalovirus infection. BJOG 2003; 110:572.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/21/12634/abstract/32\">",
"      Wang C, Zhang X, Bialek S, Cannon MJ. Attribution of congenital cytomegalovirus infection to primary versus non-primary maternal infection. Clin Infect Dis 2011; 52:e11.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/21/12634/abstract/33\">",
"      Fowler KB, McCollister FP, Dahle AJ, et al. Progressive and fluctuating sensorineural hearing loss in children with asymptomatic congenital cytomegalovirus infection. J Pediatr 1997; 130:624.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/21/12634/abstract/34\">",
"      Hagay ZJ, Biran G, Ornoy A, Reece EA. Congenital cytomegalovirus infection: a long-standing problem still seeking a solution. Am J Obstet Gynecol 1996; 174:241.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/21/12634/abstract/35\">",
"      Revello MG, Gerna G. Diagnosis and management of human cytomegalovirus infection in the mother, fetus, and newborn infant. Clin Microbiol Rev 2002; 15:680.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/21/12634/abstract/36\">",
"      Liesnard C, Donner C, Brancart F, et al. Prenatal diagnosis of congenital cytomegalovirus infection: prospective study of 237 pregnancies at risk. Obstet Gynecol 2000; 95:881.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/21/12634/abstract/37\">",
"      Daiminger A, B&auml;der U, Enders G. Pre- and periconceptional primary cytomegalovirus infection: risk of vertical transmission and congenital disease. BJOG 2005; 112:166.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/21/12634/abstract/38\">",
"      Gindes L, Teperberg-Oikawa M, Sherman D, et al. Congenital cytomegalovirus infection following primary maternal infection in the third trimester. BJOG 2008; 115:830.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/21/12634/abstract/39\">",
"      Pass RF, Fowler KB, Boppana SB, et al. Congenital cytomegalovirus infection following first trimester maternal infection: symptoms at birth and outcome. J Clin Virol 2006; 35:216.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/21/12634/abstract/40\">",
"      Boppana SB, Rivera LB, Fowler KB, et al. Intrauterine transmission of cytomegalovirus to infants of women with preconceptional immunity. N Engl J Med 2001; 344:1366.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/21/12634/abstract/41\">",
"      Boppana SB, Fowler KB, Britt WJ, et al. Symptomatic congenital cytomegalovirus infection in infants born to mothers with preexisting immunity to cytomegalovirus. Pediatrics 1999; 104:55.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/21/12634/abstract/42\">",
"      Gabrielli L, Bonasoni MP, Lazzarotto T, et al. Histological findings in foetuses congenitally infected by cytomegalovirus. J Clin Virol 2009; 46 Suppl 4:S16.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/21/12634/abstract/43\">",
"      Stagno S, Whitley RJ. Herpesvirus infections of pregnancy. Part I: Cytomegalovirus and Epstein-Barr virus infections. N Engl J Med 1985; 313:1270.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/21/12634/abstract/44\">",
"      Iwasenko JM, Howard J, Arbuckle S, et al. Human cytomegalovirus infection is detected frequently in stillbirths and is associated with fetal thrombotic vasculopathy. J Infect Dis 2011; 203:1526.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/21/12634/abstract/45\">",
"      Kovacs A, Schluchter M, Easley K, et al. Cytomegalovirus infection and HIV-1 disease progression in infants born to HIV-1-infected women. Pediatric Pulmonary and Cardiovascular Complications of Vertically Transmitted HIV Infection Study Group. N Engl J Med 1999; 341:77.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/21/12634/abstract/46\">",
"      Mussi-Pinhata MM, Yamamoto AY, Figueiredo LT, et al. Congenital and perinatal cytomegalovirus infection in infants born to mothers infected with human immunodeficiency virus. J Pediatr 1998; 132:285.",
"     </a>",
"    </li>",
"    <li>",
"     www.cdc.gov/mmwr/preview/mmwrhtml/mms5703a2.htm (Accessed May 14, 2010).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/21/12634/abstract/48\">",
"      Eggers M, B&auml;der U, Enders G. Combination of microneutralization and avidity assays: improved diagnosis of recent primary human cytomegalovirus infection in single serum sample of second trimester pregnancy. J Med Virol 2000; 60:324.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/21/12634/abstract/49\">",
"      Lazzarotto T, Ripalti A, Bergamini G, et al. Development of a new cytomegalovirus (CMV) immunoglobulin M (IgM) immunoblot for detection of CMV-specific IgM. J Clin Microbiol 1998; 36:3337.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/21/12634/abstract/50\">",
"      Grangeot-Keros L, Mayaux MJ, Lebon P, et al. Value of cytomegalovirus (CMV) IgG avidity index for the diagnosis of primary CMV infection in pregnant women. J Infect Dis 1997; 175:944.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/21/12634/abstract/51\">",
"      Bod&eacute;us M, Van Ranst M, Bernard P, et al. Anticytomegalovirus IgG avidity in pregnancy: a 2-year prospective study. Fetal Diagn Ther 2002; 17:362.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/21/12634/abstract/52\">",
"      Kanengisser-Pines B, Hazan Y, Pines G, Appelman Z. High cytomegalovirus IgG avidity is a reliable indicator of past infection in patients with positive IgM detected during the first trimester of pregnancy. J Perinat Med 2009; 37:15.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/21/12634/abstract/53\">",
"      Nelson CT, Demmler GJ. Cytomegalovirus infection in the pregnant mother, fetus, and newborn infant. Clin Perinatol 1997; 24:151.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/21/12634/abstract/54\">",
"      Guerra B, Lazzarotto T, Quarta S, et al. Prenatal diagnosis of symptomatic congenital cytomegalovirus infection. Am J Obstet Gynecol 2000; 183:476.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/21/12634/abstract/55\">",
"      Azam AZ, Vial Y, Fawer CL, et al. Prenatal diagnosis of congenital cytomegalovirus infection. Obstet Gynecol 2001; 97:443.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/21/12634/abstract/56\">",
"      Cahill AG, Odibo AO, Stamilio DM, Macones GA. Screening and treating for primary cytomegalovirus infection in pregnancy: where do we stand? A decision-analytic and economic analysis. Am J Obstet Gynecol 2009; 201:466.e1.",
"     </a>",
"    </li>",
"    <li>",
"     American College of Obstetricians and Gynecologists: Perinatal viral and parasitic infections. Practice Bulletin No. 20. September 2000.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/21/12634/abstract/58\">",
"      Adler SP, Finney JW, Manganello AM, Best AM. Prevention of child-to-mother transmission of cytomegalovirus by changing behaviors: a randomized controlled trial. Pediatr Infect Dis J 1996; 15:240.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/21/12634/abstract/59\">",
"      Adler SP, Finney JW, Manganello AM, Best AM. Prevention of child-to-mother transmission of cytomegalovirus among pregnant women. J Pediatr 2004; 145:485.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/21/12634/abstract/60\">",
"      Vauloup-Fellous C, Picone O, Cordier AG, et al. Does hygiene counseling have an impact on the rate of CMV primary infection during pregnancy? Results of a 3-year prospective study in a French hospital. J Clin Virol 2009; 46 Suppl 4:S49.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/21/12634/abstract/61\">",
"      Nigro G, Adler SP, La Torre R, et al. Passive immunization during pregnancy for congenital cytomegalovirus infection. N Engl J Med 2005; 353:1350.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/21/12634/abstract/62\">",
"      Bod&eacute;us M, Hubinont C, Bernard P, et al. Prenatal diagnosis of human cytomegalovirus by culture and polymerase chain reaction: 98 pregnancies leading to congenital infection. Prenat Diagn 1999; 19:314.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/21/12634/abstract/63\">",
"      Yinon Y, Farine D, Yudin MH, et al. Cytomegalovirus infection in pregnancy. J Obstet Gynaecol Can 2010; 32:348.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/21/12634/abstract/64\">",
"      Lazzarotto T, Varani S, Guerra B, et al. Prenatal indicators of congenital cytomegalovirus infection. J Pediatr 2000; 137:90.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/21/12634/abstract/65\">",
"      Revello MG, Zavattoni M, Furione M, et al. Quantification of human cytomegalovirus DNA in amniotic fluid of mothers of congenitally infected fetuses. J Clin Microbiol 1999; 37:3350.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/21/12634/abstract/66\">",
"      La Torre R, Nigro G, Mazzocco M, et al. Placental enlargement in women with primary maternal cytomegalovirus infection is associated with fetal and neonatal disease. Clin Infect Dis 2006; 43:994.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/21/12634/abstract/67\">",
"      Simonazzi G, Guerra B, Bonasoni P, et al. Fetal cerebral periventricular halo at midgestation: an ultrasound finding suggestive of fetal cytomegalovirus infection. Am J Obstet Gynecol 2010; 202:599.e1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/21/12634/abstract/68\">",
"      Malinger G, Lev D, Zahalka N, et al. Fetal cytomegalovirus infection of the brain: the spectrum of sonographic findings. AJNR Am J Neuroradiol 2003; 24:28.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/21/12634/abstract/69\">",
"      Graham D, Guidi SM, Sanders RC. Sonographic features of in utero periventricular calcification due to cytomegalovirus infection. J Ultrasound Med 1982; 1:171.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/21/12634/abstract/70\">",
"      Ghidini A, Sirtori M, Vergani P, et al. Fetal intracranial calcifications. Am J Obstet Gynecol 1989; 160:86.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/21/12634/abstract/71\">",
"      Fakhry J, Khoury A. Fetal intracranial calcifications. The importance of periventricular hyperechoic foci without shadowing. J Ultrasound Med 1991; 10:51.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/21/12634/abstract/72\">",
"      Estroff JA, Parad RB, Teele RL, Benacerraf BR. Echogenic vessels in the fetal thalami and basal ganglia associated with cytomegalovirus infection. J Ultrasound Med 1992; 11:686.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/21/12634/abstract/73\">",
"      Teele RL, Hernanz-Schulman M, Sotrel A. Echogenic vasculature in the basal ganglia of neonates: a sonographic sign of vasculopathy. Radiology 1988; 169:423.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/21/12634/abstract/74\">",
"      Mittelmann-Handwerker S, Pardes JG, Post RC, et al. Fetal ventriculomegaly and brain atrophy in a woman with intrauterine cytomegalovirus infection. A case report. J Reprod Med 1986; 31:1061.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/21/12634/abstract/75\">",
"      Ceballos R, Ch'ien LT, Whitley RJ, Brans YW. Cerebellar hypoplasia in an infant with congenital cytomegalovirus infection. Pediatrics 1976; 57:155.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/21/12634/abstract/76\">",
"      Shackelford GD, Fulling KH, Glasier CM. Cysts of the subependymal germinal matrix: sonographic demonstration with pathologic correlation. Radiology 1983; 149:117.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/21/12634/abstract/77\">",
"      Butt W, Mackay RJ, de Crespigny LC, et al. Intracranial lesions of congenital cytomegalovirus infection detected by ultrasound scanning. Pediatrics 1984; 73:611.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/21/12634/abstract/78\">",
"      Marques Dias MJ, Harmant-van Rijckevorsel G, Landrieu P, Lyon G. Prenatal cytomegalovirus disease and cerebral microgyria: evidence for perfusion failure, not disturbance of histogenesis, as the major cause of fetal cytomegalovirus encephalopathy. Neuropediatrics 1984; 15:18.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/21/12634/abstract/79\">",
"      Friede RL, Mikolasek J. Postencephalitic porencephaly, hydranencephaly or polymicrogyria. A review. Acta Neuropathol 1978; 43:161.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/21/12634/abstract/80\">",
"      Perlman JM, Argyle C. Lethal cytomegalovirus infection in preterm infants: clinical, radiological, and neuropathological findings. Ann Neurol 1992; 31:64.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/21/12634/abstract/81\">",
"      Drose JA, Dennis MA, Thickman D. Infection in utero: US findings in 19 cases. Radiology 1991; 178:369.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/21/12634/abstract/82\">",
"      Twickler DM, Perlman J, Maberry MC. Congenital cytomegalovirus infection presenting as cerebral ventriculomegaly on antenatal sonography. Am J Perinatol 1993; 10:404.",
"     </a>",
"    </li>",
"    <li>",
"     Malinger, G, Lev, D, Zahalka, N, Ben Aroia, Z, et al. Fetal cytomegalovirus infection of the brain: the spectrum of sonographic findings. AJNR Am J Neuroradiol 24:128.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/21/12634/abstract/84\">",
"      Lipitz S, Achiron R, Zalel Y, et al. Outcome of pregnancies with vertical transmission of primary cytomegalovirus infection. Obstet Gynecol 2002; 100:428.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/21/12634/abstract/85\">",
"      Enders G, B&auml;der U, Lindemann L, et al. Prenatal diagnosis of congenital cytomegalovirus infection in 189 pregnancies with known outcome. Prenat Diagn 2001; 21:362.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/21/12634/abstract/86\">",
"      Lipitz S, Hoffmann C, Feldman B, et al. Value of prenatal ultrasound and magnetic resonance imaging in assessment of congenital primary cytomegalovirus infection. Ultrasound Obstet Gynecol 2010; 36:709.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/21/12634/abstract/87\">",
"      Fabbri E, Revello MG, Furione M, et al. Prognostic markers of symptomatic congenital human cytomegalovirus infection in fetal blood. BJOG 2011; 118:448.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/21/12634/abstract/88\">",
"      Romanelli RM, Magny JF, Jacquemard F. Prognostic markers of symptomatic congenital cytomegalovirus infection. Braz J Infect Dis 2008; 12:38.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/21/12634/abstract/89\">",
"      Benoist G, Salomon LJ, Mohlo M, et al. Cytomegalovirus-related fetal brain lesions: comparison between targeted ultrasound examination and magnetic resonance imaging. Ultrasound Obstet Gynecol 2008; 32:900.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/21/12634/abstract/90\">",
"      Picone O, Simon I, Benachi A, et al. Comparison between ultrasound and magnetic resonance imaging in assessment of fetal cytomegalovirus infection. Prenat Diagn 2008; 28:753.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/21/12634/abstract/91\">",
"      Doneda C, Parazzini C, Righini A, et al. Early cerebral lesions in cytomegalovirus infection: prenatal MR imaging. Radiology 2010; 255:613.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/21/12634/abstract/92\">",
"      Farkas N, Hoffmann C, Ben-Sira L, et al. Does normal fetal brain ultrasound predict normal neurodevelopmental outcome in congenital cytomegalovirus infection? Prenat Diagn 2011; 31:360.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/21/12634/abstract/93\">",
"      Jacquemard F, Yamamoto M, Costa JM, et al. Maternal administration of valaciclovir in symptomatic intrauterine cytomegalovirus infection. BJOG 2007; 114:1113.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/21/12634/abstract/94\">",
"      Nigro G, Adler SP, Parruti G, et al. Immunoglobulin therapy of fetal cytomegalovirus infection occurring in the first half of pregnancy--a case-control study of the outcome in children. J Infect Dis 2012; 205:215.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/21/12634/abstract/95\">",
"      Visentin S, Manara R, Milanese L, et al. Early primary cytomegalovirus infection in pregnancy: maternal hyperimmunoglobulin therapy improves outcomes among infants at 1 year of age. Clin Infect Dis 2012; 55:497.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/21/12634/abstract/96\">",
"      Duff P. Immunotherapy for congenital cytomegalovirus infection. N Engl J Med 2005; 353:1402.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/21/12634/abstract/97\">",
"      McCarthy FP, Giles ML, Rowlands S, et al. Antenatal interventions for preventing the transmission of cytomegalovirus (CMV) from the mother to fetus during pregnancy and adverse outcomes in the congenitally infected infant. Cochrane Database Syst Rev 2011; :CD008371.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/21/12634/abstract/98\">",
"      Adler SP, Nigro G. Findings and conclusions from CMV hyperimmune globulin treatment trials. J Clin Virol 2009; 46 Suppl 4:S54.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/21/12634/abstract/99\">",
"      Di Mario S, Basevi V, Gagliotti C, et al. Prenatal education for congenital toxoplasmosis. Cochrane Database Syst Rev 2013; 2:CD006171.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/21/12634/abstract/100\">",
"      Pass RF, Zhang C, Evans A, et al. Vaccine prevention of maternal cytomegalovirus infection. N Engl J Med 2009; 360:1191.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/21/12634/abstract/101\">",
"      Dekker CL, Arvin AM. One step closer to a CMV vaccine. N Engl J Med 2009; 360:1250.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/21/12634/abstract/102\">",
"      Dasari V, Smith C, Zhong J, et al. Recombinant glycoprotein B vaccine formulation with Toll-like receptor 9 agonist and immune-stimulating complex induces specific immunity against multiple strains of cytomegalovirus. J Gen Virol 2011; 92:1021.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?12/21/12634/abstract/103\">",
"      Sabbaj S, Pass RF, Goepfert PA, Pichon S. Glycoprotein B vaccine is capable of boosting both antibody and CD4 T-cell responses to cytomegalovirus in chronically infected women. J Infect Dis 2011; 203:1534.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 4810 Version 20.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0503-122.72.80.101-E34D2EC933-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f12_21_12634=[""].join("\n");
var outline_f12_21_12634=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H21\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      CLASSIFICATION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      SEROPREVALENCE",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      SEROCONVERSION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      VERTICAL TRANSMISSION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3786126\">",
"      Route",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3786034\">",
"      Rate",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      CLINICAL FEATURES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Maternal infection",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Congenital infection",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3786739\">",
"      HIV infection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Whom to test",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      How to test",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      SCREENING",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      PRENATAL DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      MANAGEMENT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Antiviral treatment",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      Hyperimmunoglobulin",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      PREVENTION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      Precautions to prevent transmission",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H25104731\">",
"      - Seronegative pregnant women",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H25104746\">",
"      - Breastfeeding women",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H25104767\">",
"      - Women who care for young children",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H25104774\">",
"      - Healthcare workers",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H25104821\">",
"      - Children",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      Vaccine development",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"OBGYN/4810\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"OBGYN/4810|DiagnosticImage\">",
"      <a href=\"#\" title=\"DIAGNOSTIC IMAGES\">",
"       DIAGNOSTIC IMAGES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?29/22/30053\" title=\"diagnostic image 1\">",
"      In utero fetal CMV infection",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?35/51/36664?source=related_link\">",
"      Cytomegalovirus infection and disease in newborns, infants, children and adolescents",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?8/25/8597?source=related_link\">",
"      Diagnosis of cytomegalovirus",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?13/25/13722?source=related_link\">",
"      Epidemiology, clinical manifestations, and treatment of cytomegalovirus infection in immunocompetent hosts",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?30/18/31018?source=related_link\">",
"      Infectious mononucleosis in adults and adolescents",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/24/28041?source=related_link\">",
"      Overview of TORCH infections",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?42/52/43843?source=related_link\">",
"      Patient information: Avoiding infections in pregnancy (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?32/39/33395?source=related_link\">",
"      Patient information: Avoiding infections in pregnancy (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?19/10/19618?source=related_link\">",
"      Patient information: Cytomegalovirus (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?3/63/4089?source=related_link\">",
"      Placental infections",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?15/4/15433?source=related_link\">",
"      Prenatal evaluation and intrapartum management of the HIV-infected patient in resource-rich settings",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?24/44/25290?source=related_link\">",
"      Use of antiretroviral medications in pregnant HIV-infected patients and their infants in resource-rich settings",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f12_21_12635="Secondary causes";
var content_f12_21_12635=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=NEPH%2F77787&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=NEPH%2F77787&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Secondary causes of resistant hypertension",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Common",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Obstructive sleep apnea",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Renal parenchymal disease",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Primary aldosteronism",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Renal artery stenosis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Uncommon",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Pheochromocytoma",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Cushing's disease",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Hyperparathyroidism",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Aortic coarctation",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Calhoun DA, Jones D, Textor S, et al. Resistant Hypertension: Diagnosis, Evaluation, and Treatment: A Scientific Statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research. Hypertension 2008; 51:1403. Copyright &copy; 2008 Lippincott Williams &amp; Wilkins.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f12_21_12635=[""].join("\n");
var outline_f12_21_12635=null;
var title_f12_21_12636="Verbal skills pt interview";
var content_f12_21_12636=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PC%2F76848&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=3\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PC%2F76848&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=3\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Verbal skills applying to data gathering",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Strategy",
"       </td>",
"       <td class=\"subtitle1\">",
"        Rationale",
"       </td>",
"       <td class=\"subtitle1\">",
"        Examples",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Joint agenda setting",
"       </td>",
"       <td>",
"        Negotiates priorities together; shares control",
"       </td>",
"       <td>",
"        \"We agree that A is important. I want to be sure we also address B, and you've said you were worried about C. I'm not certain we can cover all our concerns today. Where should we start?\"",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        The \"exhaustive what else?\"",
"       </td>",
"       <td>",
"        Seeks patient's entire agenda; minimizes \"oh, by the way\" questions",
"       </td>",
"       <td>",
"        \"What else has concerned you lately?\" \"Are you worried about anything else?\" \"Should we consider anything else before we do your exam?\"",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Storytelling: Open-ended questions (and careful, uninterrupted listening to the story)",
"       </td>",
"       <td>",
"        Invites patient to state the agenda; allows patient to use judgment about problems to emphasize; often is most efficient way to hear story",
"       </td>",
"       <td>",
"        \"How can I be of help to you today?\" \"What problems should we consider today?\" \"Tell me about A.\" \"You say that B is bothering you - tell me about it.\"",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Facilitation",
"       </td>",
"       <td>",
"        Encourages patient to tell story in open-ended fashion; conveys sense that clinician wishes to hear and understand",
"       </td>",
"       <td>",
"        \"Tell me more about that.\" \"Uh-huh, go on.\" Attentive silence, urges patient to continue; echo patient's last few words: \"It hurt when you took a deep breath...\"",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Clarification",
"       </td>",
"       <td>",
"        Seeks specificity and clarity",
"       </td>",
"       <td>",
"        \"Help me understand what you mean by dizziness.\"",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Checking and summarizing",
"       </td>",
"       <td>",
"        Seeks to assure accurate understanding; assures patient that he/she has been heard; invites further clarification",
"       </td>",
"       <td>",
"        \"Let me review what I think I've heard you say.\" \"You were well until...\" \"I'd like to summarize my understanding of the problem and have you be sure I have the story straight.\"",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Adapted by permission from Clark W, Hewson M, Fry M, et al. American Academy on Physician and Patient (AAPP) 1998.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f12_21_12636=[""].join("\n");
var outline_f12_21_12636=null;
var title_f12_21_12637="Medications and toxins associated with acute liver failure";
var content_f12_21_12637=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F83765&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=4\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F83765&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=4\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Medications and toxins associated with acute liver failure",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Anti-infective",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Clavulanic acid/amoxicillin",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Trimethoprim-sulfamethoxazole",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Isoniazid",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Minocycline, doxycycline or tetracycline",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Quinolone (ciprofloxacin, norfloxacin)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Voriconazole",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Ketoconazole",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Macrolide (erythromycin, clarithromycin, azithromycin, roxithromycin)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Nitrofurantoin",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Rifampin",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Others",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Anticonvulsants",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Phenytoin",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Valproic acid",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Carbamazepine",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Felbamate",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Others",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Immunomodulators/anti-inflammatory",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Methotrexate",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Azathioprine",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Nonsteroidal anti-inflammatory drugs",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Acetaminophen (APAP)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Biological (ie, infliximab, basiliximab, etc)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Others",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Other",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Propylthiouracil (a thionamide)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Halothane",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Amiodarone",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1_start\">",
"        Antidepressants:",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Trazodone (SSRI)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Monoamine oxidase inhibitors",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Tricyclic antidepressants",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Recreational drugs",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Ecstasy (3,4-methylenedioxyamphetamine, MDMA)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Cocaine",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Solvent-sniffing (glue)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Others",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Complementary, alternative or herbal medications",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Pyrrolizidine alkaloids",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Germander",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Ma huang",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Chaparral",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Black cohosh root",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Pennyroyal",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Kava",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Others",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Environmental toxins or industrial solvents",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Amatoxin (mushrooms from Amanita sp)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Carbon tetrachloride",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Trichloroethylene",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        2-nitropropane",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        1,2,3-trichloropropane",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     SSRI: selective serotonin reuptake inhibitor.",
"    </div>",
"    <div class=\"reference\">",
"     Modified with permission from: Squires RH, Alonso EM. Acute liver failure in children. In: Liver Disease in Children, 4th ed, Suchy FJ, Sokol RJ, Balistreri WF (Eds), Cambridge University Press, New York 2012. Copyright &copy; 2012 Cambridge University Press.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f12_21_12637=[""].join("\n");
var outline_f12_21_12637=null;
var title_f12_21_12638="Syndromes with hearing loss";
var content_f12_21_12638=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F66758&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=8\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F66758&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=8\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Selected syndromes associated with hearing loss",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tr>",
"      <td class=\"subtitle1\">",
"       Syndrome",
"      </td>",
"      <td class=\"subtitle1\">",
"       Features",
"      </td>",
"      <td class=\"subtitle1\">",
"       Caused by mutation",
"      </td>",
"      <td class=\"subtitle1\">",
"       Sensorineural",
"      </td>",
"      <td class=\"subtitle1\">",
"       Conductive",
"      </td>",
"      <td class=\"subtitle1\">",
"       Mixed",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Waardenburg syndrome (AD)",
"      </td>",
"      <td>",
"       White forelock, heterochromic irides, broad mandible, deafness",
"      </td>",
"      <td>",
"       X",
"      </td>",
"      <td>",
"       X",
"      </td>",
"      <td>",
"       &nbsp;",
"      </td>",
"      <td>",
"       &nbsp;",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Usher syndrome (AR)",
"      </td>",
"      <td>",
"       Retinitis pigmentosa, ataxia, deafness",
"      </td>",
"      <td>",
"       X",
"      </td>",
"      <td>",
"       X",
"      </td>",
"      <td>",
"       &nbsp;",
"      </td>",
"      <td>",
"       &nbsp;",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Pendred syndrome (AR)",
"      </td>",
"      <td>",
"       Familial goiter, dysfunctional iodide organization, deafness",
"      </td>",
"      <td>",
"       X",
"      </td>",
"      <td>",
"       X",
"      </td>",
"      <td>",
"       &nbsp;",
"      </td>",
"      <td>",
"       &nbsp;",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Alport syndrome (XL, AR, AD)",
"      </td>",
"      <td>",
"       Nephritis, deafness, lens, defects, retinitis",
"      </td>",
"      <td>",
"       X",
"      </td>",
"      <td>",
"       X",
"      </td>",
"      <td>",
"       &nbsp;",
"      </td>",
"      <td>",
"       &nbsp;",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Craniofacial anomalies (eg, Apert syndrome, Pfeiffer syndrome, Crouzon syndrome)",
"      </td>",
"      <td>",
"       Craniosynostosis, micrognathia, syndactyly",
"      </td>",
"      <td>",
"       &nbsp;",
"      </td>",
"      <td>",
"       X",
"      </td>",
"      <td>",
"       X",
"      </td>",
"      <td>",
"       X",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       CHARGE (AD, isolated cases)",
"      </td>",
"      <td>",
"       Choanal atresia, colobomas, heart defect, MR, genital hypoplasia, ear anomalies, deafness",
"      </td>",
"      <td>",
"       X",
"      </td>",
"      <td>",
"       X",
"      </td>",
"      <td>",
"       &nbsp;",
"      </td>",
"      <td>",
"       X",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Hemifacial microsomia (oculo-auriculo-vertebral spectrum, Goldenhar syndrome)(sporadic, AD)",
"      </td>",
"      <td>",
"       Facial hypoplasia, ear anomalies, hemivertibrae, parotid gland dysfunction",
"      </td>",
"      <td>",
"       X",
"      </td>",
"      <td>",
"       &nbsp;",
"      </td>",
"      <td>",
"       X",
"      </td>",
"      <td>",
"       X",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Mucopolysaccharidosis Hurler (AR), Hunter (XL), Maroteaux-Lamy (AR)",
"      </td>",
"      <td>",
"       Coarse facies, stiff joints, MR, cloudy corneas",
"      </td>",
"      <td>",
"       X",
"      </td>",
"      <td>",
"       &nbsp;",
"      </td>",
"      <td>",
"       &nbsp;",
"      </td>",
"      <td>",
"       X",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Treacher-Collins syndrome (AD)",
"      </td>",
"      <td>",
"       Facial malformation, cleft palate, deafness",
"      </td>",
"      <td>",
"       X",
"      </td>",
"      <td>",
"       &nbsp;",
"      </td>",
"      <td>",
"       X",
"      </td>",
"      <td>",
"       &nbsp;",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Otopalatodigital syndrome (XL)",
"      </td>",
"      <td>",
"       Deafness, cleft palate, broad digits",
"      </td>",
"      <td>",
"       &nbsp;",
"      </td>",
"      <td>",
"       &nbsp;",
"      </td>",
"      <td>",
"       X",
"      </td>",
"      <td>",
"       &nbsp;",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Stickler syndrome (AD)",
"      </td>",
"      <td>",
"       Cleft palate, micrognathia, myopia, cataracts, spondyloepiphyseal dysplasia, deafness",
"      </td>",
"      <td>",
"       X",
"      </td>",
"      <td>",
"       &nbsp;",
"      </td>",
"      <td>",
"       X",
"      </td>",
"      <td>",
"       &nbsp;",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       LEOPARD syndrome (AD)",
"      </td>",
"      <td>",
"       Multiple lentigenes, pulmonic stenosis, hypertelorism, deafness, genital anomalies",
"      </td>",
"      <td>",
"       X",
"      </td>",
"      <td>",
"       X",
"      </td>",
"      <td>",
"       &nbsp;",
"      </td>",
"      <td>",
"       &nbsp;",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Kartagener syndrome (AR)",
"      </td>",
"      <td>",
"       Situs inversus, immobile cilia, heart defects, splenic anomalies, deafness",
"      </td>",
"      <td>",
"       X",
"      </td>",
"      <td>",
"       &nbsp;",
"      </td>",
"      <td>",
"       &nbsp;",
"      </td>",
"      <td>",
"       &nbsp;",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Cockayne syndrome (AR)",
"      </td>",
"      <td>",
"       Retinal degeneration, senile-like changes, growth retardation, photosensitivity, deafness",
"      </td>",
"      <td>",
"       X",
"      </td>",
"      <td>",
"       X",
"      </td>",
"      <td>",
"       &nbsp;",
"      </td>",
"      <td>",
"       &nbsp;",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Achondroplasia (AD)",
"      </td>",
"      <td>",
"       Short limbs, hydrocephalus",
"      </td>",
"      <td>",
"       X",
"      </td>",
"      <td>",
"       &nbsp;",
"      </td>",
"      <td>",
"       &nbsp;",
"      </td>",
"      <td>",
"       X",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Branchiootorenal syndrome (AD)",
"      </td>",
"      <td>",
"       Branchial anomalies, ear malformations, renal anomalies",
"      </td>",
"      <td>",
"       X",
"      </td>",
"      <td>",
"       X",
"      </td>",
"      <td>",
"       X",
"      </td>",
"      <td>",
"       X",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Klippel-Feil syndrome (sporadic, AD, AR)",
"      </td>",
"      <td>",
"       Fused cervical vertebrae, webbed neck, deafness, CHD",
"      </td>",
"      <td>",
"       &nbsp;",
"      </td>",
"      <td>",
"       X",
"      </td>",
"      <td>",
"       X",
"      </td>",
"      <td>",
"       X",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Duane syndrome (sporadic, AD)",
"      </td>",
"      <td>",
"       Ocular strabismus, ear anomalies, skeletal anomalies, cranial nerve palsies, deafness",
"      </td>",
"      <td>",
"       X",
"      </td>",
"      <td>",
"       &nbsp;",
"      </td>",
"      <td>",
"       X",
"      </td>",
"      <td>",
"       &nbsp;",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Marfan syndrome (AD)",
"      </td>",
"      <td>",
"       Lens subluxation, arachnodactyly, aortic aneurysm, hyperextensibility, deafness",
"      </td>",
"      <td>",
"       X",
"      </td>",
"      <td>",
"       X",
"      </td>",
"      <td>",
"       X",
"      </td>",
"      <td>",
"       X",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Mobius syndrome (sporadic, AD, AR)",
"      </td>",
"      <td>",
"       Cranial nerve palsies, limb anomalies, hypoglossia, micrognathia, deafness",
"      </td>",
"      <td>",
"       &nbsp;",
"      </td>",
"      <td>",
"       &nbsp;",
"      </td>",
"      <td>",
"       X",
"      </td>",
"      <td>",
"       &nbsp;",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Muckle-Wells syndrome (AD)",
"      </td>",
"      <td>",
"       Amyloid nephropathy, urticaria, deafness",
"      </td>",
"      <td>",
"       X",
"      </td>",
"      <td>",
"       X",
"      </td>",
"      <td>",
"       &nbsp;",
"      </td>",
"      <td>",
"       &nbsp;",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Pierre-Robin syndrome (AR, XL)",
"      </td>",
"      <td>",
"       Micrognathia, cleft palate, glossoptosis, deafness",
"      </td>",
"      <td>",
"       &nbsp;",
"      </td>",
"      <td>",
"       &nbsp;",
"      </td>",
"      <td>",
"       X",
"      </td>",
"      <td>",
"       &nbsp;",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Jervell and Lange-Nielsen syndrome (AR)",
"      </td>",
"      <td>",
"       Long QT, deafness",
"      </td>",
"      <td>",
"       X",
"      </td>",
"      <td>",
"       X",
"      </td>",
"      <td>",
"       &nbsp;",
"      </td>",
"      <td>",
"       &nbsp;",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Neurofibromatosis type I (AD)",
"      </td>",
"      <td>",
"       Neurofibromas, cafe-au-lait spots, optic glioma",
"      </td>",
"      <td>",
"       X",
"      </td>",
"      <td>",
"       &nbsp;",
"      </td>",
"      <td>",
"       &nbsp;",
"      </td>",
"      <td>",
"       &nbsp;",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Osteogenesis imperfecta (AD, AR)",
"      </td>",
"      <td>",
"       Fragile bones, blue sclera",
"      </td>",
"      <td>",
"       X",
"      </td>",
"      <td>",
"       &nbsp;",
"      </td>",
"      <td>",
"       &nbsp;",
"      </td>",
"      <td>",
"       X",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Ehlers-Danlos (AD, AR)",
"      </td>",
"      <td>",
"       Joint hyperextensibility, fragile skin",
"      </td>",
"      <td>",
"       X",
"      </td>",
"      <td>",
"       &nbsp;",
"      </td>",
"      <td>",
"       &nbsp;",
"      </td>",
"      <td>",
"       X",
"      </td>",
"     </tr>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     AD: autosomal dominant inheritance; AR: autosomal recessive inheritance; XL: X-linked inheritance.",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f12_21_12638=[""].join("\n");
var outline_f12_21_12638=null;
var title_f12_21_12639="T shaped uterus 2";
var content_f12_21_12639=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F80368&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F80368&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Diethylstilbestrol (DES)-related anomalies: T-shaped uterus",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 352px; height: 208px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Pediatric and Adolescent Gynecology, 6th ed, Emans SJ, Laufer MR (Eds), Lippincott Williams &amp; Wilkins, Philadelphia 2012. Copyright &copy; 2012 Lippincott Williams &amp; Wilkins.",
"    </div>",
"    <div class=\"contractual\">",
"     <br/>",
"     <a href=\"file://www.lww.com\">",
"      file://www.lww.com",
"     </a>",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f12_21_12639=[""].join("\n");
var outline_f12_21_12639=null;
